Molecular genetic analysis of the Drosophila MRL adapter protein in hyperplastic growth and experimental metastasis by Alqadri, NA
  
Molecular genetic analysis of the 
Drosophila MRL adapter  
protein in hyperplastic growth and 
experimental metastasis 
 
Thesis submitted in accordance with the requirements of 
the University of Liverpool for the degree of Doctor in 
Philosophy by 
Nada Ali Alqadri 
April 2016 
 
	  	   ii	  
Declaration  
This thesis is the result of my own work unless otherwise stated, and is based upon 
results from experimental and theoretical work performed as a PhD student between 
March 2012 and April 2016 within the Institute of Integrative Biology at the 
University of Liverpool.  
Neither this thesis nor any part of it has been submitted in support of an application 
for another degree or qualification at this or any other University or Institute of 
Learning.  
 
Nada Ali Alqadri 
April 2016 
	  	   iii	  
Abstract 
Members of the Mig-10/RIAM/Lamellipodin (MRL) family of adapter proteins 
transduce signals derived from growth factor receptors, via interactions with Ras 
GTPases and/or phospholipids, to changes in the actin cytoskeleton, increased cell 
motility, and altered cell adhesion properties. MRL proteins have roles in normal 
development and their overexpression is implicated in tumour development and 
cancer progression. The focus of this thesis has been to explore signalling upstream 
and downstream of the Drosophila MRL protein, encoded by pico, to better 
understand the effects of manipulating its function. This has been done both in the 
developing wing, where overexpressed pico is capable of driving hyperplastic 
overgrowth, and in the larval CNS, where pico cooperates with oncogenic Ras to 
promote both hyperproliferation and cell invasion. An important downstream 
consequence of pico overexpression is thought to be activation of the Serum 
Response Factor (SRF), which responds to changes in actin dynamics through the 
action of its cofactor Mal. An SRF-responsive reporter gene, whose expression 
recapitulates the distribution of SRF protein in the developing wing, has been used to 
provide the first in vivo evidence that pico, and its associated actin regulatory 
proteins, promote SRF signalling. This work has also helped to identify deterin, 
which encodes Drosophila Survivin, as an SRF target that is necessary for pico-
mediated overgrowth of the wing by suppressing proliferation-associated cell death. 
SRF is also likely to be a key effector of pico in the brain, based on genetic evidence 
and the observation that cooperation between pico and oncogenic Ras is restricted to 
two populations of Repo-positive glial cells, which are enriched for SRF expression. 
This work has also explored the involvement of a potential cascade of protein 
phosphorylation upstream of pico using a panel of site-directed mutants in pico 
designed to abolish binding to specific MRL-associated proteins and/or mimic its 
phosphorylation state. Importantly, these findings are consistent with the known 
roles of MRL proteins in promoting growth via changes in the actin cytoskeleton, 
and support the potential involvement of MRL gain-of-function in tumour cell 
invasion and metastasis. 
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1 Introduction 
1.1 Introducing cancer and the characteristics of tumourigenesis 
Statistics point to an alarming rate of cancer incidence in the future. The American 
Cancer Society, ACS, 2010, has predicted that the number of death cases caused by 
cancer will increase to 12 million per year by 2030. Consequently, cancer is 
considered as an enormous health problem worldwide (The American Cancer 
Society, ACS, 2010). The largest percentage of cancer deaths has been dicovered in 
the countries with low- and medium- income due to the unavailability of the 
treatments. Nowadays, number of death cases caused by cancer has exceeded the 
number of deaths due to other major diseases, such as heart disease and stroke. The 
increase of this disease worldwide leads to an urgent need for new medical 
discoveries and inventions in order to prevent and treat this disease. Primarily, 
important discoveries that unravelled the many facets of cancer have been 
discovered due to the biological studies of the disease occurrence and progression.  
 
Amongst the most important of these discoveries has been the identification of 
genes, called tumour suppressor genes, that can act as molecular brakes, preventing 
the onset of tumour formation (Lodish et al., 2000), and genes that act as 
accelerators, acting to promote cancer progression, called oncogenes (Lodish et al., 
2000). Many of these genes encode components of signalling pathways, normally 
acting inside the cell, to transduce extracellular cues, such as growth factors or 
hormones, into the appropriate biological responses. Mutation of tumour suppressors 
or overexpression of oncogenes often leads to aberrant cell signaling events, 
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ultimately triggering a range of inappropriate cellular behaviours, such as 
uncontrolled proliferation or cell invasion, which underpin cancer development 
(Pitot et al., 1981, Schmidt, 2007).  
 
Intensive cancer research over the past decade has highlighted the varied dynamics 
of the disease- its initiation and progression. According to early experiments on 
animal models, cancer was primarily categorised into three stages: Initiation, 
Promotion and Progression (Yamagiwa and Ichikawa, 1977). Initiation might be 
caused for example when a subject is exposed to a DNA reactive agent, causing 
irreversible mutations in the DNA (Pitot, 1993). The cells then proliferate leading to 
formation of daughter cells that also contain the same mutations. This step 
predisposes the cell towards cancer. Promotion was proposed to be the step when a 
non-reactive agent acts on the affected cells through receptors and instigates tumour 
development (Troll and Wiesner, 1985). Progression is the term coined initially by 
Rous, but later extended and applied by a British pathologist Leslie Foulds in 1958, 
to define the development of tumors by multiple, stepwise changes in several “unit 
characteristics”. Foulds described cancer as “a dynamic process advancing through 
stages that are qualitatively different” (Foulds, 1958). 
 
Over the years, based on accumulated knowledge on biochemical and cellular 
processes, Clark (1991) classified the progression of cancer in 4 stages (Clark, 
1991). According to this classification, the first stage is when the effects of 
carcinogens cause lesions that are temporally restricted in growth. These 
proliferations are considered to be uniform and are termed as “Benign tumours”. 
These benign tumors can sometimes take almost half a life span of an individual 
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before symptoms develop and grow into primary cancers. The second stage shows 
abnormal differentiation in the lesion leading to disorganisation of cell growth and 
cytological abnormalities of the neoplasm. The cells do not remain temporally 
constricted but still remain within the tissue of origin and are generically termed as 
carcinoma in situ or in situ malignancy (Chang, 2006). The stage when the 
proliferative lesions are not temporally restricted and move to nearby tissue is the 
third stage and called as the invasive stage. Fourth stage is the final stage when 
cancerous cells can grow over surrounding tissues and sometimes travel from the site 
of origin to various other organs; this stage is known as “metastases.” 
 
Interestingly, studies (Chang, 2006) have shown that every stage is unique in regard 
to its biochemistry and morphology. Each stage is marked by a set of abnormal 
genetic information triggering dysregulated signalling events.  Signalling by the Ras 
GTPase, for example, is known to play important roles in cancer initiation, invasion 
and metastasis (Hanahan and Weinberg, 2000), as discussed in more details in 
Section 1.2. 
 
The hallmarks of cancer involve of six biological capabilities that are acquired 
during a multi-step process of tumor development (Figure 1.1) (Hanahan and 
Weinberg, 2000). The six hallmarks of cancer include sustaining proliferative 
signalling, resisting cell death, enabling replicative mortality, inducing angiogenesis, 
evading growth suppressors and activation invasion and metastasis (Hanahan and 
Weinberg, 2011). These hallmarks of cancer are complementary capabilities that 
enable tumor growth and metastasis and they also provide a foundation for 
understanding the biology of cancer (Hanahan and Weinberg, 2011). 
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Figure 1.1. The hallmarks of cancer. The traits cancer cells acquire, contributing to 
their growth advantage over neighbouring healthy cells. Figure redrawn after 
Hanahan and Weinberg, 2011. 
 
As the comprehension of biological pathways and cellular processes driving cancer 
progression increases, so too do treatment options for patients (Hudis, 2007). 
Surgery, radiotherapy and chemotherapy are the most common forms of cancer 
treatments. Surgery can be used as a treatment of non-haematological neoplasms that 
have not reached metastatic stages. Surgery is also useful in palliative treatment to 
regulate symptoms of bowel and spinal cancers (Nelson et al., 2001).Depending on 
the stage of the tumour, surgery can be used either before or after the other 
treatments with the goal of shrinking the tumour.  
  
Radiotherapy entails the shrinking of tumours and killing of tumourigenic cells 
though irradiation with ionizing radiation (Ettinger et al., 2006, Sheehan et al., 
2010). This form of treatment is localised to the target region, it destroys the 
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malignant genetic composition preventing further division and growth and triggers 
cell death. It is administered in fractions to prevent the extensive damage of normal 
cells. This however depends on the specific radio- sensitivity of the target region and 
its adjacent organs/tissues’ sensitivity (Bange et al., 2001). 
 
Chemotherapy involves the administration of anti-cancer drugs that are either 
cytotoxic or targeted therapies (Bild et al., 2006a). The former inhibit the cell 
division while the latter deregulate cancer-promoting proteins. The combination of 
these drugs is a common undertaking and may have synergistic effects (Hirsch, 
2006). This form of treatment however causes the damage of non-cancerous tissues 
making treatment often hard to tolerate.  
 
The use of genomic technologies has achieved the goal of personalised cancer 
therapies. These therapies have been aided in the identification of targets for new 
drug development that can exclusively attack a given tumor (Garman et al., 2007). 
Imatinib mesylate (Gleevec) and trastuzumab (Herceptin), that have achieved 
therapeutic successes, are examples of drug developments in cancer whereby the 
drug is matched to a specific target, for which assays are available (Fischer et al., 
2003). 
 
Gene expression patterns which reflect the activation status of a number of well- 
defined oncogenic pathways, such as the Ras pathway, have now been identified 
(Bild et al., 2006b). This has aided the identification of cell-based model systems in 
which to test the potential efficacy and specificity of therapeutic agents (Bild et al., 
2006b). It is hoped that the increased specificity of targeted treatments will improve 
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disease outcome and may also reduce the number of side affects that are experienced 
with traditional treatments. However, it is likely that the most effective treatment 
regimes will involve a combination of targeted agents and carefully chosen cytotoxic 
compounds. 
 
1.2 Oncogenic Ras signalling 
Ras (whose name is derived from the Rat Sarcoma) was one of the first proto-
oncogenes identified (Harvey, 1964), and has since been implicated in the 
development of many different types of cancer.   
 
Ras proteins belong to a superfamily of GTPases that can be categorised into several 
sub-families including- Ras (H, K, M and R), Rap (1 and 2) and Ral, with these three 
types sharing more than 50% sequence identity (Matozaki et al., 2000). The Ras 
gene product is a 21 kDa monomeric membrane-bound protein that acts as an 
interlinking switch between receptors and intracellular kinases that form the 
signalling pathway. The Ras proteins have two interconvertible forms: GDP-bound 
inactive and GTP-bound active forms (Figure 1.2). 
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Figure 1.2. The active and inactive forms of Ras proteins. The Ras proteins 
alternate between inactive GDP-bound and active GTP-bound states, reproduced 
from (Cooper, 2000). 
 
 
When Ras protein is bound to GDP it is in an inactive/neutral state. Upon signalling, 
cell surface receptors transmit information to Ras through Guanine nucleotide 
exchange factors (GEFs) that remove GDP, and promotes GTP binding, which is 
vital for Ras GTPase activation. A cascade of Mitogen activated kinases is activated 
in response to Ras, ultimately leading to phosphorylation of transcription factors that 
trigger the expression of genes that promote cell proliferation, growth and cell 
survival. This is identified as a self-limiting process, wherein activated Ras turns off 
immediately with the help of GTPase activating proteins (GAPs) that stimulate 
hydrolysis of GTP to GDP bringing back Ras to its inactive/neutral state. Studies 
have shown that mutations in the Ras gene allow the Ras signalling pathway to be 
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continuously switched “on” giving the cell unchecked permission to continuously 
proliferate, leading to the formation of tumours (Bos, 1989, Ehrhardt et al., 2002).  
 
In addition to promoting tissue growth and tumourigenesis, Ras has been linked to 
metastasis. To define the role of Ras signalling cascades in metastasis, researchers 
have utilised the fruit fly Drosophila melanogaster, which is a genetically tractable 
in vivo model (Miles et al., 2011). 
 
1.3 Using Drosophila melanogaster to Model Tumourigenesis 
The fruit fly Drosophila melanogaster is a model organism that has been widely 
used in research for over a century; more recently, it has proven to be an effective 
system for modelling cancer in vivo. There are several reasons for it being an 
appealing system with which to work, not least the ease of rearing fly stocks in the 
laboratory, its short generation time and the plethora of powerful genetic techniques 
that have been developed over time, thereby allowing the efficient identification of 
genes that give a desired phenotype and their subsequent characterisation. 
Furthermore, both human and flies shared conserved pathways that control the 
cellular biological processes and most of the cancer causing genes found in humans 
are conserved in flies (Miles et al., 2011). For instance, Ras plays a conserved role in 
promoting cell proliferation, growth and survival in flies and human (Legg and 
Machesky, 2004). 
 
A wide variety of in vivo experiments can be performed according to the 
development of the powerful genetic tools in the Drosophila system. For identifying 
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genes involved in the regulation of specific biological processes, such as migration, 
development or growth, large- scale forward genetic screens can be used. In 
Drosophila genome, multiple independent gene mutations can be generated through 
either exposure to mutagens such as EMS (ethyl methanesulfonate) followed by 
chemical mutagenesis, or transposable element insertion using P-elements (St 
Johnston, 2002, Adams and Sekelsky, 2002). Although, this allows screening of a 
large number of genes for a specific phenotype of interest, genes with redundant 
functions often fail to produce a visible phenotype when mutated (St Johnston, 2002, 
Brumby and Richardson, 2005).  
 
Performing mis-expression screens that exploit the yeast GAL4-UAS bipartite 
expression system for inducing tissue specific ectopic gene expression can help to 
avoid the above issue (St Johnston, 2002, Adams and Sekelsky, 2002). In brief, P-
elements carrying the yeast upstream activating sequence (UAS) element and a gene 
of interest are initially inserted into the Drosophila germline. Progeny that have 
incorporated the UAS construct into their genome are consequently crossed to flies, 
which under the control of an endogenous promoter, express the yeast transcriptional 
activator GAL4 in a defined spatial and temporal pattern. Large numbers of 
transgenic GAL4 strains, each under the control of different regulatory elements, are 
publicly available, making this a very flexible technique. Once expressed, GAL4 
binds to the UAS site leading to expression of any gene that lies immediately 
downstream of the activating sequence in the same tissue/temporal specific pattern 
(Figure 1.3) (Adams and Sekelsky, 2002, St Johnston, 2002, Duffy, 2002). 
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Figure 1.3. The Gal4-UAS bipartite expression system. GAL4 gene expression is 
controlled by nearby genetic enhancers. A range of GAL4 enhancer lines are 
available, which express the transcription activator in tissue- and temporal-specific 
patterns. The GAL4 protein binds to any UAS sites present in the Drosophila 
genome and any gene that lies immediately downstream of the activating sequence 
will be expressed in the same spatial and temporal pattern as the GAL4 gene (Adams 
and Sekelsky, 2002, St Johnston, 2002, Duffy, 2002). 
 
The GAL4-UAS system can also be used to knock down expression of genes by 
utilising inverted-repeat constructs that express double-stranded hairpin RNA 
resulting in sequence-specific post-transcriptional silencing of the targeted gene 
through RNA interference (RNAi) (Duffy, 2002). Any phenotype of interest that has 
produced by any gene can be used to identify further genes acting in the same 
pathway. This is achieved by analysing the ability of other genes to enhance or 
suppress the original phenotype (Adams and Sekelsky, 2002, St Johnston, 2002). 
Similarly, known homologues of the genes of interest can be ectopically expressed to 
determine if they can produce similar phenotypes. Lastly, modified proteins 
produced by in vitro genetic alterations can be expressed, enabling the role of 
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various binding domains and post translational modification sites in a given protein 
to be determined. 
 
Mutational analysis using classical mutants has been the mainstay of Drosophila 
genetics. However, analysis of gene function using mutations can be problematic if 
the gene is essential for viability and insects die before the stage of development 
under investigation. The FLP recombinase/FLP recombinase target (FLP/FRT) 
system has been developed to overcome this limitation, by enabling clones of 
homozygous mutant cells to be created in otherwise heterozygous insects 
(Theodosiou and Xu, 1998). This approach is also of particular relevance to cancer 
studies, since it is possible to recapitulate the kind of genetic changes that occur in 
tumour cells residing in otherwise wild type tissue in humans. The FLP/FRT system 
can also be exploited to allow homozygous mutant clone (Golic, 1991). Briefly, 
mitotic recombination between two FRT sites present on homologous chromosome 
arms is driven by tissue or developmental-specific expression of the yeast FLP 
recombinase. Clones of homozygous mutant cells can be produced only when one 
chromosome arm contains a mutant allele of the gene of interest, (Figure 1.4.A) 
(Theodosiou and Xu, 1998). On the other hand, coupling the FLP/FRT 
recombination system with the UAS-GAL4 system results in generating mis-
expression clones. In this instance, induction of FLP recombinase induces 
recombination between two FRT sites flanking a reporter/silencer cassette. The 
removal of this cassette brings the GAL4 gene under the control of a constitutive 
promoter driving its expression of GAL4, which in turn drives the expression of any 
UAS-linked genes (Figure 1.4.B) (Theodosiou and Xu, 1998). 
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Figure 1.4. Generating mosaic clones using FLP/FRT-mediated mitotic 
recombination. (A) FLP enzyme expression induces recombination between FRT 
sites on homologous chromosomes, allowing generating of daughter cells that 
homozygous for a mutant allele. (B) Conversely, activation of FLP can initiate 
recombination between two FRT sites flanking a reporter/silencer cassette leading to 
its excision (Theodosiou and Xu, 1998). 
 
 
1.4 Metastasis at the cellular level 
Tumour cells disseminate either as single cells, using mesenchymal- or amoeboid-
type movement, or as sheet, chains and cluster using collective movement 
mechanisms when leaving the primary mass (Friedl and Wolf, 2003). All these 
different migration strategies are similar or identical to those that are observed when 
normal cells migrate during physiological processes such as wound healing and 
embryo morphogenesis (Friedl and Wolf, 2003). It is assumed that pro-migratory 
signalling pathways are stimulated by genetic changes that occur in tumour cells, 
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causing inappropriate activation of the cell’s normal migration machinery. In vivo 
experiments indicated that there are a number of interdependent steps that occur in a 
continuous cycle to drive movement of cell migration (Friedl and Bröcker, 2000). 
The initial step is when a quiescent, non-motile cell becomes polarized, responding 
to extracellular signals, and reorganises its cytoskeleton into a front ‘moving portion’ 
and a rear ‘retracting portion’. Cellular protrusions, known as lamellipodia and 
filopodia, subsequently form at the leading edge of the cell; the extension of these 
protrusions is driven by actin polymerisation involving both the formation of new 
actin filaments (F-actin) via actin nucleation and the addition of actin monomers (G-
actin) to the fast-growing, barbed ends of pre-existing filaments (Pollard and Borisy, 
2003, Small et al., 2002). This rapid increase in F-actin is restricted to the tips of the 
cellular protrusions where the Arp2/3 complex, which drives actin nucleation, and 
other modulatory factors, such as the Ena/VASP family proteins, are localised (Bear 
et al., 2002, Pollard and Borisy, 2003). The extended protrusions subsequently 
adhere to the substrate over which the cell is moving, thereby providing the traction 
required for the cell to pull itself forward. It is the presence of actin-linked adhesion 
molecules, such as integins, on the outer membrane of the cellular protrusions that 
enable cell-substrate interactions to occur (Hynes, 2002). Finally, adhesions linking 
the trailing edge of the cell to the substrate are disassembled and myosin-driven 
retraction of the cell rear occurs (Hynes, 2002). It is thought that all the migration 
strategies used by motile tumour cells are variations on this basic 4-step model of the 
cell migration (Friedl and Wolf, 2003). 
 
In addition to promoting cell motility, proteolytic degradation mediated by 
extracellular protease activity is required for tumour cell penetration of the basement 
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membrane and other tissue barriers. Protease genes are typically upregulated, 
whereas protease inhibitor genes are typically downregulated in mammalian cancer. 
However, as the production of proteases is also involved in growth signaling and 
angiogenesis it cannot be described as a unique characteristic of metastatic tumour 
cells (Hanahan and Weinberg, 2000). 
 
In Drosophila there are two different approaches that have been adopted to model 
cell migration. Firstly, to identify groups of proteins that could potentially drive 
metastasis if misregulated, researchers have exploited the stereotypical cell 
migration patterns that occur normally during Drosophila development (Jang et al., 
2007). Secondly, to identify genes that can cause inappropriate migration when 
deregulated, researchers have studied the effects of perturbing the function of 
specific tumour suppressors and oncogenes, triggering the acquisition of 
transformation in otherwise non-motile cells. 
 
During Drosophila embryogenesis and oogenesis, single cells and groups of cells 
migrate in a predictable pattern, at a predictable stage. For instance, during 
gastrulation, germ cells actively migrate across the epithelium of the posterior 
midgut before assembling into the gonads (Santos and Lehmann, 2004).  Proteins 
that possess the capacity to regulate cell migration can be identified by 
overexpressing and knocking down genes in the motile cells; this is typically 
achieved by screening for migration events that do not occur, do not reach 
completion, that occur at a different stage to that expected or do not occur on the 
expected trajectory. The main advantage of these models is that the migration 
process occurs in vivo and the entire event can be observed and recorded. 
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In addition to elucidating the mechanisms underlying naturally-occuring forms of 
cell migration, it is also possible to screen for genes that can promote the acquisition 
of motile behaviours in stationary cells. For example, loss of Moesin function in a 
subset of wing imaginal disc epithelial cells results in a loss of apical-basal polarity 
and the adoption of mesenchymal characteristics, with mutant cells exhibiting motile 
behaviour by migrating between wild type epithelial cells (Speck et al., 2003). This 
behaviour has been found to be dependent on the activity of a well-known regulator 
of cell migration, Rhol (Raftopoulou and Hall, 2004). Moreover, for screening of 
genes that can promote invasive cell behaviour when misexpressed, benign tumours 
in Drosophila tissues can be induced through overexpressing/knocking down genes 
that induce overproliferation but not migration (Xu et al., 1995). It is hoped that by 
insights such as these in in vivo models of migration will lead to the indentification 
of genes that could potentially regulate tumour cell invasion and metastasis in 
humans and pave the way for the development of novel anti-metastasis therapies.  
 
1.5 The RA-PH family of adapter proteins 
Adapter proteins play an essential role in the regulation of diverse range of cellular 
activities through the coupling of extracellular signalling events with intracellular 
signal transduction pathways. Although these proteins do not possess any intrinsic 
enzymatic activity themselves, they contain multiple protein and lipid binding 
domains that determine their function through facilitating the formation of various 
protein complexes. These adapter-protein recruited complexes can respond to 
physical/behavioural changes in cell surface receptors and regulate intracellular 
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activity, leading to a diverse array of outcomes, such as changes in cell proliferation, 
cell metabolism and cell motility (Samelson, 2002). 
 
One class of molecular adaptors are the RA (Ras-association) and PH (Pleckstrin 
homology) domain containing proteins. This class of proteins are sub-divided into 
two small but distinct families; the Grb (Growth Factor Receptor-Bound) 7/10/14 
family and the MRL (Mig-10/RIAM/Lamellipodin) family (Figure 1.5) (Shen and 
Guan, 2004, Lafuente et al., 2004). While the MRL proteins can be found in 
Caenorhabditis elegans (C. elegans) and Drosophila melanogaster, Grb proteins are 
only found in higher multicellular organisms; with no orthologues identified in either 
Caenorhabditis elegans (C. elegans) or Drosophila melanogaster, which indicates 
that the acquisition of Grb7/10/14 structure and function has been relatively late in 
evolutionary term (Holt and Siddle, 2005). 
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Figure 1.5. Dendrogram of the full-length proteins of the Grb7/10/14 and MRL 
families. The MRL family (Lpd in red, RIAM in blue, Mig-10 in pink and Pico in 
blak) and the Grb7/10/14 family( in green) represent two distinct sub-groups of the 
RA- PH superfamily. No Grb7/10/14 orthologues are found in C. elegans or 
Drosophila melanogaster. Basic Local Alignment Search Tool (BLAST) algorithms 
were used to identify MRL and Grb homologues in a wide variety of species. 
Sequence alignments and a phylogenetic tree were then performed using Clustal 
Omega. Finally, the tree was visualised using Figtree program. 
 
 
1.5.1 The Grb7/10/14 family 
Grb7, Grb10 and Grb14 constitute the Grb7/10/14 family of adapter proteins and 
they all share a common domain structure; in addition to the central RA and PH 
domains mentioned previously, these proteins also possess an N-terminally located 
proline-rich region, a C-terminal SH2 (Src homology 2) domain and a BPS (Between 
the PH and SH2) domain (Figure 1.6) (Han et al., 2001). 
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Figure 1.6. A schematic representation of the Grb7/10/14 family of proteins. The 
Grb7/10/14 all possess central RA and PH domains in addition to an N-terminal 
proline rich region and a C-terminal SH2 domain. The BPS domain appears to be 
unique to the Grb7/10/14 family. 
 
The Ras superfamily of proteins is prolific signal-transducing GTPases that cycle 
between inactive GDP-bound and active GTP-bound forms as mentioned previously. 
They have been shown to interact with a spectrum of effector molecules enabling 
them to act through various signalling pathways; most notably those involved in cell 
proliferation, cellular adhesion, and membrane trafficking (Bourne et al., 1990, 
Wennerberg et al., 2005). A number of effector molecules can be identified by the 
presence of a Ras-Association (RA) domain, which facilitates the interaction 
between Ras and components of the downstream signalling cascade (Ponting and 
Benjamin, 1996). Accordingly, it has been reported that the RA domains present in 
the Grb7/10/14 facilitate interactions with members of the Ras superfamily. Grb7 
has been shown to bind to N-Ras, K- Ras and R-Ras3 in addition to activated Rap1 
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and Rap2, albeit with a much weaker affinity (Rodriguez-Viciana et al., 2004, 
Depetris et al., 2009). Grb10 and Grb14 have only been found to bind to N-Ras, but 
not Rap1 or Rap2 so far, suggesting that further experimentations are required to 
determine if other Ras family GTPases can interact (Depetris et al., 2009). 
 
PH domains can be found in numerous proteins involved in cellular signalling, they 
are small protein modules typically around 120 amino acids in length (Haslam et al., 
1993, Mayer et al., 1993, Lemmon and Ferguson, 2000). It is thought that these 
domains predominantly function in targeting proteins to the plasma membrane 
through direct interactions with phospholipids (Lemmon, 2007, Rameh et al., 1997). 
In addition to their role in membrane localisation, they have also been shown to 
interact with a small number of proteins, such as isoforms of PKC (protein kinase C) 
and heterotrimeric G-proteins (Wang et al., 1994, Yao et al., 1994). 
 
As expected, the PH domains of the Grb7/10/14 proteins have been shown to interact 
with a range of specific phosphoinositides. Grb7 has been reported to interact 
strongly with PI(3)P and PI(5)P, while only moderate or weak binding was observed 
with PI(4)P, PI(3,5)P2, PI(3,4)P2 and PI(3,4,5)P3 (Depetris et al., 2009, Shen et al., 
2002). The PH domain of Grb10 was reported to have a fairly high affinity 
association with PI(5)P, PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3, whereas Grb14 has  
been found to interact weakly with PI(3,4,5)P3 (Depetris et al., 2009).  
 
The most highly conserved region amongst the Grb7/10/14 family is the SH2 
domain that acts as a phosphotyrosine-binding module, allowing interactions with 
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receptor tyrosine kinases and other intracellular signalling proteins (Holt and Siddle, 
2005). 
 
Despite the high degree of sequence similarity between members of the Grb family, 
the binding preferences of the SH2 domain vary between the proteins. The SH2 
domains have been shown to interact with the activated IP, insulin receptor, in the all 
three Grb7/10/14 members, nevertheless, the affinity association significantly differs 
and may be important in influencing the outcome of IR-dependent signalling (Kasus-
Jacobi et al., 2000, Kasus-Jacobi et al., 1998, Hansen et al., 1996). The SH2 domain 
of Grb7 associates with the cytoplasmic tyrosine kinase FAK (focal adhesion kinase) 
and the receptor tyrosine kinase ErbB2, however both Grb10 and Grb14 do not 
(Frantz et al., 1997, Han and Guan, 1999, Janes et al., 1997). 
 
The BPS domain is unique to Grb7/10/14 proteins and named due to its location 
between the PH and SH2 domains, it is short region approximately 80 amino acids 
long (He et al., 1998). It appears to be intrinsically unstructured yet the isolated 
domain retains physiological activity by interacting with activated IR and IGFR, and 
inhibiting IR catalytic activity (Moncoq et al., 2003, Stein et al., 2001, Béréziat et 
al., 2002). The BPS domain cooperates with the SH2 domain to facilitate interactions 
with tyrosine-phosphorylated signalling molecules, involving receptor tyrosine 
kinases (He et al., 1998). Additionally, despite its high sequence conservation among 
the Grb7/10/14 proteins, it is believed that the BPS domain acts as an important 
receptor-binding determinant to impart specificity amongst the family (Holt and 
Siddle, 2005). 
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Lastly, the N-terminal regions of the Grb7/10/14 proteins contain a conserved 
proline rich sequence in addition to a number of PXXP motifs, enabling interaction 
with Src homology 3 (SH3) domains, such as the SH3 domain of c-Abl (Abelson) 
has been reported to interact, in vitro, with the proline rich region of Grb10 (Frantz 
et al., 1997). Grb10 proline rich regions in the N-terminus have also been shown to 
interact with GIGYF-1 and GIGYF-2 (Grb10-interacting GYF proteins 1 and 2); two 
proteins implicated in EGFR mediated Akt activity regulation, via GYF motifs rather 
than SH3 domains (Giovannone et al., 2003, Ajiro et al., 2010). In addition, the N-
terminal region of Grb14 associate with Tankyrase 2, an ankyrin repeat region of the 
poly (ADP-Ribose) polymerase, in vivo; however, neither the functional significance 
or exact site of this interaction have yet been determined (Lyons et al., 2001). So, far 
no N-terminal binding partners have yet been identified for Grb7. 
 
The three Grb7/10/14 family proteins share significant structural and sequence 
homology, but have been found to regulate distinct cellular activities (Holt and Daly, 
2005), with only some functional overlap existing between Grb10 and Grb14 due to 
their different binding partners (Figure 1.7). 
 
It is thought that Grb7 acts as a positive regulator of cell migration and plays a role 
in tumourigenesis (Holt and Daly, 2005). Overexpression of Grb7 has frequently 
been observed in metastatic cell lines and in clinical tumour samples, usually in 
association with FAK or ErbB2 overexpression (Holt and Daly, 2005, Siamakpour‐
Reihani et al., 2009). Particularly, in a range of breast carcinoma cell lines as well as 
in tissue samples taken from primary breast tumours, Grb7 has been reported to be 
upregulated in conjunction with ErbB2 (also known as HER2) (Stein et al., 1994). In 
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addition, Grb7 and FAK are required for integrin-stimulated cell migration and that 
Grb7/FAK complex formation correlated with the metastatic behaviour of 
esophageal carcinoma cells (Tanaka et al., 2000).  Furthermore, expression of a 
peptide inhibitor, which binds to the SH2 domain of Grb7, has been shown to 
significantly reduce the migratory behavior exhibited by pancreatic cancer cells 
(Tanaka et al., 2006).  Recently, it has been proposed that the rate of tumour cell 
proliferation can be influenced by Grb7. In addition, it has been found that the 
proliferation of breast cancer cells can be suppressed by the expression of the 
aforementioned Grb7-specific peptide inhibitor (Pero et al., 2007). However, the 
ability to regulate cell migration is not shared by Grb10 and Grb14. 
 
Grb10 and Grb14 have been shown to play a key role in the control of cellular 
growth, proliferation and metabolism by directly associating and inhibiting the 
activated insulin receptor (IR); this prevents insulin-induced activation of signalling 
cascades involved in metabolic and mitogenic pathways (Wick et al., 2003, Kairouz 
et al., 2005, Kasus-Jacobi et al., 1998). It has been thought that Grb10 and Grb14 
binding can inhibit the catalytic activity of the IR, and also block access of substrates 
to the activated receptor (Béréziat et al., 2002, Wick et al., 2003, Langlais et al., 
2004). Contradicting this, some studies have indicated that Grb10/14 positively 
regulates insulin signalling. Grb10 reportedly associates with and increases the 
activity of the insulin signalling pathway molecule Akt (Holt and Siddle, 2005). 
Grb14 has been shown to constitutively interact with PDK-1 leading to recruitment 
of the activated IR, Akt phosphorylation and insulin signal transduction (Holt and 
Siddle, 2005, Jahn et al., 2002, King and Newton, 2004) 
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Grb10 has been shown to be involved in controlling cell growth and proliferation, in 
addition to apoptosis. Genomic imprinting and inheritance of a maternal regulate 
Grb10, loss-of-function of Grb10 allele can promote placental and embryonic 
growth, leading to neonates that are 30% larger than wild type progeny 
(Charalambous et al., 2003, Charalambous et al., 2010, Wang et al., 2007). 
Moreover, overexpression of Grb10 results in growth retardation; it has been found 
that transgenic mice with elevated levels of Grb10 are significantly smaller than 
sibling control mice when compared at 3 weeks old (Shiura et al., 2005). 
 
Figure 1.7. The different functions of the Grb7/10/14 family. Grb7/10/14 
interactions play a key role in their functionality (Holt and Siddle, 2005). 
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1.5.2 The MRL family of adapter molecules 
The MRL family of adapter proteins consists of the C. elegans orthologue Mig-10 
(abnormal cell migration protein 10), as well as two mammalian paralogues RIAM 
(Rap1-GTP-interacting adapter molecule) and Lpd (Lamellipodin), and the most 
recently characterised Drosophila orthologue, Pico (CG11940) (Figure 1.8) (Manser 
and Wood, 1990, Lafuente et al., 2004, Lyulcheva et al., 2008, Krause et al., 2004). 
It has been proposed that members of this recently identified family facilitate in 
transducing signals derived from membrane receptors to changes in the actin 
cytoskeleton allowing regulation of actin dynamics, cell adhesion, migration and 
growth (Krause et al., 2004, Lafuente et al., 2004, Lyulcheva et al., 2008, Coló et al., 
2012). Much like the Grb7/10/14 family members, the MRL proteins all contain a 
well-defined central RA domain and PH domain; in addition they possess a number 
of proline-rich regions. While these regions are located at the N-terminus in the 
Grb7/10/14 protein, they are predominatly found in the to C-terminal region of MRL 
proteins, with the exception of RIAM, which contains an N-terminal proline rich 
region. Unlike the Grb7/10/14 proteins none of the MRL protein contains BPS and 
SH2 domains (Figure 1.8). The RA domain is approximately 90 amino acids long, it 
directly interacts with specific Ras-like GTPases, potentially playing a critical role in 
activation of the protein and/or its other associated factors (Holt and Daly, 2005). 
The PH domain has been found to target the MRL proteins to the plasma membrane 
via direct interactions with phosphoinositides, and spans roughly 100 amino acid 
residues (Holt and Daly, 2005, Krause et al., 2004).  
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Figure 1.8. Common structural domains of the MRL proteins. Drosophila Pico, 
human Lamellipodin, human RIAM and C.elegans MIG-10. RA = Ras-association 
domain, PH = Pleckstrin homology domain, P = Proline rich regions. The % refers to 
the identity between the members of the MRL proteins  (Lyulcheva et al., 2008). 
 
The MRL proteins also possess a highly charged N- terminal region around 55 
amino acids in length in addition to the RA and PH domains. Amphipathic helical 
structured talin binding sites have been identified within the first 100 amino acids of 
RIAM and Lpd (Lafuente et al., 2004, Krause et al., 2004, Lee et al., 2009). MRL 
proteins also contain a characteristic 25 amino acid putative coiled-coil motif 
adjacent to the N-terminus of the RA domain, and may function in promoting either 
homodimeric or heterodimeric interactions (Legg and Machesky, 2004, Lupas, 
1996). Finally, proline-rich C-termini have been found in all MRL proteins 
containing multiple FPPPP motifs enabling interactions with EVH1 (Ena/VASP 
homology 1) domains that can be found in the actin regulatory proteins Enabled and 
VASP; together with XPPPP motifs that bind to profilin and other SH3-binding 
motif containing proteins (Coló et al., 2012, Krause et al., 2004, Lafuente et al., 
2004). 
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The two mammalian MRL proteins, RIAM and Lpd, have well conserved RA and 
PH domains, however, the C-terminal and N-terminal regions of these proteins show 
considerable divergence pointing to there being both overlapping and distinct 
functions (Lafuente et al., 2004). RIAM possesses an additional proline- rich region 
with two putative EVH1 binding sites and an extra coiled-coil motif at its N-
terminus that have not found in the other MRL members (Figure 1.8) (Lafuente et 
al., 2004). At its C-terminus, RIAM contains a proline-rich motif including five 
profilin-binding sites and five EVH1 binding motifs, whereas Lpd contains the larger 
C-terminal proline rich region that consists of eight potential SH3 binding sites, six 
EVH1 domain binding regions and three profilin interacting motifs (Lafuente et al., 
2004, Krause et al., 2004). 
 
Profilin and Ena/VASP bind profilin and EVH1 sites respectively; potentially 
facilitating their recruitment towards the leading edge to enable regulation of the 
actin cytoskeleton (Lafuente et al., 2004, Krause et al., 2004). Indeed, RIAM and 
Lpd co-localise with Ena/VASP proteins as well as F-actin at lamellipodia and 
filopodia tips (Krause et al., 2004, Lafuente et al., 2004). In addition, they have been 
found to regulate actin dynamics in an Ena/VASP dependent manner (Lafuente et 
al., 2004, Krause et al., 2004, Jenzora et al., 2005). When overexpressed, RIAM 
induces cell spreading and lamellipodia formation whilst Lpd increases lamella 
protrusion velocity (Krause et al., 2004). Blocking Ena/VASP functionality can 
suppress the increased lamellipodial protrusion velocity that resultd from Lpd 
overexpression (Krause et al., 2004). Contrastingly, lamella formation is reduced 
when knocking down Lpd in addition to reducing actin branching density and F-
actin levels within the lamellipodium; while F-actin quantities is decreased when 
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silencing RIAM (Krause et al., 2004, Lafuente et al., 2004). RIAM and Lpd have 
been shown to bind to Talin through their N-terminal amphipathic helices, leading to 
integrin activation and promotion of cell adhesion (Lafuente et al., 2004, Lee et al., 
2009, Han et al., 2006, Watanabe et al., 2008). Moreover, it has been found that 
RIAM co-localise with Vinculin and actin in early focal adhesions during initial cell 
spreading but is absent in more mature formations (Han et al., 2006). In addition to 
the role of RIAM in controlling actin dynamics and integrin mediated adhesion, it 
has also been shown to regulate the directionality of cell migration and play a role in 
FA disassembly through an integrin-RIAM dependent MEK/Erk activated feedback-
loop (Hernández-Varas et al., 2011, Coló et al., 2012). 
 
RIAM and Lpd also show differences with respect to the binding preferences. RIAM 
has been reported to interact predominantly with active Rap-1, which is a well-
known regulator of integrin activation; it can also bind to active Ras at a lower 
affinity (Lafuente et al., 2004, Bos, 2005). This interaction requires both the RA and 
PH domains, and is enhanced by the RIAM N-terminus (Lafuente et al., 2004c). 
Contrastingly, interaction of Lpd with Rap-1 has not been observed yet, however it 
has been found to associate with active H-Ras, K-Ras, N-Ras, R-Ras and Rac 
(Rodriguez-Viciana et al., 2004, Jenzora et al., 2005, Krause et al., 2004). RIAM and 
Lpd display differential PH domain binding preferences, with RIAM interacting with 
the more common PI(3)P and PI(5)P, whilst Lpd associates with the relatively rarer 
PI(3,4)P2 (Krause et al., 2004, Jenzora et al., 2005, Lemmon, 2008). Since PIs 
represent early polarising molecules during cell activation, the differential binding 
capacities of the Lpd and RIAM PH domains may contribute to the characteristic 
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temporal and spatial localisations observed in these proteins (Lemmon, 2003, Coló et 
al., 2012b). At the cellular level, Lpd is mostly located at the plasma membrane, 
while RIAM is found both in the cytoplasm and in lamellipodia at the leading edge 
of the cell membrane (Lafuente et al., 2004, Jenzora et al., 2005, Krause et al., 
2004). 
 
It is thought that RIAM and Lpd are also regulated by further protein interactions 
and post-translational modifications that lead to tight control over their divergent 
downstream functions. RIAM has been found to be a substrate for the tyrosine 
kinases Fyn, Lck and ZAP-70, in stimulated T cells, enabling the C-terminal proline-
rich region to bind to the SH3 domain of PLC-γ1 (Patsoukis et al., 2009). RIAM 
then assists in the translocation of PLC- γ1 to the actin cytoskeleton where, through 
interactions with PI(4,5)P2, a signalling cascade is initiated by PLC- γ1 that 
increases Ras-GTP formation, MEK/Erk activation, and changes in gene expression 
(Patsoukis et al., 2009). Following phosphorylation of key tyrosine residues within 
Lpd, it can then bind the SH2 domain of c-Abl tyrosine kinase (Michael et al., 2010). 
Abl family kinases are critical regulators of cytoskeletal dynamics they have been 
also implicated in axon guidance in both Drosophila and mammals (Lanier and 
Gertler, 2000). In fibroblasts, phosphorylation of Lpd by c-Abl downstream of 
PDGF regulated formation of dorsal ruffle via recruiting Ena/VASP proteins 
(Michael et al., 2010). Cooperation of Lpd with c-Ab1 has been reported to mediate 
the regulation of axon morphogenesis in primary hippocampal neurons (Michael et 
al., 2010). Lastly, interactions of Lpd with the SH3 domain of srGAP3 (SLIT-ROBO 
Rho GTPase activating protein) in primary fibroblasts can negatively regulate 
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lamellipodial dynamics. It is believed that srGAP3 interacts with Lpd close to the 
membrane, leading to release the binding between Lpd and Rac1, causing inhibition 
of membrane protrusions associated with a reduction in the local Rac1-GTP levels 
(Endris et al., 2011). 
 
Although RIAM and Lpd have both been implicated in cell growth and proliferation, 
the mechanisms by which they act are thought to be different.  It has been shown that 
the reduction in integrin-dependent adhesion in RIAM silenced cells is correlated 
with the reduction in Erk1/2 and PI3K activation, two central molecules controlling 
cell growth and survival (Hernández-Varas et al., 2011). In addition to inhibition of 
anchorage-independent growth, RIAM depleted cells showed reduced tumour 
growth as well as delayed metastasis, suggesting that RIAM mediated activation of 
Erk1/2 and PI3K contributes to cellular proliferation (Hernández-Varas et al., 2011, 
Coló et al., 2012b). Lpd, on the other hand, has been implicated in proliferation of 
mammalian cells by regulation of the Serum Response Factor (SRF), see also 
Section 1.6 below. F-actin levels increased by Lpd leads to depletion of G-actin. 
Consequently, the co-factor MAL is released from G-actin and is transported into the 
nucleus where associated with SRF and induces gene expression.  
(Coló et al., 2012b, Lyulcheva et al., 2008, Pinheiro et al., 2011). The regulation of 
SRF activity via Lpd is also implicated in directing pyramidal neurons to select a 
radial migration pathway along glia rather than a tangential migration mode 
(Pinheiro et al., 2011). 
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Mig-10, the only C. elegans MRL homologue, like all MRL proteins, contains the 
characteristic central RA and PH domains, C-terminal proline rich regions and N-
terminal coiled-coil motif (Manser and Wood, 1990, Coló et al., 2012b). Studies 
have been shown that Mig-10 is required for processes requiring well controlled 
directional migration including long-range antero-posterior migration of embryonic 
CAN (canal- associated neurons), ALM (anterior lateral microtubule cells) and HSN 
(hermaphrodite-specific neurons), as well as efficient development of excretory 
canals used in osmoregulation (Coló et al., 2012b, Manser et al., 1997, Manser and 
Wood, 1990, Chang et al., 2006). However, unlike the other members of the MRL 
family, Mig-10 has not yet been found to play a role in cellular growth and 
proliferation (Coló et al., 2012b). 
 
MIG-10 shares significant homology with Lpd, it contains consensus EVH1 binding 
sites thought to facilitate interactions with members of the Ena/VASP family which 
can then assist in their recruitment to the leading edge, enabling cytoskeletal changes 
and enhancement of migration (Holt and Daly, 2005, Drees and Gertler, 2008). 
Indeed, disrupted embryonic cell migration responses instigated by mig-10 mutants 
resemble those of mutants for unc-34, the C. elegans Ena/VASP orthologue 
(Forrester and Garriga, 1997). Moreover, during neuronal development, MIG-10 and 
UNC-34 act in conjunction to guide the migration of axons toward UNC-6 (Netrin), 
an attractive guidance cue, and away from SLT-1 (Slit), a repulsive guidance cue, 
with UNC-34 required for the formation of filopodia and MIG-10 enhancing their 
numbers (Chang et al., 2006, Quinn et al., 2006). 
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However, double mutants of unc-34 and mig-10 cause much more severe defects 
than either mutant separately, while in unc-34 mutants alone, developing axons that 
lack filopodia are still guided to UNC-6 through MIG-10 mediated lamellipodial 
growth. This suggests that the two proteins may act in overlapping functional 
pathways (Chang et al., 2006). In particular, it is thought that MIG-10 is likely to 
interact with actin polymerisation machinery through additional partner molecules, 
however interactions with UNC-34 through a common pathway are still probable 
(Chang et al., 2006, McShea et al., 2013). 
 
1.6 pico encodes the Drosophila MRL homologue 
Pico is a Drosophila MRL orthologue (CG11940), it is the most recently 
characterised MRL family member (Lyulcheva et al., 2008). pico encodes two major 
transcripts generated from alternative transcription start sites, pico and pico-L. pico-
L encodes a 1159 amino acid protein identical to the shorter form, except for the 
presence of additional 128 N-terminal amino acids (Lyulcheva et al., 2008). 
  
Previous experiments showed that knocking down pico in Drosophila wing discs 
caused a significant reduction in tissue growth through reduced cellular proliferation 
rather than induced apoptosis (Lyulcheva et al., 2008). Further investigations 
demonstrated that homozygous pico mutant clones generated in Drosophila imaginal 
discs also showed severe growth and proliferation defects and were gradually 
extruded from the otherwise wild type tissue (Lyulcheva et al., 2008). Conversely, 
overexpression of pico induced growth at both the tissue and whole organism level, 
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owing to co-ordinated increases in both cell number and size (Lyulcheva et al., 2008, 
Lyulcheva, 2006).  
 
Reduction in pico levels is accompanied by reduction of monomeric (G)-actin levels 
and a concomitant increase in filamentous (F)-actin (Lyulcheva et al., 2008). 
Conversely, when pico is overexpressed, it leads to an increase in G:F actin ratios 
and promotes tissue overgrowth (Lyulcheva et al., 2008). This has led to the 
suggestion that pico induces serum response factor (SRF) signalling, which responds 
to reduced levels of G: F- actin ratios through its co-factor Mal (Miralles et al., 
2003). Overexpression of mal also stimulated tissue growth leading to the suggestion 
that Pico promotes growth via Mal-SRF signalling, (Figure 1.9) (Lyulcheva et al., 
2008). Unpublished data from the Bennett laboratory has also revealed that Pico 
functionally interacts with constitutively active Ras to promote tumour growth and 
invasion (Taylor, 2010). SRF signalling is also implicated in this process, see 
Chapter 4. 
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Figure 1.9. Model of Pico signalling mediating tissue growth. Pico and its 
associated proteins enhance F-actin formation leading to release of G-actin bound to 
MAL. Unbound MAL translocates to the nucleus where it complexes with SRF 
enabling transcription of a subset of SRF Responsive Element (SRE)-containing 
growth-related genes. The figure is  adapted from (Lofthouse, 2013).  	  
Sequence analysis has revealed that Pico contains all the characteristic domains 
found in the MRL proteins, namely an N-terminal coiled motif, the consecutive RA 
and PH domains, and numerous proline-rich regions (Figure 1.8). In addition, 
currently unpublished work performed within the laboratory has identified a highly 
conserved Mitogen Activated Protein Kinase (MAPK) binding site N-terminal to the 
RA domain, which has been shown to interact with the MAPK Erk1/2 in both full-
length Pico and Lpd, and a short fragment of RIAM. Preliminary work has shown 
that bound MAPK may phosphorylate Pico at Serine 819 (a phosphorylation site 
initially identified in a high-throughput proteomics screen), which in turn enables 
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Protein Phosphatase 1 (PP1) to bind at a putative binding site located at residues 
810-817.  
 
1.7 Project aims 
The focus of this project has been to interrogate signalling upstream and downstream 
of pico, to better understand the effects of manipulating its function. This has been 
done both in the developing wing, where overexpressed pico is capable of driving 
hyperplastic overgrowth (Chapter 3), and in the larval CNS, where pico cooperates 
with oncogenic Ras to promote both hyperproliferation and cell invasion (Chapter 
4). A key focus has been to explore the involvement of SRF signalling, making use 
of a range of genetic tools including an in vivo reporter for SRF, which is 
characterised here for the first time. In addition, a panel of site-directed mutants in 
pico, including a Protein Phosphatase 1 binding site mutation, non-phosphorylatable 
and phosphomimetic (SD) mutations of S819 and mutation of the MAPK binding 
site, have been used to test the effect of specific regulatory interactions on pico 
function.  (Chapter 5). Insights gained from this work are likely to feed into studies 
being conducted in more complex organisms, including mammals, and may have 
relevance to our understanding of cancer development or progression. Furthermore, 
a better understanding of the regulation of MRL signalling may make the affected 
pathways open to pharmacological manipulation. 
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2 Materials and methods 
2.1 Commonly used media and solutions 
2.1.1 Lysogeny broth (LB) Media 
LB medium essential for growth of bacterial strains. It is composed of 1.0% (w/v) 
Tryptone, 0.5% (w/v) Bacto-yeast Extract and 1.0% (w/v) NaCl dissolved in pure 
deionised water with a pH of 7.0. The solution has to be autoclaved before use. 
2.1.2 LB Agar 
LB agar Required for growth of bacterial strains on solid plates. It is comprised of 
1.0% (w/v) Tryptone, 0.5% (w/v) Bacto-yeast Extract, 1.0% (w/v) NaCl and 1.6% 
(w/v) agar dissolved in in pure deionised water with a pH of 7.0. The mixture has to 
be autoclaved and left to cool to 55°C before pouring the mixture into plates to set, 
an appropriate antibiotic has to be added. Plates can be stored at 4°C. 
2.1.3 Complete Schneider’s Insect Medium (S2)  
Drosophila Medium ((with L-glutamine and sodium bicarbonate, Sigma)  modified 
with 10% (v/v) heat-inactivated Foetal Calf Serum (FCS, Gibco) and Penicillin- 
Streptomycin (Invitrogen) to a final concentration of 50 units Penicillin G and 50 µg 
Streptomycin sulphate per millilitre of medium. 
2.1.4 Tris-EDTA (TE) Buffer (Sigma)  
Using For resuspension of DNA: 10mM Tris-Cl pH 7.5 and 1mM EDTA 
(Ethylenediaminetetraacetic acid). 
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2.1.5 ChromoTek lysis buffer 
ChromoTek lysis buffer contains 10 mM Tris- Cl pH 7.5, 150 mM NaCl, 0.5 mM 
EDTA, and 0.5% (v/v) NP-40. 
It has been optimised by the manufacturer for GFP-Trap co- immunoprecipitation 
and enables efficient cell lysis and protein solubilisation while avoiding protein 
degradation and interference with the proteins immunoreactivity and biological 
activity.   
2.1.6 2x SDS-Sample Buffer 
Laemmli sample buffer (Sigma) was used for preparation and loading of protein 
samples onto an SDS- polyacrylamide gel for SDS-PAGE and Western Blotting. It is 
composed of 4% SDS, 20% glycerol, 10% (v/v) 2-mercaptoethanol, 0.004% (w/v) 
bromophenol blue and 0.125M Tris-HCl, pH 6.8. 
2.1.7 1x SDS-PAGE Running Buffer 
1x SDS-PAGE running buffer allows protein separation by SDS-polyacrylamide gel 
electrophoresis to occur and is comprised of 25 mM Tris (Anachem), 250 mM 
glycine (Anachem) pH 8.3 and 0.1% (v/v) SDS dissolved in pure deionised water. 
2.1.8 Tris-glycine Transfer Buffer 
Tris-glycine transfer buffer enables protein transfer from SDS-polyacrylamide gels 
to nitrocellulose membrane. The solution is comprised of 25 mM Tris, 193 mM 
glycine and 20% (v/v) methanol in pure deionised water. 
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2.1.9 PBS (Phosphate Buffered Saline)/PBST 
PBS is a buffer solution designed to replicate the osmolarity and ion concentrations 
of normal cells and is composed of 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 
and 1.46 mM KH2PO4. PBST is made up of 1 x PBS with 0.1% (v/v) Tween-20. 
2.1.10 Tris-buffered saline with Tween (TBST)  
For washing nitrocellulose membranes for during western blotting: 150mM NaCl, 
10mM Tris-HCl and either 0.1% or 0.05% (v/v) Tween-20 (Sigma) diluted in pure 
deionised water. 
2.1.11 Blocking buffer (Western Blots) 
5% (w/v) Marvel skimmed milk powder  in PBST or 5% (w/v) Bovine Serum 
Albumin (BSA, Sigma Aldrich) in 0.05% TBST. 
2.1.12 3.7% (w/v)  Paraformaldehyde (Sigma)  
A 37% stock was made by dissolving 0.185g in 500µL  1 x PBS (+7µL 1M NaOH to 
aid solubilisation) at 95°C for 5 minutes before diluting in  1X PBS to make a 3.7% 
solution for fixation of Drosophila tissue.  
2.1.13 Blocking solution (Drosophila tissues)  
1 x PBS, 5% (w/v) Fetal Bovine Serum, 0.1% (v/v) Triton X-100. 
2.1.14 PBST (Drosophila tissues)  
1 x PBS, 0.1% (v/v) Triton X-100. 
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2.2 Commonly used strains 
2.2.1 Bacterial lines utilised 
One Shot® Top 10 chemically competent E. coli (Life Technologies) F- mcrmrr-
hsdRMS-mcrlaclacX74 recA1 araara-leu) 7697 galU galK rpsL (StrR) endA1 nupG. 
2.2.2 Cell lines used 
• Drosophila Schneider Receptor + (S2R+) Cells 
Drosophila Schneider Receptor + (S2R+) cells are a line derived from the Schneider 
laboratory, which possess the wingless receptors Dfrizzled-1 and Dfrizzled-2 and 
formed a highly adherent monolayer in tissue culture flasks (Yanagawa et al., 1998). 
• Initiating cultures from frozen stocks  
To initiate cultures from a frozen stock, cells need to be quickly thawed at 30oC then 
transferred to a 25cm
2 
flask containing 5 ml of room temperature complete 
Schneider’s Medium. The cells were resuspended in and centrifuged at 1000 x g for 
5 minutes then incubated at 28oC for 30 minutes the supernatant was discarded to 
remove DMSO present in the storage medium. The cells were resuspended in 10ml 
fresh complete Schneider’s medium and split into 2 25cm2 tissue culture flasks (5ml 
each). Next, cells were incubated at 28oC for 3-4 days until they reached a density of 
6-20 x10
6 
cells/ml. 
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• Passaging S2 cells 
When cells reached an optimum density of 6-20 x 10
6 
cells/ml, the most adherent 
cells were selected for by gently tapping the flask to remove the least adhered cells 
and discard the excess. Then, 10 ml was added of fresh complete medium and by 
pipetting up and down the conditioned medium several times the clumps of cells will 
be broken and wash the surface of the flask to remove adherent cells. The cells were 
split at a 1:2 to 1:5 dilutions into new culture vessels and fresh Complete S2 Medium 
added to create a final density of 2-4 x 10
6 
cells/ml. The cells were then incubated at 
28oC until an optimum density was reached. 
• Freezing S2 cells 
 To create a frozen stock, cells were grown to a density of 1-2 x 10
7 
cells/ml and 
pelleted by centrifuging at 1000 x g for 5 minutes. The cells were then washed in 10 
ml PBS and pelleted again before being resuspended at a density of 1.1 x 10
7 
cells/ml in Freezing Medium (45% (v/v) conditioned Complete S2 Medium, 45% 
(v/v) fresh Complete S2 Medium, and 10% (v/v) DMSO). 1 ml of the cell 
suspension was aliquoted per vial and the cells were frozen in a control rate freezer 
to - 80oC for 24 hours before being transferred to liquid nitrogen for long term 
storage. 
2.3 Growth and maintenance of Drosophila 
Fly stocks were kept at 18°C, 22°C or 25°C on standard yeast/dextrose medium (1% 
(w/v) agar, 7.3% (w/v) dextrose, 5% (w/v) yeast, 6.7% (w/v) organic wholemeal 
flour, 0.25% (v/v) nipagin, 0.3% (v/v) propionic acid) in 30/50ml vials or 250ml 
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bottles as appropriate. Flies were anaesthetised with CO2 and examined using Nikon 
SMZ-645 or Nikon SMZ-800 microscopes and Photonics 200 light sources using 
standard fly-pushing techniques (Roberts, 1998, Greenspan, 2004). Fly stocks were 
ordered from the Vienna Drosophila RNAi Centre (VDRC, Austria), The National 
Institute of Genetics (NIG-FLY, Japan) and The Bloomington Stock Centre (Indiana, 
USA). Crosses were kept at 25°C and transferred to fresh vials every 2-3 days. 
 
2.3.1 Drosophila GAL4 stocks employed 
• da-GAL4  
w; 13B/CyO; da-GAL4/MKRS Ubiquitous expression of GAL4 under the control of 
daughterless. 
• en-GAL4  
w; enGAL4/CyO Expresses GAL4 in the posterior compartment of embryonic 
segments in the pattern of the engrailed gene. 
• hs-GAL4  
w; hsp70-GAL4/ hsp70-GAL4 Heat shock inducible ubiquitous expression of GAL4. 
 
• MS1096-GAL4  
MS1096-Gal4 on X Expresses GAL4 across the wing pouch in early third instar 
larval wing discs and predominantly in the in dorsal half of the wing disc in mid-late 
third instar larvae. 
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2.4 Polymerase Chain Reaction (PCR) 
2.4.1 Taq Polymerase (Qiagen)  
The Taq PCR Master Mix Kit (Qiagen) was used for all PCR reactions where not 
specified. Reactions were set up in a final volume of 20µl as shown in (Table2.1) . 
Conditions for most PCR reactions are shown in (Table2.2). 
Table 2.1. PCR reaction components 
 
 
	  
	  
 
	  
 
 
  
 
Component Volume 
(µl) 
Mastermix 10 
Forward Primer (10µM) 1 
Reverse Primer (10µM) 1 
cDNA (~2µg) - 
H2O to 20 
 
Table 2.2. PCR reaction conditions 
Temperature (°C) Time No of Cycles 
94 3 min 1 
92 
54 
72 
30s 
30s 
40s 
 
30 
72 40s 1 
4 ∞ - 
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2.4.2 Pfx PCR 
 Pfx amplification was done using the Platinum® Pfx DNA Polymerase Kit 
(Invitrogen). Reactions were set up in a 20µl volume. Reaction components 
(Table2.3) and reaction conditions (Table2.4) are shown below.  
 
 
 
Table 2.3. Pfx amplification reaction components 
Component Amount 
10 × Pfx amplification buffer 2µl 
50mM MgSO4 0.4µl 
10mM dNTPs (Qiagen) 0.6µl 
10µM Forward Primer 1µl 
10µM Reverse Primer 1µl 
Pfx enzyme 0.25µl 
Vector clone DNA 50ng 
H2O to 20µl 
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2.5 List of oligonucleotides 
All oligonucleotides were designed using primer3 and synthesised by MWG 
Biotech. The primers were diluted in TE buffer (Sigma, pH 8.0) according to the 
manufacturer’s recommendations to make 100 µM stock and stored at -20 oC. A 
dilution of 10 µM was made with ultrapure water to use for PCR and sequencing 
reactions. Sequencing was performed by GATC Biotech. 
• Making	  double	  mutation	  
       -F816A+: 5’- CAGAAGAAGGTCTCCGCCGCCGATGACCCCGTG -3’ 
-F816A-: 5’- ACGGGGTCATCGGCGGCGGAGACCTTCTTCTGGG - 3’ 
• Primers	  for	  testing	  pico	  insertion	  
-M13-fwd: 5’- TTGTAAAACGACGGCCAGTC - 3’ 
-M13-rev: 5’ -TGCCAGGAAACAGCTATGAC -3’ 
• Sequencing	  primers	  for	  pico	  constructs	  
-Pico_Seq1: 5’- GGCATGATGGTCCAACCGC  -3’ 
Table 2.4. Pfx reaction conditions 
Temperature (°C) Time No of Cycles 
94 3 min 1 
92 
55 
68 
20s 
30s 
2min/kb 
 
30 
68 10min 1 
4 ∞ - 
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-Pico_Seq2: 5’- GGGCTGCGGACACGTGACC  -3’ 
- Pico_Seq3: 5’- CTGTTCCACGGCCACAACGTG -3’ 
- Pico_Seq4: 5’- ACGCCTTCGATAGCGAGTTC  -3’ 
- Pico_Seq5: 5’- GCTGTCGCTGGCCTCCCTG -3’ 
- Pico_Seq6: 5’- TGAGCAGCCTGTCCAACGGC -3’ 
2.6 Agarose gel electrophoresis 
DNA molecules were separated by size using agarose gel electrophoresis. According 
to Sambrook, 2001, agarose gels were prepared and run. Ethidium bromide (Sigma) 
was added to the gel at a final concentration of 0.2-0.5 µg/ml. 1 X loading buffer (10 
X agarose loading buffer, 30% (v/v) glycerol, 0.35% (v/v) bromophenol blue) were 
added to samples before being loaded on the gel. The samples were electrophoresed 
in 1 x TAE at 100 volts for 30-45 minutes, using a GIBCO BRL electrophoresis 
power supply and Fisher Brand gel tank. To determine DNA concentration as well as 
fragment size, 5µl SmartLadder I (Eurogentec), a molecular weight marker, or 
Hyperladder I (bioline) was loaded. An ultraviolet light source (UVi-tech) was used 
to visualise the DNA fragments and documented with a PULNiX TM-300 video 
camera system and Syngene UP-895MD video graphic printer. 
2.7 Gel extraction 
DNA fragments were cut from the gel using a scalpel blade under a UV light then 
purified using the QIAquick Gel Extraction Kit (Qiagen) according to 
manufacturer’s instructions. Briefly, agarose was dissolved in an optimised buffer 
containing a pH indicator, to determine the optimal pH for DNA binding. DNA is 
purified by binding to an anion-exchange membrane, washed and eluted in an 
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appropriate volume of TE buffer. DNA could only be semi-quantified by gel 
electrophoresis because of the nature of the protocol. 
2.8 Restriction digestion 
Restriction digests were performed using enzymes and compatible buffers (New 
England Biolabs) as per the manufacture’s guidelines. Typically, 20 µl reactions 
were carried out using 1×enzyme buffer, 0.4-1µl (3 units) of each enzyme, 0.2µl 
BSA and 0.3/0.4µg DNA for diagnostic digests or 1µg DNA for gel purification. For 
double or triple digests, buffers compatible with all enzymes were used. Reactions 
were incubated at 37°C in a hot block or water bath for 2-3 hours or at 25°C (room 
temperature) overnight. 
2.9 DNA ligation 
Products produced from the digestion step were run on an appropriate percentage 
agarose gel and the gel extraction protocol was used for fragments extraction. 
Complementary linear DNA fragments formed from digestion and extraction were 
ligated into circular plasmids using a T4 DNA ligase Kit (Roche). For ligation, two 
fragments totalling an approximate 3:1 molar ratio of insert:vector were used The 
following equation was used to calculate appropriate amounts of DNA to use for a 
3:1 molecular ratio:                                   !"  !"  !"#$%&  ×  !"  !"#$  !"  !"#$%&!"  !"#$  !"  !"#$%&            ×   Insert: vector molar ratio= ng of insert  
Depending on experimental success, molecular ratios could be altered. One unit of 
T4 DNA ligase was incubated with a total of 100 ng of DNA in T4 reaction buffer 
(Roche). Reaction volumes were kept at 20 µl as per manufacturer’s guidelines. 
Reaction mixtures were incubated at 16°C for 20 hours before 2-4µl of the ligation 
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reaction was transformed into One Shot® Top 10 chemically competent E. coli (Life 
technologies). Ligations were screened by PCR and restriction digestion before 
sequencing was carried out. 
2.10 Gateway LR Recombination Reaction 
The Gateway LR Clonase™ II Enzyme Mix (Life Technologies) was performed to 
shuttle the Pico wild type and mutant construct from the entry vector pDONRTM221 
into the desired   destination vectors pTVW (Drosophila Genomics Resource 
Center). Giving a final volume of 8 µl, 50 -150 ng of the entry clone containing the 
gene of interest was mixed with 1µl (150ng/µl) of the destination vector and TE 
buffer pH 8.0. Before adding 2 µl of the LR Clonase™ II Enzyme Mix to the 
reaction, the enzyme mix was thawed on ice for 2 minutes then vortexed briefly. 
Reactions were incubated at 25oC for a minimum of 1 hour, although overnight 
incubation is recommended for large plasmids (over 10 kb). Following incubation, 
the reaction was stopped by adding 1 µl of Proteinase K (Invitrogen) solution and 
incubated at 37oC for 10 minutes. 1 µl of the reaction mix was then transformed into 
One Shot® Top10 Chemically Competent Cells (Life Technologies). The 
transformed cells were plated onto ampicillin-LB agar plates and incubated at 37oC 
overnight. Colonies were screened by restriction digestion. 
2.11 Transformation of TOP10 chemically competent cells 
For every two transformations, one vial (50µl) of One Shot® Top10   Chemically 
Competent Cells (Life Technologies) was thawed on ice split between two fresh 
microcentrifuge tubes and 1-5 µl of the DNA added and mixed gently, incubating the 
cells on ice for 30 minutes, then heat shock at 42oC for exactly 30 seconds. 
Following, the cells were placed on ice for two minutes and 200 µl of pre-warmed 
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S.O.C Medium (Life Technologies) was added to each reaction. In a shaking 
incubator the microcentrifuge tubes were placed horizontally at 225 rpm for 1 hour 
at 37oC before spreading each transformation reaction on pre-warmed selective LB 
agar plates using sterile technique. The plates were inverted and incubated overnight 
at 37oC. 24 hours later colonies were picked using sterile technique and propagated 
in 6ml LB broth plus selective antibiotic overnight at 37°C with shaking at 225rpm. 
Plasmid DNA was purified as in 2.12. 
2.12 DNA extraction from culture  
Small-scale plasmid purification (≤20 µg) was carried out using QIAprep Spin 
Miniprep Kits (Qiagen), while medium ( ≤100 µg) and large-scale (≤2.5 mg) plasmid 
purification was carried out using QIAfilter Plasmid Midi kits or Mega kits (Qiagen) 
respectively according to the manufacturer’s instructions. Briefly, in selective LB 
media cells were grown overnight then, were pelleted at approximately 4500rpm for 
5 minutes and the supernatant removed. Cells  were then lysed under alkaline 
conditions and debris removed by centrifugation (mini) or filtering (midi). Clear cell 
lysates were applied to columns containing a silica gel membrane capable of binding 
DNA, yet allowing contaminants to be washed away. DNA was eluted from the 
columns with an appropriate volume of Qiagen Elution Buffer or TE buffer. The 
concentration of DNA obtained was then measured using a NanoDrop (see section 
2.13). DNA was stored at -20°C until use. 
2.13 DNA quantification 
A Thermo scientific NanoDropTM 1000 Spectrophotometer was used for quantifying 
DNA concentrations according to the manufacturer’s instructions. The NanoDrop 
uses a 1-2 µl sample held in place by surface tension of the liquid and measures 
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absorbance of the sample over a 220nm-750nm spectrum, reporting DNA 
concentration and relative purity of the sample with 230/260 and 260/280 ratio 
measurements. DNA could also be semi-quantified by analysing the intensity of 
DNA run on an agarose gel compared to reference ladder of known concentration. 
2.14 Vector storage  
Working purified DNA stocks were stored at -20°C. A frozen bacterial stock of each 
vector was prepared by adding glycerol to cultures to a final concentration of 15% 
and stored at -80°C.  
2.15 DNA sequencing 
DNA sequencing was carried out by GATC Biotech (Germany), (http://www. gatc- 
biotech.com/en). DNA was provided for a total of 6 reactions at a concentration of 
30- 100 ng/µl (typically 50ng/µl) in a total volume of 20 µl DNA diluted in ultra 
pure ddH2O.  
2.16 Insertion of constructs into flies 
Transgenic flies expressing the Venus tagged Pico constructs under the control of the 
upstream activator sequence (UAS) were generated through P-element mediated 
germline transformation by Genetic Services Inc (Cambridge, MA, USA) (Rubin 
and Spradling, 1982, Sentry and Kaiser, 1992). The Pico constructs were injected 
into w1118 embryos along with the helper plasmid pUChsDelta2-3, which provided 
a source of P-element transposase. The progeny were screened for non-white eyes 
indicating that the constructs, which carried a white+ minigene, had successfully 
been transformed into the germline cells. The chromosome harbouring each 
independent insert was determined by crossing individual transgene-carrying males 
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to w; Tft/CyO and then crossing the progeny to w; Tft/CyO; MKRS/TM6B. Each 
insert was then balanced with an appropriate, dominantly marked, balancer 
chromosome (Greenspan, 2004). Verification and analysis of ectopic protein 
expression was carried out by visualisation of fluorescent Venus in larvae carrying 
the engrailed-GAL4 driver and one copy of the transgene of interest or by western 
blot using GFP antibody. 
2.17 Transfection of S2 and S2R+ cells 
2.17.1 Transient transfection with Effectene®  
For transient transfection in 6 well dishes, S2R+ cells were plated at 2 × 106 cells in 
4ml complete Schneider’s medium (approximately 60% confluency) and allowed to 
adhere for a minimum of 2 hours under normal conditions. Before transfection, the 
Schneider’s medium was removed and replaced with 1.6ml of fresh medium. The 
cells were then transfected using the Effectene® Transfection Reagent as per 
manufacturer’s instructions (Qiagen). Briefly, 0.8 µg of total plasmid DNA was 
diluted with EC buffer to a volume of 100µl and condensed by adding 6.4µl of 
Enhancer. The mixture was vortexed for 1s, incubated for 5 minutes at room 
temperature and then centrifuged briefly. 20µl of Effectene transfection reagent was 
added to the DNA-enhancer mixture, mixed by gently pipetting up and down then 
incubated for 15-20 minutes at room temperature to allow complex formation. 600µl 
of fresh complete Schneider’s medium was added to the transfection tube, mixed by 
pipetting up and down twice and directly added drop-wise onto the cells in the 6-
well plates. Swirling the plates gently to ensure the transfection solution was 
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properly diffused. Cells were incubated for 48-72 hours following transfection to 
enable suitable gene expression. 
2.18 Immunoprecipitation 
2.18.1 GFP-Trap immunoprecipitation of GFP tagged proteins  
Cells were pelleted by centrifugation at 4000 rpm for 3 minutes and the supernatant 
removed. For immunoprecipitate GFP tagged proteins, the magnetic GFP-Trap®_M 
kit (Chromotek) was used. 125 µl of ChromoTek lysis buffer (plus 1mM PMSF 
[SIGMA] and 1×Protease Inhibitor Cocktail) was added to each sample for 
resuspening the cells. The samples were placed on ice for 30 minutes with extensive 
pipetting every 10 minutes. The lysate was then centrifuged at 13,000 rpm for 10 
minutes at 4°C to pellet the cells before the supernatant was carefully removed using 
a pipette, transferred to a pre-cooled 1.5 ml labelled eppendorf tube and set on ice. 
The supernatant was diluted to 500 µl with ice-cold Chromotek dilution buffer (plus 
1mM PMSF and PIC). 50 µl samples were removed to act as a positive control. 
Next, 20 µl of GFP-Trap magnetic beads were equilibrated by washing three times in 
500 µl ice cold ChromoTek dilution buffer. Between each wash step the beads were 
pulled down using a DiaMag1.5 magnetic separator (Diagenode) and the buffer 
removed. Once equilibrated, the Drosophila lysate was added to the beads and 
subjected to over-end mixing for 2 hours at 4°C. Following the 2 hour incubation, 
the GFP-Trap beads were pelleted using the magnetic separator and the supernatant 
removed. The beads were then washed two times with 500 µl ice cold ChromoTek 
dilution buffer before being boiled for 20 minutes in 100 µl 2x SDS-Sample buffer at 
95°C. The beads were once again pulled down using the magnetic separator and the 
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remaining supernatant transferred to a 1.5ml tube and loaded onto a polyacrylamide 
gel for SDS-PAGE (see section 2.19) or stored at -20°C until use.  
2.19 SDS-PAGE 
Proteins were separated on the basis of molecular weight on SDS-polyacrylamide 
gels as described in Sambrook, 2001. In brief, The protein extracts were run on Tris-
buffered SDS-polyacrylamide gels, made according to Table 2.5 or purchased from 
Bio-Rad (7.5% or 12% Mini-PROTEAN® TGX™ Precast Gels), in 1 x Running 
Buffer, with the acrylamide concentration of the separating gel varying depending on 
the size of the proteins being separated.  5µl Precision Plus Protein™ WesternC™ 
prestained protein standards (Bio-Rad) was employed to allow the size of separated 
proteins to be estimated.  Mini-Protean II Vertical Electrophoresis apparatus (Bio-
Rad) was used according to manufactuer’s instructions. Samples were run at 
approximately 100 volts with time varying depending on the size and level of 
separation required. 
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2.20  Western blotting 
Following sufficient separation of proteins by SDS-PAGE, proteins were transferred 
overnight at 25 volts and 4oC onto a nitrocellulose membrane (Amersham Hybond 
ECL, GE Healthcare). Before setting up the transfer apparatus the membrane was 
pre-wetted in Tris-Glycine transfer buffer, using Bio- Rad electrophoretic transfer 
apparatus as per manufacturer’s instructions. After blotting, membranes were stained 
briefly with Ponceau S solution (Sigma Aldrich) to determine adequate 
Table 2.5. Components for SDS-PAGE gels 
Component Separating Gel (10ml) Stacking gel 
(5ml) 6% 8% 10% 12% 14% 
40% 
Acrylamide 
(Sigma) 
1.5ml 2.0ml 2.5ml 3.0ml 3.5ml 0.625ml 
1.5M Tris-
HCl pH 8.8. 
2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 
1M Tris-
HCl pH 6.8 
- - - - - 0.63ml 
10% SDS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
DdH2O 5.9ml 5.3ml 4.8ml 4.4ml 3.9ml 3.6ml 
10% APS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
TEMED 5µl 5µl 5µl 5µl 5µl 5µl 
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electrophoretic transfer and to label the lanes with a pencil. Membranes were rinsed 
with water and 0.1% PBST or TBST to remove the stain. 
Membranes were incubated in blocking buffer (PBST or TBST + 5% w/v Marvel 
skimmed milk powder) for 90 minutes, at room temperature, to reduce non-specific 
binding of the antibody before being incubated for overnight at 4°C with a suitable 
primary antibody, diluted in blocking buffer, under optimised conditions detailed in 
Table 2.6 Membranes were then washed three times in PBST or TBST for 10 
minutes and incubated with an appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibody (Table 2.7), plus StrepTactin-HRP conjugate (1:10,000, Bio-
Rad) for detection of the protein standards in blocking buffer for 2 hours at room 
temperature on a roller. Next, membranes were washed three times in PBST  or 
TBST for 10 minutes and once in PBS for 10 minutes. SuperSignal® West Pico 
chemiluminescent substrate (Pierce) was used to detect the HRP-conjugated 
secondary antibodies on the membrane. The chemiluminescent signal was detected 
and imaged using the ImageQuant™ LAS 4000 Biomolecular Imager (GE 
Healthcare) or by exposure to Amersham Hyperfilm ELC (GE healthcare) for a 
length of time dependent on the signal intensity and then developed and fixed using 
Kodak GBX developer and fixer according to the manufacturer’s instructions. 
	  	   54	  
 
 
 
Table 2.7. Secondary antibodies used in western blots 
Secondary 
Antibody 
Supplier Species Concentration 
 
Anti-mouse HRP 
 
Cell Signalling 
 
Goat 
 
1:2000  
Anti-rabbit HRP Cell Signalling Goat 1:2000 
Anti-rat HRP Cell Signalling Goat 1:2000 
 
Table 2.6. Primary antibodies used in western blots 
Primary Antibody   Supplier Species Concentration     
                     
          MAPK Cell Signalling Rabbit    1:2000 
          RFP 
          SRF 
          GFP 
       β -Actin   
     
Chromotek 
Active Motif 
Life technologies 
Merck Millipore 
Rat 
Mouse 
Rabbit 
Mouse 
   1:1000 
   1:200 
   1:1000 
   1:1000000 
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2.21 Western blot analysis 
A membrane was scanned and intensity was computed using Image Studio Lite 
software V5.2 (LiI-COR Biotechnology, UK Ltd). For relative quantification, equal 
sized rectangular boxes for each antibody were drawn around images of the bands 
and the mean value for each protein band was calculated. To correct for slight 
loading differences, the intensity of each band was divided by that of actin. Finally 
the mean values of three separate experiments ± SE were recorded. 
2.22 Dissection and Immunofluorescence 
2.22.1 Dissection and staining of wing and eye discs for fluorescence microscopy 
Tissues were dissected from wandering third instar larvae in cold 1× PBS, 
transferred to a watchglass, and fixed with 3.7% (v/v) paraformaldehyde in PBS for 
20 minutes at room temperature.  Tissues were subjected to three 10-minute washes 
with 1× PBS and then blocked with PBST + 5% (v/v) FCS for 30 minutes at room 
temperature or a minimum of 2 hours at 4°C. tissues were then incubated with 
primary antibodies diluted in PBST + 5% (v/v) FCS (Table 2.8) overnight at 4oC and 
then washed a further three times((10 minutes per wash) in PBST. Secondary 
antibodies diluted in PBST + 5% FCS (Table 2.9) added to the tissues and incubated 
at room temperature in the dark for two hours. The tissues were then subjected to a 
further two 15 minutes PBST washes and one 15 minutes wash in PBS. Lastly, 
tissues were mounted in 17.5µl of Vectashield mounting medium (Vector 
Laboratories) on a standard glass microscope slide and covered with a coverslip 
(22mm × 22mm). The slides were sealed with clear nail polish and slides stored in 
the dark for no longer than a week at 4oC. 
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Table 2.8. Primary antibodies used in wing and eye discs staining 
Primary Antibody Supplier    Species Concentration 
         
   Anti-MMP 
 
DSHB 
 
   Mouse 
           
          1:10 
   Anti-RFP Chromotek    Rat           1:1000 
   Anti- pJNK Cell Signalling 
Technology 
   Rabbit           1:1000 
   Anti-Repo DSHB    Mouse           1:10 
   Anti-SRF 
   Anti-cleaved caspase- 3 
Active motif 
Cell Signalling 
Technology 
   Mouse 
   Rabbit 
 
          1:200 
          1:100 
    
    
	  
 
 
 
 
 
 
 
Table 2.9. Secondary antibodies used in wing and eye discs staining 
Secondary Antibody   Supplier Species Concentration 
  Anti-mouse AF555 
  Anti-mouse AF633 
  Invitrogen 
  Invitrogen 
Goat 
Goat 
       1:500 
       1:500 
  Anti-rabbit AF488   Invitrogen Goat        1:500 
  Anti-rabbit AF555 
  Anti-rabbit AF633 
  Anti-Rat AF555 
  Anti Rat AF633 
  Invitrogen 
  Invitrogen 
  Invitrogen 
  Invitrogen 
Goat 
Goat 
Goat 
Goat 
       1:500 
       1:500 
       1:500 
       1:500 
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2.23 Generation of clones by FLP/FRT mediated recombination 
Crosses were allowed to lay for 48 hours. Embryos were left to develop for a further 
48 hours and then heat shocked in a 37°C water bath for 1 hour. Wing discs were 
dissected from third instar larvae at 48 hours post heat shock. 
2.24 Confocal microscopy 
Tissues prepared using the above immunostaining protocols were examined using an 
LSM 710 or LSM 780 confocal microscope (Zeiss) and Zen 2011 confocal software 
(Zeiss) equipped with 405nm, 488nm, 561nm and 633nm lasers. GFP and Venus 
fusion proteins were excited at 488nm using an argon laser. Fluorescence was 
measured by the 32-channel internal detector and images visualised using Zen 2011 
Lite (Zeiss). Wing and eye discs were assessed by multiple 2.5µm slides z-stacks. 
Table 2.10. Antibodies and stain used for confocal microscopy 
Name Type Supplier Concentration Laser (nm) 
TO-PRO®-3 Fluorescent 
stain 
Life 
Technologies 
1:1000 633 
Alexa Fluor® 
555 Phalloidin 
Fluorescent 
dye 
Life 
Technologies 
1:500 561 
Alexa Fluor® 
633 Phalloidin 
Fluorescent 
dye 
Life 
Technologies 
1:500 633 
Alexa Fluor® 
488 
Secondary 
antibody 
(Goat) 
Life 
Technologies 
1:500 488 
Alexa Fluor® 
555  
Secondary 
antibody 
(Goat) 
Life 
Technologies 
1:500 561 
Alexa Fluor® 
633  
Secondary 
antibody 
(Goat) 
Life 
Technologies 
1:500 561 
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2.25 Image analysis 
Images were prepared using Fiji (ImageJ). Then, Images were imported to Adobe 
Photoshop and adjusted for brightness and contrast uniformly across entire fields. 
Omero figures were also used. 
2.26 Wing size analysis 
For wing preparations, appropriate adult flies were stored in 70% (v/v) ethanol for at 
least 24 hours to dehydrate and preserve the wings. Wings were removed from flies 
using dissection tweezers (Dumont Medical) and placed on a microscope slide to 
dry. Twenty-five wings, from individual flies, were dissected per genotype. Once 
dry, the wings were transferred to a small drop of mounting medium (1:1 
methylsalicylate/ Canada balsam) where air bubbles could be removed. The wings 
were then transferred to a fresh 15µl drop of mounting medium on a new slide and 
covered with a coverslip. The slides were examined using a Leica MZ10F 
microscope. A Leica DFC420 digital camera and Leica application suite software 
(Version 2.8.1) were used to take images of the tissues. Wing areas were measured 
using the polygon tool within ImageJ to mark the area of the wing to be measured, 
and the area calculated using the measurement function.  
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3 Monitoring SRF-dependent gene expression in vivo 
3.1  Introduction 
3.1.1 Reporter genes 
Reporter gene technology is used for monitoring the cellular events and 
transcriptional responses associated with signal transduction. The term reporter gene 
is used to define a gene with a readily measurable phenotype that can be 
distinguished easily over a background of endogenous proteins (Alam and Cook, 
1990). Generally, reporters can be selected according to their sensitivity, dynamic 
range, convenience, and reliability of their assay (Alam and Cook, 1990, Bronstein 
et al., 1994, Wood et al., 1995, Suto et al., 1997). Reporter gene technology involves 
alteration in gene activity by defined cis regulatory sequences (response elements), 
which are responsive to alterations in gene expression and regulation inside the cells. 
There are several hormones and growth factors that have been shown to stimulate 
target cells through activating second messenger pathways that regulate the 
phosphorylation of specific nuclear factors to alter gene transcription (Karin, 1994). 
lacZ-encoded β-galactosidase is one of the reporter genes that has been used as a 
valuable tool for cell and developmental biologists (Naylor, 1999). The activity of β-
galactosidase, which is comprised of a homotetramer of 116-kDa subunits, in a cell 
or fixed tissue, can be monitored colorimetrically with its substrate 5- bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal), which produces a blue precipitate 
upon cleavage.  In live cells, the enzyme's activity can also be detected 
fluorometrically with the synthetic substrate, fluorescein-β-digalactopyranoside 
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(FDG) (Rotman et al., 1963). By cleaving FDG, free fluorescein is produced which 
can be then detected in live cells using epifluorescence microscopy or flow 
cytometry. Although the combination of β-galactosidase/FDG has been used in 
FACS, it has some shortcomings (Nolan et al., 1988). Firstly, the FDG cannot 
readily cross the plasma membrane, because it is polar. Cells must be exposed to a 
harsh hypotonic shock procedure to introduce FDG inside them, which leads to 
uneven substrate loading. This uneven substrate loading affects the fluorescence 
signal intensity from the cells that depends on both enzyme and substrate 
concentrations. Secondly, the free fluorescein produced by cleavage of FDG rapidly 
diffuses out of the cell. To reduce this efflux, cells must be kept on ice during the 
entire loading period. Although there are several problems associated with the β-
galactosidase/FDG system, it has been used as a tool for studying protein-protein 
interactions in live cells (Rossi et al., 2000).  
 
Green fluorescent protein (GFP) is another commonly used reporter (Tsien, 1998). 
GFP is a protein that was originally isolated from the jellyfish Aequorea victoria and 
fully characterised by Cody et al (Cody et al., 1993).  The value of GFP lies with its 
unique autofluorescence properties, as it does not require the presence of any 
cofactors or substrates to generate its green light (510 nm); thus, intracellular events 
can be studied in intact living cells easily. In 1991, the gene for GFP was cloned 
(Prasher et al., 1992), and numerous GFP mutants are now available, which exhibit 
improved fluorescence properties over wild-type GFP (Misteli et al., 1997, Welsh et 
al., 1997). 
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The main advantage of the green fluorescence protein is that it is noninvasive and 
inherently fluorescent so it does not require substrate for detection. In addition, two 
or more genes in the same cell can be tracked by an investigator using different 
spectrally-resolved mutants of GFP. Since GFP is a non-enzymatic reporter, its limit 
of detection is approximately 105 molecules/cell. The low sensitivity of GFP 
undermines its effectiveness as a good reporter system.  
3.1.2 Serum reponse factor signalling is induced by two key pathways 
Serum response factor (SRF), a ubiquitously expressed member of the MADS box 
family of transcription factors, is considered as the master regulator of the actin 
cytoskeleton (Miano et al., 2007). It plays essential functions in multiple cellular 
processes, for example, cell contractility, migration, cell growth, and cell 
differentiation in several tissues and cell types (Miano et al., 2007).  
 
 In the human proteome, SRF is considered to be one of the best-understood DNA-
binding proteins. The laboratory of Richard Treisman was the first to define the 
DNA-binding properties of SRF (Treisman, 1986, Norman et al., 1988); while SRF 
has relatively low intrinsic transcriptional activity, its interaction with over 60 
cofactors confers strong transactivation potential in a cell- and context-specific 
manner. 
 
There are at least two major signalling pathways that converge on SRF to direct 
SRF-dependent gene expression, Figure 3.1 (Posern et al., 2006, Pipes et al., 2006). 
The classic pathway involves stimulation of growth factor and mitogen-activated 
protein kinase signalling leading to the phosphorylation of the SRF cofactor, and the 
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activation of growth-related genes (Shaw et al., 1989, Janknecht et al., 1993). Rho-
dependent changes in actin dynamics is a second regulatory pathway (Sotiropoulos 
et al., 1999b). In this pathway, the ratio of globular actin (G-actin) to fibrillar actin 
(F-actin) is lowered by the signal inputs, releasing the binding of myocardin-related 
transcription factor-A (MRTF A)/MAL to G-actin, leading to nuclear accumulation 
of MAL and subsequent SRF-dependent gene expression (Miralles et al., 2003). SRF 
binds as a dimer to at least 1216 permutations of a 10-bp segment of DNA known as 
the CArG box. CArG boxes can be found mostly in the first intron of hundreds of 
experimentally validated or hypothesized target genes and in the proximal promoter 
(Philippar et al., 2004, Sun et al., 2006, Balza and Misra, 2006, Niu et al., 2007, 
Verdoni et al., 2008, Selvaraj and Prywes, 2004, Zhang et al., 2005, Cooper et al., 
2007). Bioinformatics and Microarrays studies have revealed a disproportionate 
number of SRF-target genes encoding for elements of the actin cytoskeleton 
(Philippar et al., 2004, Sun et al., 2006, Balza and Misra, 2006, Verdoni et al., 2008). 
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Figure 3.1. Model of two pathways regulating Serum Response Factor (SRF) 
activity. Both Rho-dependent (left) and Ras-dependent (right) signaling are 
activated by extracellular inputs. MAP kinase pathway is activated through Ras, Raf, 
MEK and ERK leading to phosphorylation of TCFs. TCFs then bind to their own 
sequence-specific target sequence (Ets motif, depicted) and to SRF. Activation of 
signalling through Rho family GTPases results in dissociation of MAL from G-actin, 
and accumulation of MAL in the nucleus where it binds and activates SRF (Posern 
and Treisman, 2006).  
 
Mammalian tissue culture cells have been used to confirm that SRF activity is 
regulated by changes in actin dynamics (Sotiropoulos et al., 1999). Experiments 
using latrunculin and C2 toxin, which are actin polymerization inhibitors, have been 
shown to inhibit the expression of SRF reporter genes (Sotiropoulos et al., 1999). In 
contrast, preventing F-actin disassembly by jasplakinolide or promoting de novo 
actin polymerization by VASP and WASP can induce the activation of SRF (Grosse 
et al., 2003, sotiropoulos et al., 1999). Importantly, it was also found that SRF is 
strongly activated by promoting G-actin dimerization using swinholide A and 
cytochalasin D but not by inducing polymerization per se. This indicates that SRF 
dependent-transcription occurs particularly as a result of G-actin depletion rather 
than as a response to increased levels of F-actin (Sotiropoulos et al., 1999). 
3.1.3 Mal/MRTF regulates the response of SRF to altered actin dynamics  
SRF activation that results from decreasing G-actin levels has been found to be 
mediated by myocardin and myocardin-related transcription factor (MRTFs), which 
are transcriptional co-activators of SRF (Miralles et al., 2003) Wang et al., 2001, 
Wang et al., 2002). MRTFs associate with G-actin via their N-terminal RPEL 
domains (Miralles et al., 2003), which then continuously cycle between the 
cytoplasm and the nucleus depending on their bound state. MRTFs are transferred 
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from the nucleus and remain cytoplasmic when bound to G-actin.  MRTFs are 
imported back into the nucleus when separated from the actin monomers (Posern et 
al., 2004, Posern et al., 2002). Increasing the actin polymerization rates reduces the 
G-actin levels in the cytoplasm and nucleus leading to increases of unbound MRTFs, 
which then become predominantly nuclear (Miralles et al., 2003, Posern et al., 2004, 
Posern et al., 2002). It has been found that increasing the rates of protein 
translocation into the nucleus and reducing the rates of MRTF nuclear export result 
in the relocalisation of MRTFs to the nucleus (Vartiainen et al., 2007). Nuclear 
MRTF is able to interact with SRF at the promoter of a range of target genes and 
allow SRF-mediated transcription (Miralles et al., 2003, Wang et al., 2002) (Figure 
3.2.). 
         
Figure 3.2. MAL interacts with actin in both cytoplasm and nucleus. Multiple 
roles for actin in MAL regulation. MAL is mainly located in the cytoplasm in 
unstimulated cells (left), whereas SRF activation is prevented by nuclear actin. Upon 
stimulation (right), decreased export leads to MAL accumulation in the nucleus, and 
reduced interaction with actin allows SRF activation (Vartiainen et al., 2007). 
3.1.4 MRL proteins and SRF signalling 
Studies using a range of species have determined that MRL (Mig-10; RIAM; 
Lamellipodin) proteins act as scaffold molecules linking upstream growth factor 
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signalling with downstream effects on the cytoskeleton (Krause et al., 2004, 
Lafuente et al., 2004, Lyulcheva et al., 2008). For instance, both RIAM and Lpd bind 
with Ena/VASP proteins and Profilin through their EVH1- and Profilin- binding 
sites respectively; potentially enabling their recruitment towards the leading edge to 
facilitate regulation of the actin cytoskeleton (Lafuente et al., 2004, Krause et al., 
2004). RIAM and Lpd have been shown to control actin dynamics in an Ena/VASP 
dependent manner by co-localising with Ena/VASP proteins and filament actin at 
lamellipodia and filopodia tips (Jenzora et al., 2005, Lafuente et al., 2004, Krause et 
al., 2004).  
 
Recent studies suggest that MRL proteins play a role in growth control. 
Overexpression of Pico induced hyperplastic growth at both the tissue and whole 
organism level in a dose-dependent manner, owing to co-ordinated increases in both 
cell number and size (Lyulcheva, 2006, Lyulcheva et al., 2008). Knock-down of pico 
in Drosophila wing discs led to a reduction in tissue growth by reducing cellular 
proliferation without an increase in apoptosis (Lyulcheva et al., 2008). Remarkably 
this growth phenotype seems to be closely linked to the actin/MAL/SRF proliferative 
pathway. Results from an earlier study indicated that the expression of an SRF-
responsive reporter gene in mammalian cell cultures can be increased by 
overexpression of Pico, whereas a hypomorphic mutation in blistered (bs), the 
Drosophila SRF homologue, decreased pico-mediated wing overgrowth (Lyulcheva 
et al., 2008). The ability of pico to increase the cellular F:G actin ratio provides an 
explanation for SRF activation through release of its cofactor MAL bound G- actin 
(Lyulcheva et al., 2008, Miralles et al., 2003, Settleman, 2003). 
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3.2 Results  
This chapter describes the use of a transcriptional reporter to monitor SRF-dependent 
gene expression in vivo. Results of this work and other work related to this study are 
reported in the submitted manuscript reproduced below. 
3.2.1 Paper summary 
Jonchère.V., Alqadri.N., Herbert.J., Dodgson.L., Mason.D., Messina.G., Falciani.F., 
Bennett.D. (2015). Transcriptional responses to hyperplastic MRL signalling in 
Drosophila 
 
Contributions of Authors: 
Jonchère.V: Generated all RNA-Seq data, performed validation by q-RTPCR and 
performed initial bioinformatics analysis using GO descriptors (Fig.1). Generated the 
SRE-mCherry reporter construct used in Figure 3. Performed comparative analysis 
of growth literature and screen of RNAi lines (Fig.7A-B). Performed ChIP (Fig.8A). 
Contributed to writing and editing the paper. 
Alqadri. N: Analysed wing discs of different genetic backgrounds to determine 
effect on expression of an in vivo SRF-responsive reporter gene (Fig.3B) and 
(fig.5A). Dissected and mounted adult wings to examine whether genes induced by 
ectopic pico were required for pico-mediated tissue growth (Fig.7C). Analysed wing 
discs to determine the role of deterin in suppressing proliferation-induced apoptosis 
during pico-mediated tissue overgrowth (Fig. 8B). Contributed to writing and editing 
the paper. 
Herbert.J: Performed PCA bioinformatics analysis on RNA-Seq data (Fig 3A-B-C). 
Contributed to writing and editing the paper. 
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Dodgson.L: Generated expression construct and transgenic flies for FLAG-SRF. 
Performed initial experiments validating the use of this reagent for ChIP as done in 
Fig.8. Contributed to writing and editing the paper. 
Mason.D: Developed the image analysis pipeline for quantification of SRE-
mCherry expression presented in Figs. 4-5. 
Messina.G: Analysed the effect of knocking down pro-survival genes and 
contributed data to Fig. 7B. 
Bennett.D: Conceived and designed the experiments; secured funding for the work; 
analysed the data; contributed to writing and editing the paper. 
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Abstract 
Recent work has implicated the actin cytoskeleton in tissue size control, but 
how changes in actin dynamics contribute to hyperplastic growth is still 
unclear. Overexpression of Pico, the only member of the MRL adapter 
protein in Drosophila, has been linked to tissue overgrowth via its effect on 
the F-actin sensor Mrtf, and consequently Mrtf’s DNA-binding factor SRF, 
providing a model for mechanistic investigation. Whilst Mal/SRF-induced 
transcriptional changes have been largely linked to actin biosynthesis and 
cytoskeletal regulation, we report here that RNA profiling of Drosophila wing 
discs overexpressing pico or mrtf did not reveal a cytoskeletal gene 
signature. Indeed, prominent among the common response to mrtf and pico 
overexpression was upregulation of ribosome protein and mitochondrial 
genes, which are known growth drivers and are conserved Mrtf/SRF targets 
in flies and human cells. Consistent with their ability to induce a common 
transcriptional response and activate SRF signalling in vitro, both pico and 
mrtf stimulate expression of an SRF-responsive reporter gene in wing discs. 
Multiple transcriptional targets are likely to be important for pico-mediated 
overgrowth, but in a functional genetic screen, we also identified deterin, 
which encodes Drosophila Survivin, as a Mrtf/SRF target that is necessary 
for pico-mediated tissue overgrowth by suppressing proliferation-associated 
cell death. Taken together, these data point to an unappreciated effect of 
Mrtf/SRF on protein biosynthesis and proliferation control under conditions of 
chronic MRL or Mrtf overexpression, with potential implications for the 
understanding of growth control during normal development and 
tumourigenesis.  
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Introduction 
1. Actin cytoskeleton and transcriptional regulation 
The actin cytoskeleton has emerged over the last few years as an important 
regulator of gene expression, with actin being involved both in the direct 
regulation of transcription complexes but also in the transduction of signals to 
downstream transcriptional responses via the Serum Response Factor (SRF) 
and Hippo signalling pathways (Rajakyla and Vartiainen, 2014). In actin-
induced SRF signalling, the SRF cofactor Mrtf (Myocardin-Related 
Transcription Factor) responds to levels of monomeric (G)-actin, which 
inhibits nuclear import and enhances nuclear export of Mrtf and represses 
transcriptional activation of SRF target genes (Vartiainen et al., 2007). 
Correspondingly, actin regulators that drive F-actin formation, including 
Ena/VASP (Grosse et al., 2003), release the inhibition of Mrtf by G-actin and 
activate SRF. Increased levels of F-actin, e.g. mediated by anti-Capping 
protein or by the nucleation factor Diaphanous, also stimulate Hippo target 
gene expression (Sansores-Garcia et al., 2011, Fernandez et al., 2011) via 
the transcriptional coactivator Yorkie/YAP/TAZ, which is normally inhibited by 
Hippo signalling. Correspondingly, disruption of F-actin has been shown to 
exclude YAP from the nucleus and suppress its transcriptional activation 
(Dupont et al., 2011, Aragona et al., 2013, Wada et al., 2011). Despite 
similarities between the regulation of Yorkie/YAP/TAZ and Mrtf-SRF by the 
actin cytoskeleton, expression of a mutant actin that cannot polymerise 
inhibits Mrtf signalling (Miralles et al., 2003b, Posern et al., 2002) but has no 
effect on YAP/TAZ (Dupont et al., 2011), suggesting that the Hippo pathway 
is not affected by G-actin, but rather might respond to changes in a particular 
F-actin structure (Aragona et al., 2013, Dupont et al., 2011).  
 
Results obtained in a range of species support the idea that MRL (Mig-10; 
RIAM; Lamellipodin) proteins act as molecular scaffolds for Ras-like 
GTPases and actin regulators, including Ena/VASP and the Scar/WAVE 
complex, to remodel the actin cytoskeleton, linking extracellular signalling to 
changes in cell adhesion and migration (Lafuente et al., 2004, Krause et al., 
2004, Law et al., 2013). Recent evidence suggests that MRL proteins also 
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play a role in growth control. For instance, in mammalian cells, Lpd 
knockdown abrogates the effect of EGF on proliferation (Lyulcheva et al., 
2008) and abolishes Rac-induced cyclin D accumulation and 
mechanosensitive cell cycling (Bae et al., 2014). In Drosophila, the MRL 
orthologue, encoded by pico, is capable of driving growth of the developing 
wing, by inducing a coordinated increase in cell size and number (Lyulcheva 
et al., 2008, Jonchere and Bennett, 2013). Genetic experiments in 
Drosophila have linked pico-mediated tissue overgrowth to activation of 
Mrtf/SRF since overexpression of mrtf or blistered, which encodes 
Drosophila SRF, induced tissue overgrowth and loss of function in blistered,  
suppressed the effect of pico on wing size (Lyulcheva et al., 2008, Han et al., 
2004). However, the Mrtf/SRF pathway has predominantly been associated 
with the expression of cytoskeletal- rather than growth-promoting genes in 
other contexts (Cenik et al., 2016, Esnault et al., 2014). Consequently, it is 
not clear which genes might be induced to drive hyperplastic tissue growth 
and to what extent the transcriptional response to MRL protein 
overexpression is elicited by the Mrtf-SRF pathway. 
 
Here we have used digital transcriptomics to determine the transcriptional 
responses to hyperplastic MRL signalling in the Drosophila wing imaginal 
disc. We found little evidence for involvement of the Hippo pathway in pico-
induced overgrowth, based on minimal effect on the genes used as readouts 
of pathway activation. Through analysis of the Mrtf-induced transcriptome in 
wing discs, we identify a common signature representing possible targets of 
a Pico-Mrtf signalling pathway, with an in vivo reporter confirming the ability 
of mrtf and pico to drive SRF activation. Although there were clear 
differences in the transcriptional responses to pico and mrtf overexpression, 
notably, we did not see an enrichment of cytoskeletal genes in either 
condition. Instead, the common transcriptional signature, associated with 
mrtf and pico-mediated hyperplastic growth, includes ribosomal protein and 
mitochondrial genes that are known to be associated with Mrtf/SRF in 
mammalian cells, but whose significance to Mrtf/SRF function had not 
established. Functional analysis supports the involvement of a selection of 
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these genes in growth control including the Drosophila Survivin orthologue, 
encoded by deterin, which is required for suppressing apoptosis in discs 
overexpressing pico. 
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Results 
Genome-wide transcriptional changes observed in Drosophila wing 
discs with pico overexpression 
 
Overexpression of pico with MS1096-GAL4 (MS1096>pico) in the developing 
larval wing imaginal disc leads to a significant overgrowth of the adult wing 
(Lyulcheva et al., 2008). To identify molecular signatures of ectopic pico 
expression, we micro-dissected wing imaginal discs from MS1096>pico and 
control (w1118) third instar larvae and determined their mRNA profiles by 
RNA-Seq. For these experiments four biological replicates were prepared 
from each strain. A comparison of the overall gene expression profiles of the 
MS1096>pico and control lines is shown in Fig.S1. Hierarchical clustering of 
the replicates, shows close agreement between the different samples of 
each line Fig.S1. Using Cufflinks (see Materials and Methods) we identified a 
total of 1490 differentially expressed genes (10.7% of 13,895) in wing discs 
ectopically expressing pico (P<0.05, Table S1), with 691 and 799 genes 
under- and over-expressed, respectively.  
 
To identify biological processes that might be affected by ectopic pico, we 
compared the frequency of GO terms (GO) amongst differentially expressed 
genes using DAVID (Huang et al., 2009). A large number of terms (193) 
were enriched amongst the underexpressed genes, making it hard to 
interpret the functional significance of these descriptors. In constrast, only 23 
GO terms for biological functions were enriched amongst genes over-
expressed in MS1096>pico wing discs belonging to 5 main categories 
(Fig.1A), with translation and chromosome organisation being the most 
significant (P=3.6 e10-3 and P=8.4 e10-3, respectively). Drosophila specific 
searches with Flymine also revealed enrichment of ribosome pathways 
(P=2.7 e10-6, Holm-Bonferroni). We used STRING (Franceschini et al., 2013) 
to help visualise over-expressed protein networks, which revealed 6 key 
network hubs genes overexpressed in response to ectopic pico (Fig.1B): 
ribosomal proteins, eukaryotic initiation factors (eIFs), heat shock proteins, 
tubulins, mitochondrial proteins and proteins involved in glycolysis. These 
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patterns of transcriptional change are consistent with the wing overgrowth 
phenotype exhibited by animals with ectopic pico. To confirm our RNA-Seq 
results, we selected genes representative of enriched GO categories for 
quantitative real-time qRT-PCR analysis. Measurements of relative mRNA 
expression level determined using this method were in close agreement with 
RNA-Seq data. Indeed, even genes that that were only modestly 
overexpressed (~1.5 fold) by RNA-Seq were found to be significantly 
increased when assessed by qRT-PCR (P<0.05, Fig.2). The transcriptome 
dataset therefore accurately captures the expression profile of hyperplastic 
tissues and contains genes that promote overgrowth induced by ectopic pico. 
Pico is capable of inducing SRF-responsive gene expression in vivo 
Actin dynamics have been reported to induce Hippo signalling, a tumour 
suppressor network regulating growth (Esnault et al., 2014, Sansores-Garcia 
et al., 2011). However, the absence of any induction of canonical Hippo 
targets in response to ectopic pico suggests that the pico-mediated growth is 
unlikely to be driven by engagement of the Hippo pathway (Fig.S2). We 
previously reported that mrtf overexpression phenocopied the effect of 
ectopic pico in the wing and pico-mediated overgrowth was sensitive to the 
levels of blistered, suggesting that tissue overgrowth might require SRF-
dependent gene expression (Lyulcheva et al., 2008). To test the ability of 
pico overexpression to induce SRF signalling in the wing disc, we generated 
transgenic flies harbouring an in vivo SRF reporter, consisting of an SRF-
responsible element (SRE), containing 9 CArG binding motifs (CC[A/T]6GG), 
upstream of the coding sequence for mCherry (SRE-mCherry) (Fig.3A). In 
wing discs from 3rd instar larvae, expression of SRE-mCherry was often very 
weak, but recapitulated the expression pattern of SRF protein, which is 
restricted to intervein cells (Fig.3B). Although relatively few SRF-expressing 
cells expressed the mCherry reporter, 93.1% ±10.6 (mean ±SD, n=5 discs) 
of cells with detectible SRE-mCherry expressed SRF. Stronger expression of 
the reporter was detected as the wing disc matured; by pupariation, in 
animals with two copies of the reporter, mCherry was clearly visible in the 
pupal wing but not other tissues.  
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To test the effect of pico on the expression of our reporter gene, we 
overexpressed UAS-pico in the posterior half of the wing disc, together with 
UAS-GFP, under the control of hh-GAL4, and measured the ratio of mCherry 
fluorescence in anterior (GFP-negative):posterior (GFP-positive) cells 
(Figures 4, 5). To ensure signal intensities were in the linear range, laser 
power was adjusted so that the maximum intensity signal was below the 
level of saturation for the detectors. Cells in control discs from 3rd instar 
larvae showed a mean anterior:posterior mCherry ratio of 1:1.4, reflecting the 
fact there are more intervein cells in the posterior half of the disc. There was 
a 1.5 fold increase in the mean ratio of mCherry intensity (to 1:2.1) in wing 
discs overexpressing pico compared to the controls (P=0.001). A similar 
induction (of 1.5 fold) in SRE-mCherry expression was seen in wing discs 
from white pre-pupae, indicating this effect was not stage specific (Figure 4). 
We also confirmed this effect by pooling intensity measurements from 
multiple discs and comparing the intensity bias in GFP and non-GFP 
compartments (Figure 5B). This revealed a 1.4 fold increase in the mean 
intensity of mCherry in the presence of overexpressed pico compared to 
controls (x2 <0.001). A similar effect was observed for overexpressed mrtf 
(mean fold change 1.9, x2 <0.001). These data indicate that both mrtf and 
pico are capable of inducing the SRE-mCherry reporter gene in the wing 
imaginal disc, consistent with their reported effects on SRF signalling in 
mammalian cells (Lyulcheva et al., 2008, Pinheiro et al., 2011). 
 
Upregulation of ribosome and mitochondrial genes is a common 
response to overexpressed pico and mrtf 
To identify potential targets of Mrtf/SRF signalling that might be subject to 
regulation by pico, we analysed the mRNA expression levels of wing discs 
overexpressing wild type mrtf (MS1096>mrtf) by RNA-seq. This revealed a 
total of 1526 differentially expressed genes (11% of 13,895) in wing discs 
ectopically expressing mrtf compared to w1118 controls (P<0.05, Table S1), 
with 820 and 706 genes under- and over-expressed, respectively. A 
comparison of the overall gene expression profiles of the MS1096>mtrf lines 
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and hierarchical clustering of the replicates is shown in Fig.S1. Interestingly, 
we did not observe a significant induction of Actin5C, which has been 
proposed to be a homeostatic target of Mrtf/SRF in ovaries (Salvany et al., 
2014), nor did we see enrichment of GO categories corresponding to 
cytoskeletal genes amongst the overexpressed genes in DAVID or Flymine 
(Table S2). 
 
To determine the relationship between the effects of mrtf and pico, we 
subjected our RNA-Seq datasets to Principal component analysis, which is 
not subject to thresholding and therefore has the ability to scrutinise all the 
available transcriptomics data in a non-biased fashion. We took this 
approach because we reasoned that Mrtf-SRF responsive genes might show 
modest changes in transcript levels (similar to our reporter gene), but be 
biologically relevant when individual genes belong to a cohort of genes with 
related functions that show a consistent change in expression. Principal 
component analysis identified a divergent (PC1) and common (PC2) 
response to overexpressed pico and mrtf, respectively, which together 
explain approximately 70% of the variance in gene expression (Figure 6A). 
Clustering of the biological replicates for each genotype indicated these 
responses are highly reproducible.  
 
To determine whether there was any enrichment of genes belonging to 
functionally-related biological processes, we analysed the distribution of GO 
terms in the PC1 and PC2 loadings. The signatures associated with the 
divergent response related to broad GO terms such as morphogenesis, 
transcription and regulation of cell development (Figure 6B). Literature 
mining of PC1 components identified a significant enrichment in circadian 
clock genes (P=3.3e-8), with 76 Clock target genes (Abruzzi et al., 2011) 
being associated with the divergent response. Correspondingly, we found 
differential expression of mRNA for core clock components timeless and 
clock, but not period, whose human orthologue is a target of Mrtf (Esnault et 
al., 2014). This suggests that part of the divergent response might be 
explained by alterations in phasing of the circadian clock. 
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Strikingly, the overexpression of ribosome protein and mitochondrial protein 
genes were highly significant common responses to pico and mrtf 
overexpression (Figure 6C). We wondered whether ribosome genes 
representing part of the common transcriptional signature (PC2) for mrtf and 
pico may be direct targets of Mrtf. To assess this we referred to a dataset of 
genes known to be bound by Mrtf in Drosophila adult ovaries based on ChIP-
Seq (Salvany et al., 2014). We examined the overlap between the top 10% 
of Mrtf-binding sites ranked according to their P-value score (Salvany et al., 
2014), and the top 10% of upregulated genes in PC2. Contained in this 
dataset are a total of 19 ribosome protein genes representative of the 
enriched GO category in PC2. Since ribosome protein genes are highly 
conserved, we were also able to ask whether these genes represent targets 
of Mrtf in mammalian cells. 90% of homologous genes were found to be 
experimentally associated with both SRF and Mrtf in fibroblasts (Esnault et 
al., 2014).  
 
Identification of differentially expressed genes contributing to pico-
mediated overgrowth by directed screening 
To identify potential effectors of pico-mediated tissue overgrowth, we 
compared the overlap of our transcriptomics data with functional information 
from three publications (Bjorklund et al., 2006, Schertel et al., 2013, Guest et 
al., 2011) describing 651 genes involved in cell cycle progression or growth 
in Drosophila (Figure 7A). This identified 42 pico-responsive genes 
previously demonstrated to regulate cell cycle progression or cell growth. Of 
these proteins, 45% (19/42) are ribosomal proteins, 2 belong to tubulin family 
(α, β tubulin) and 1 is a subunit of eIF3 protein (eIF3p66), and are 
representative of the protein hubs identified in our GO enrichment and 
STRING network analyses (Figure 1). Next, to assess their role in pico-
mediated overexpression, we selected 17 genes with heritable RNAi 
constructs in flies and measured their effect on adult wing size and 
morphology alone or in the background of overexpressed pico driven by 
MS1096-GAL4 (Figure 7B). This group of proteins included genes described 
above, other ribosomal proteins, tubulin proteins, mitochondrial proteins and 
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chromosome passenger complex proteins. RNAi lines for 7 genes (VhaM9.7-
c; CG30382; RpL24; Grip75; SH3PX1; Jra; γTub37C) did not show any 
detectable effect on wing size; 3 (Prosalpha5; NP15.6; RpL6) caused larval 
lethality; 4 others (RpS3; alphaTub85E; RpS27A; RpS17) induced a wing 
dysmorphology phenotype making interpretation of effects on growth difficult. 
RNAi for two genes (RpS9 and deterin) showed a significant reduction 
(P<0.05) on the size of MS1096>pico wings but not MS1096-GAL4 controls 
(Figure 7B, C).  
 
 
 
Deterin is required for pico-mediated tissue overgrowth 
Since deterin knockdown had the strongest effect on pico-mediated growth 
we focused our attention on this genetic interactor. deterin encodes 
Drosophila Survivin, a member of the inhibitor of apoptosis (IAP) gene family 
that has been implicated in apoptosis, chromosome segregation and 
cytokinesis (Jiang et al., 2001, Jones et al., 2000). Firstly, to determine how 
specific the effects of deterin were, we examined whether knockdown of 
other apoptosis inhibitors, diap2 and bruce, was similarly able to suppress 
pico-mediated growth. Notably, although both diap2 and bruce knockdown 
were able to reduce adult wing size, this effect was independent of pico 
overexpression, suggesting that overgrowth driven by MS1096>pico was 
particularly sensitive to the levels of deterin and not these other apoptosis 
regulators (Figure 7B). 
 
Human Mrtf and SRF have been shown to associate with the Survivin/BIRC5 
promoter in fibroblasts, prompting us to examine whether this is conserved in 
flies. To establish whether deterin is direct target of SRF, we searched the 
presence of CarG boxes in the deterin promoter and found three sites at -
1091, -598 and +63 from the transcription start site (TSS). To test SRF 
binding experimentally we expressed FLAG-tagged SRF in larvae with da-
GAL4, precipitated tagged SRF from extracts by ChIP and analysed 
chromatin recovery using qPCR (Figure 8A). The site at -598 showed 
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significant enrichment following ChIP with anti-Flag antibody compared to 
controls (IgM ChIP in da>FLAG-SRF and FLAG ChIP in da-GAL4 extracts). 
A comparison with the Mrtf ChIP-Seq dataset (Salvany et al., 2014) revealed 
a Mrtf-binding site corresponding to the SRF-binding site at -598, suggesting 
both SRF and Mrtf are capable of associating at this site. 
 
Studies of other growth drivers, such as the miRNA bantam, have 
demonstrated that genes stimulating cell proliferation can simultaneously 
suppress apoptosis (Brennecke et al., 2003). Therefore we wondered 
whether pico only drives net proliferation when apoptosis is simultaneously 
prevented in a deterin-dependent manner. To test this, we examined the 
effect of overexpressing pico in wing imaginal discs with or without deterin 
RNAi knockdown (deterinIR) using MS1096-GAL4. The line of deterinIR that 
we used for these experiments (detTRiP.GL00572) is a 21 bp hairpin line with no 
predicted off-targets with matches greater than or equal to 15 bp (Hu et al., 
2013). Cells undergoing apoptosis were identified by activated Caspase 3 
staining (Figure 8B). As we had previously observed, stimulation of growth 
by pico was not associated with an increase in apoptosis. Similarly deterinIR 
had little effect on its own, but in discs coexpressing pico we observed a 
dramatic increase in the number of cells undergoing cell death (Figure 
8B,C).   
 
Discussion 
MRL proteins are key molecules that modulate the actin cytoskeleton in 
response to guidance cues to effect changes in cell morphology and 
migration. Additionally to this role, several lines of evidence suggest that 
MRL proteins play also an important role in cell growth in normal and 
pathological conditions (Colo et al., 2012, Bae et al., 2014). This role in 
growth was highlighted in Drosophila where pico overexpression resulted in 
a coordinated increase in cell proliferation and growth (Lyulcheva et al., 
2008). Here we have analysed global RNA expression to help delineate 
pathways linking the regulation of actin dynamics to tissue overgrowth.  
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Genetic data previously implicated Mrtf/SRF in the ability of pico 
overexpression to drive wing overgrowth. Here, using a genetic reporter, we 
found that pico is capable of activating SRF-responsive gene expression in 
the Drosophila wing imaginal disc. However, although SRF targets in 
mammalian cells include growth-promoting genes (Sun et al., 2006), the 
response to Mrtf/SRF activation, at least over short time periods, 
predominantly involves the induction of genes involved in actin filament 
dynamics, cell adhesion and extracellular matrix (ECM) synthesis (Esnault et 
al., 2014). Given this, how does excessive Mrtf/SRF signalling induce 
hyperplastic overgrowth? Our transcriptome analysis sheds light on this 
question. Cytoskeletal genes were not identified in our ontology enrichment 
analysis as being induced either by mrtf or pico overexpression in the 
Drosophila wing. Instead, the genes belonging to the common pico/mrtf 
response are ontologically-related to, and in some cases are direct 
orthologues of genes associated with mammalian Mrtf/SRF, including 
mitochondrial and ribosomal protein genes. These genes are potent growth 
promoters in flies and humans, and our functional analysis provided 
evidence that at least one of these genes (Rps9) haves a role in pico-
mediated growth, although it is likely that multiple genes are involved. One 
such gene is deterin, which we propose enables pico to overcome 
proliferation-induced apoptosis and facilitate net tissue overgrowth. 
 
Despite significant overlap in transcriptional responses to pico and mrtf 
overexpression, there was also significant divergence in the response, as 
identified by our principal component analysis. There could be several 
reasons for this. For instance, although mrtf and pico overexpression may 
increase nuclear accumulation of Mrtf by a G-actin titration mechanism, Mrtf 
dynamics may not be equivalent under the two conditions. Furthermore, 
differences in actin levels and/or actin dynamics may have additional effects. 
For instance, nuclear actin, which is constantly exchanging with a 
cytoplasmic pool (Skarp and Vartiainen, 2013), associates with the basal 
transcription machinery and chromatin modifying complexes to regulate 
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chromatin remodelling, epigenetic programming and gene expression 
(reviewed (Rajakyla and Vartiainen, 2014)). Consequently, although both 
mrtf and pico are capable of activating SRF-mediated transcription as 
measured by our in vivo reporter, there are likely to be differences in the 
chromatin environment, and consequently Mrtf/SRF occupancy, at different 
native target sites that may influence target response. 
 
Why has a growth signature not been observed to date in mammalian cells 
following induction of Mrtf signalling? The deterin/survivin homologue BIRC5, 
as well as counterparts of mitochondrial and ribosomal genes that we 
identified, show no difference in expression level in mammalian cells upon 
acute (30 min) serum-induced Rho-actin signalling (Esnault et al., 2014). 
However, promoters of all these genes are associated with SRF and Mrtf. 
One possibility is that the differences in transcriptional response may reflect 
the difference between short versus long-term exposure to Mal/SRF 
induction. The fact their Drosophila counterparts could be induced in wing 
discs with persistent overexpression of pico or mrtf might therefore reflect a 
difference between acute and chronic changes in actin dynamics. Although 
we did not identify an induction of other transcriptional regulators acting 
upstream of ribosome biogenesis genes, such as Dref (Killip and Grewal, 
2012), in response to pico overexpression, we cannot rule out the possibility 
that some of the transcriptional responses are indirect. This issue will require 
careful dissection of the promoter regions of candidate targets to monitor the 
chromatin environment, SRF/Mrtf occupancy and identify cis acting 
sequences that might confer temporal control of their expression under 
conditions of altered actin dynamics. It will be interesting to determine 
whether “constitutively expressed” genes, which were initially refractory to 
Mrtf signalling in mammalian cells, become responsive after chronic 
induction and whether this similarly promotes a proliferative phenotype. 
Models of increased extracellular matrix (ECM) rigidity might be starting point 
for this analysis since ECM rigidity has been linked to chronic changes in 
actin dynamics and nuclear MRTF accumulation (O'Connor et al., 2015) as 
well as Rac and Lpd-dependent proliferation (Bae et al., 2014). Furthermore, 
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it will be interesting to examine whether changes in responsiveness to 
altered actin dynamics over the long term are associated with alterations to 
chromatin structure and local activity states. 
 
What is the involvement of the Hippo pathway in pico-mediated overgrowth? 
The transcriptome obtained from wing discs overexpressing pico yields little 
evidence of Yorkie target gene activation, suggesting that F-actin levels, 
subcellular location and/or structures induced by pico do not modify Hippo 
pathway activity. Lack of interaction with Hippo signalling is supported by 
studies in S2 cells indicating that knockdown of pico has little effect on 
expression of Yorkie-dependent gene expression (Sansores-Garcia et al., 
2011). These data are also consistent with other studies that have suggested 
that YAP-TAZ and MRTF-SRF signalling are independent of one another 
(Calvo et al., 2013, Dupont et al., 2011). Nevertheless, it will be interesting to 
examine whether regulators of F-actin that activate Hippo also activate SRF 
and whether Mrtf/SRF-dependent gene expression contributes to Hippo-
mediated overgrowth, since Mrtf activation would be anticipated under 
conditions of elevated F-actin. Our in vivo reporter will be of use in helping to 
dissect these questions. 
 
In summary, our work provides additional insight into the molecular 
mechanisms by which actin remodelling acts as a growth promoting feature. 
Since the experimental conditions we have examined focus on the effects of 
overexpression, our findings are likely to have most relevance to abnormal 
states associated with excessive MRL activity or Mrtf/SRF signalling. Indeed, 
the transcriptome analysis we report here identifies features of human 
cancer found in hyperplastic Drosophila cells. The association between 
excessive ribosome biogenesis, translation capacity and proliferation of 
cancer cells in particular has been well documented (Teng et al., 2013, 
Johnson et al., 1976, Ruggero and Pandolfi, 2003). 
  
	  	   83	  
Material and Methods 
 
Fly husbandry and genetics 
Flies were reared at 25°C under standard conditions. For overexpression of Flag-
tagged SRF, full-length SRF cDNA from 1-3 hr Drosophila embryos was subcloned 
into pPFMW (Drosophila Genome Resource Center [DGRC]) to introduce an N-
terminal Myc-Flag tag (pUAS-SRF-Flag); transgenic flies were generated by P 
element mediated insertion into a w1118 strain. To make the SRF Response Element 
(SRE)-mCherry reporter strain, a synthetic DNA sequence containing 9 consensus 
CArG boxes (Fig.S1, Text S1), was inserted into the NotI/KpnI sites in pRedRabbit 
(Housden et al., 2012); transgenic flies were generated by φC31 Integrase-
mediated transgenesis, with insertion into the attP18 landing site. 
 
Genotypes 
RNA-Seq 
w, MS1096-GAL4/w1118      (MS1096) 
w, MS1096-GAL4/w1118;; UAS-HM-pico/+     (MS1096>pico) 
w, MS1096-GAL4/w1118; UAS-Mal-d/+      (MS1096>mal)  
 
SRE-mCherry reporter experiments 
w, SRE-mCherry; hh-GAL4, UAS-GFP/+      (SRE-mCherry, hh>GFP) 
w, SRE-mCherry; hh-GAL4, UAS-GFP/UAS-mal    (SRE-mCherry, 
hh>GFP, mal) 
w, SRE-mCherry; hh-GAL4, UAS-GFP/+; UAS-HM-pico/+   (SRE-mCherry, 
hh>GFP, pico) 
 
ChIP 
da-GAL4/+  (da) 
da-GAL4/+; UAS-FLAG-SRF     (da>SRF) 
 
Analysis of adult wing size 
MS1096>UAS-pico with UAS-geneIR (on 2 or 3)/Tft ; /MKRS 
MS1096>UAS-pico with Tft and MKRS 
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Details of inverted repeat lines used for RNAi are provided in Text S1 
 
Caspase staining 
w, MS1096-GAL4/w1118;; UAS-Venus-pico/+ 
w, MS1096-GAL4/w1118;; UAS-Venus-pico/UAS-detIR 
w, MS1096-GAL4/w1118;; +/UAS-detIR 
 
RNA-seq and bioinformatics  
3rd instar larval imaginal tissues were dissected in cold Phosphate Buffered 
Saline buffer, put in RNAlater (Invitrogen), quickly frozen in liquid nitrogen 
and stored at −80°C until isolation of RNA. 4 pools of imaginal discs were 
made for each condition tested (MS1096-GAL4 alone, MS1096>pico and 
MS1096>mal) corresponding to at least 300 imaginal discs/pool. RNA 
extractions were performed using the Ambion RNAqueous-Micro Kit 
(Invitrogen). RNA concentrations were measured at 260 nm with 
NanoDrop1000 spectrophotometer (Thermofisher) and RNA integrity was 
assessed with Agilent 2100 Bioanalyser. mRNA was enriched from total RNA 
samples, using the Dynabeads® mRNA Purification Kit for mRNA 
Purification from Total RNA Preps (Invitrogen). The libraries were prepared 
according to the ScriptSeq v2 RNA-Seq Library Preparation Kit protocol 
(Epicentre). The indexed and multiplexed mRNA libraries were sequenced 
on an Illumina HiSeq 2000, using paired-end chemistry with 2 x 100 bp read 
lengths (Illumina). More than 40M reads were generated for each sample. 
Reads were filtered for quality and mapped onto the D.melanogaster 
reference genome version dm5.39 (Adams et al., 2000) using TopHat 2.0 
(Kim et al., 2013). The number of reads mapping to each gene were 
calculated using HTSeq-count (Anders et al., 2014), and the count data were 
further analysed using EdgeR (Robinson et al., 2010). The data were 
normalised to account for differences in library size, and a generalised linear 
model (GLM) was applied, using MS1906-GAL4 alone as the reference and 
contrasting this with MS1096>pico and MS1096>mal. P-values were 
obtained using t-tests, and adjusted using the Benjamini and Hochberg 
(Benjamini and Hochberg, 1995) multiple testing procedure to control the 
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false discovery rate (FDR). An FDR cut-off of 0.05 was applied to identify 
differentially expressed genes. RNA-Seq data has been deposited in the 
NCBI Sequence Read Archive, accession no. SRP068408. 
 
Gene Ontology Analysis 
To analyse the enrichment of the genes belonging to specific biological 
processes, significantly down or up-regulated genes were analysed by 
Database for Annotation, Visualization and Integrated Discovery (DAVID) 
(Huang et al., 2009) against D. melanogaster database (P-value, 0.05; min 
genes, 5) or using Flymine http://www.flymine.org/ (Lyne et al., 2007). The 
protein-protein interactions were obtained using STRING 
http://www.webcitation.org/query.php?url=http://string-
db.org/&refdoi=10.1186/1471-2164-14-573(Franceschini et al., 2013). Active 
prediction methods were experiments, databases & textmining and a 
medium confidence score (String global scores: 0.4) was applied to identified 
the predicted interactome, which was based on experimental evidence, 
database association and co-citations. 
 
 
Principal Component Analysis 
Principal component analysis was carried out using the open source 
statistical package R and the prcomp function. The loadings of the first 2 
components were extracted, and the top 10% of the most positive and most 
negative loading genes were subject to DAVID Gene-annotation enrichment 
and functional annotation cluster analysis (Huang et al., 2009). Each 
annotation cluster was summarised into a single term, taking the most 
significant term from each cluster, using an FDR cut-off of 10%. These terms 
were displayed in a bar plot using values of -10 x log10 of the Benjamini and 
Hochburg adjusted p-values. Literature mining was performed using Flymine 
(Lyne et al., 2007). 
 
qRT-PCR 
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qRT-PCR procedures were described previously (Jonchere and Bennett, 
2013b). Briefly, 1 ug of total RNA samples were subjected to reverse-
transcription using High capacity RNA-to-cDNA kit (Applied 
biosystems/Invitrogen). Primer design was performed using Primer3 online 
software (Koressaar and Remm, 2007). cDNA were amplified in real time 
using the qPCR Master mix plus for power SYBR Green I assay (Invitrogen) 
and analysed with the StepOnePlus Real-Time PCR System (Applied 
Biosystems). The level of gene expression in extracts from MS1096>UAS-
pico, and MS1096>Mal-d was compared to controls (MS1096-GAL4 alone) 
and expressed as a ratio. Primers used for qPCR are given in Text S1. 
 
CarG predictions  
The promoting sequences of each selected genes were retrieved (positions -
4000 to 100 with respect to the transcriptional start site) with removing 
sequences shared with neighbouring genes. Using the matrix of SRF binding 
sites experimentally validated in mammals (Sun et al., 2006b) and our 
promoter sequences, a positional weight matrix were applied using the 
Matrix-scan software (Turatsinze et al., 2008). The parameters used for the 
analysis were those given by default by the software. Binding sites with a P-
value of  ≤e10-4 & a weight up to 5 were considered significant.  
 
Chromatin Immunoprecipitation-qPCR 
ChIP experiments were performed from wandering L3 larvae, as described 
previously (Zsindely et al., 2009). For the immunoprecipitations, 25 µg of 
chromatin was incubated overnight with antibody and another 4 hrs the next 
day with protein G coated magnetic beads (Diagenode or Millipore). The 
antibodies used in the IP were: mouse anti-FLAG (F3165, Sigma) and 
mouse IgM. The DNA was recovery with Ipure Kit (Diagenode). A minimum 
of 3 biological replicates was done for each genotype. For the qPCR 
analysis, reactions were done in duplicates and the quantity of DNA bound 
by specific antibodies was calculated by % Input. Primers used for qPCR are 
given in Text S1. 
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Immunofluorescence 
Tissues were dissected from 3rd instar larvae were fixed and stained as 
(Ciurciu et al., 2013) with primary antibodies: rabbit anti-cleaved caspase-3 
(Cell Signalling Technology, 1:100), rat anti-RFP (Chromotek, 1:1000). 
Secondary antibody conjugated to Alexa-Fluor 555 (1:500) for 2 hours at 
room temperature in the dark. TO-PRO-3 Iodide (Invitrogen, 1:1000) or 
Hoescht (1:1000) was used to visualise DNA. Tissues were mounted in 
Vectashield mounting medium (Vector Laboratories) and imaged on a Zeiss 
LSM780 or LSM880 microscope equipped with 405nm, 488nm, 568nm and 
633nm lasers using a 20x objective or Plan Apochromat 40x/1.3NA oil 
immersion objective. Images were imported into Omero (Allan et al., 2012) 
and adjusted for brightness and contrast uniformly across entire fields where 
appropriate. Figures were constructed in Adobe Photoshop. 
 
Image analysis 
For measurements of SRE-mCherry, image analysis was conducted using 
Bitplane Imaris version 8.2.0 (Oxford Instruments). The GFP channel was 
segmented into a single 3D volume (5µm surface grain size) by absolute 
intensity using an automatically-selected intensity threshold. Small 
unattached objects were removed using a volume filter. This segmented 
volume was used to mask the red channel into two new channels by zeroing 
all voxels inside or outside the volume. These new channels were used to 
segment the data into spots (estimated diameter of 5µm, using background 
subtraction). Spots were subjected to an automatically-thresholded intensity 
filter, which was visually inspected and adjusted if necessary. The mean 
intensity of each spot was recorded for each sample. The GFP positive 
fraction was calculated as the number of GFP +ve spots divided by the total 
number of spots. Intensity Bias was calculated as the mean intensity of GFP 
positive spots divided by the mean intensity of GFP negative spots. Using 
the data above, the individual mean spot intensities were scaled to 8-bit 
values and histograms were produced using MATLAB 2015a (Mathworks). 
Data were binned into 13 bins spread evenly across the 8-bit range for all 
conditions. The histograms were then normalised by dividing all frequency 
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values by the maximum frequency value within that dataset. Data were 
plotted in Graphpad, along with non-linear regression curve assuming a 
Gaussian distribution.  
 
For quantitation of cleaved Caspase 3 staining, data were segmented into 
spots as described above using Imaris. Spots outside the wing pouch (as 
observed in the transmitted channel) were removed manually, and the 
remaining spots were counted and their mean intensity measured. 
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Figure 1. Transcriptome analysis of wing discs overexpressing pico. A, 
Pie chart showing relative abundance of gene ontology (GO) term 
enrichment in genes under-expressed and over-expressed in wing imaginal 
discs of MS1096>pico 3rd instar larvae relative to abundance of GO terms 
for all genes in the genome as determined by DAVID. For each category of 
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functional group (in bold), the most prominent biological function (in italic) 
has been annotated with the number of genes affected in that category, the 
total number of genes in that category, the statistical significance (P value) of 
the match and fold enrichment (FE). The most prominent GO categories 
amongst those up-regulated in response to pico overexpression are related 
to protein biosynthesis, including initiation of translation, ribosomal function, 
and protein maturation. There is also an enrichment in proteins localised to 
mitochondria. B, Predicted interacting network for genes over-represented in 
response to pico overexpression, visualised using STRING. Potential 
associations are indicated by the links in the graph and colour coded by type: 
co-citation from the abstract of scientific literature (green), proteins related in 
curated databases (blue) and physical protein-protein for interaction 
databases (pink).  
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Figure 2 Validation of RNA-Seq by qRT-PCR. Expression levels of 
selected genes from MS1096>pico wing discs from third instar larvae, 
relative to control, determined by qRT-PCR and by RNA-seq. Error bars 
represent the SEM of at least 3 biological replicates. The GO categories to 
which the genes belong are shown at the top. Individual t-tests without 
adjustment for multiple comparisons showed a significant difference (P<0.05) 
in each case between transcript levels in MS1096>pico and control discs. 
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Figure 3. Distribution of an in vivo SRF-responsive reporter gene in wing 
discs. A, Model for Mrtf/SRF activation by Pico overexpression. Increased F-actin 
formation leads to sequestration of G-actin, relieving inhibition of Mrtf, which 
translocates to the nucleus and complexes with SRF to drive transcription of genes 
containing SRF-Responsive enhancer Elements (SRE). SRF activation can be 
monitored using an SRE-mCherry reporter. B, Confocal images of wing discs 
harbouring SRE-mCherry transgenic reporter, stained with anti-SRF antibody. The 
distribution of the SRE-mcherry reporter closely matches the distribution of SRF 
protein in presumptive intervein cells.  
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Figure 4. Overexpression of pico induces SRE-mCherry expression in larval 
and pupal wing discs. Scatterplot shows measurements from different wing 
imaginal discs of the ratio of mean mCherry intensity in cells inside:outside the 
GFP-labelled posterior half of each disc (from z-stacks of at least 4 wing discs per 
genotype). Mean values ±SE for each genotype are indicated with a line. The 
genotype and developmental stage are as indicated (“-“ corresponds to hh-GAL4, 
UAS-GFP alone). The results of t-tests comparing mCherry levels between discs 
with or without overexpressed pico at each stage are indicated. 
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Figure 5. Overexpression of mrtf or pico induces SRE-mCherry expression 
A, Shown are representative images of an apical view of wing discs overexpressing 
mrtf or pico in the posterior compartment of 3rd instar wing imaginal discs (marked 
with GFP) using hh-GAL4. GFP labels hh-GAL4 expressing cells (in green), anti-
RFP antibody staining reveals SRE-mCherry distribution (in red), TOPRO-3 staining 
reveals DNA (in blue). For clarity, a dotted line in the images showing SRE-mCherry 
alone indicates the position of the anterior/posterior boundary. B, mrtf and pico 
induce SRE-mCherry expression in vivo. Shown are graphs of the distribution of 
SRE-mCherry signal intensities inside (IN) or outside (OUT) GFP-labelled 
compartments (from z-stacks of at least 10 wing discs). Levels of SRE-mCherry 
were noticeably elevated in the posterior half of discs expressing mrtf or pico. 
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Figure 6. Divergent and common responses to mal-d and pico 
overexpression 
A, Principal component analysis showing divergent (PC1) and common (PC2) 
response to overexpressed pico and mrtf, respectively, which together 
explain approximately 70% of the variance in gene expression. Data points 
are 4 independent biological repeats for each condition (MS1096>pico, red; 
MS1096>mrtf, yellow, MS1096-GAL4 alone, blue). B-C, GO enrichment for 
the top (red) and bottom (blue) 10% of loadings from divergent and common 
responses. The 5 most significant GO categories for each grouping are 
shown. Both pico and mrtf overexpression stimulate ribosome protein genes 
belonging to the GO category “ribosome subunit” 
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Figure 7. Genes induced by pico overexpression are required for pico-
mediated tissue growth. A, Venn diagram showing overlap between genes 
significantly overexpressed by pico (identified in this study) and genes 
identified for their role in the cell cycle or growth control in high-throughput 
functional genetic studies (Guest et al., 2011, Bjorklund et al., 2006, Schertel 
et al., 2013). B, Results of genetic screen showing effect of inverted repeat 
(IR) contructs for 12 genes on adult male wing size, with or without 
overexpressed pico, expressed as a percentage of control (-, first column; 
MS1096-GAL4 alone). All strains contained MS1096-GAL4 to drive 
expression in the developing wing disc. Data are shown as scatterplot and 
mean values indicated with a line (n≥30). Overexpression of pico induced 
approximately a 10% increase in wing size compared to the control (red data 
points). Most IR constructs had little effect although UAS-Gadd45IR had a 
modest effect on wing size in both the presence and absence of 
overexpressed pico. Notably, UAS-RpS9IR and UAS-detIR significantly 
suppressed pico-mediated overgrowth but had little effect in an otherwise 
wildtype background (ns, not significant P>0.05 t-test) C, Knockdown of 
deterin (det) suppressed pico-mediated tissue overgrowth, but not an 
alteration to wing shape. Flies carrying a UAS-inverted repeat for deterin 
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under the control of MS1096-GAL4 (MS1096>detIR) resembled wild type 
wings (not shown).  
 
 
 
 
Figure 8. Deterin is a Mrtf/SRF target and suppresses apoptosis during 
pico-mediated tissue overgrowth. A, A site 5’ of the transcription start site 
(TSS) of deterin binds FLAG-SRF. Chromatin immunoprecipitation (ChIP) 
analyses of 3 sites at the 5’ end of deterin containing a potential CArG box. 
Position of the CArG box relative to the TSS is indicated at the bottom. ChIP 
from 3rd instar larval da>Flag-SRF and control larvae (da-GAL4 alone) was 
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performed using monoclonal anti-FLAG and mouse IgM antibodies. 
Immunoprecipitated DNA was quantified by qPCR. For each genotype, 
percent input is the amount of precipitated DNA relative to input DNA. 
Results are mean ±SEM from three independent experiments. One-way 
ANOVA: *, P<0.05; ns, not significant. Distance of sites from the TSS is 
indicated on the X axis. B, detIR induces cell death in wing discs co-
overexpressing pico. Discs overexpressing Venus-pico (in yellow) are 
overgrown and show little cleaved Caspase-3 staining (in red); coexpression 
of detIR reduced tissue size and induced cleaved Caspase-3 in the centre of 
the wing pouch (arrow). C, Quantitation of number of Caspase-3 positive foci 
in wing discs expressing Venus-pico or detIR, alone or in combination (mean 
±SEM from z-stacks of at least 3 wing discs). t-test: *, P<0.05, ns, not 
significant. 
 
 
Supporting Information 
 
Fig. S1 Comparison of global RNA-Seq gene expression profiles. A, 
When control (MS1096-GAL4), MS1096>pico and MS1096>mrtf samples 
are grouped together, very little difference in the global gene expression 
profiles can be seen between conditions.  B, Nevertheless, dendrograms 
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show close hierarchical clustering between the different replicates for each 
genotype, suggesting there are consistent changes in gene expression in 
response to pico and mrtf overexpression. 
 
 
 
 
 
Fig. S2 Levels of Yorkie target genes in wing discs overexpressing 
pico. Fold change in mRNA expression for selected genes based on RNA-
Seq data for control (MS1096-GAL4) and MS1096>pico wing discs (n=4). No 
significant difference in the level of expression between conditions was 
detected.  
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Table S1. Comparison of gene level expression in wings imaginal disks 
of pico to control by RNA-sequencing. mRNA from wings imaginal disks 
of MS1096>pico and MS1096-GAL4 alone were sequenced on illumina Hi-
seq 2000 (40 M reads each repeat) and statistically compared by t-test 
where P value were adjusted by Benjamini-Hochberg (FDR<0.05; (Benjamini 
and Hochberg, 1995)) multiple testing procedure (allDataset worksheet). 
Genes significantly under- or over-expressed in pico are displayed in 
separated worksheets. 
 
Table S2. Biological Process Ontology (BP-GO) term enrichment in 
genes showing their expression affected by pico. Gene Ontology (GO) 
enrichment was determined using DAVID (Huang et al., 2009). Biological 
process categories from GO analysis that are significantly overrepresented 
among the genes for which the expression were either decreased 
(downregulated worksheet) or increased (upregulated worksheet) in 
response to pico overexpression. BP-GO were grouped into categories 
sharing similar function and used to produce the pie chart (Figure 1A). Only 
the categories with a minimum of 5 genes per category and an EASE score 
≤0.05 were considered. 
Text S1. Details of RNAi lines and primer sequences used in this paper. 
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3.2.3 Investigating the effects of reduced SRF signalling on the SRE-mCherry 
reporter 
Data described in the paper above (section 3.2.2) confirmed that the reporter 
faithfully replicates the endogenous pattern of SRF expression and exhibits 
developmental-dependent changes in the level of expression. The reporter is 
responsive to changes in actin dynamics, which is to be expected since SRF can be 
activated by the changes in G-actin: F-actin ratios, via the cofactor mal. Although the 
expression level of mCherry from the reporter was quite weak in larval wing discs it 
could be robustly detected by using LSM 780 confocal microscope, containing 32 
channel ultra-sensitive GaAsP detectors that allow visualisation of weak fluorescent 
signals with lower photo bleaching and photo toxicity. Notably, although a degree of 
transcriptional noise was observed, expression of the reporter was restricted to 
intervein cells, thereby faithfully matching the endogenous SRF expression. In the 
pupal wing, the expression was much stronger showing there are stage-dependent 
changes in levels of the reporter.  
  
To further validate the reporter, I examined whether expression was diminished in 
cells lacking SRF. This was done by examining SRF mutant clones using bs14, 
which is a nonsense mutation in codon 102 that has been predicted to give rise to a 
shortened protein lacking the MADS domain Figure 3.4. (Montagne et al., 1996). 
The expectation was that the level of the reporter would be reduced in cells lacking 
SRF protein, and this would demonstrate the dependence of the SRE-mCherry 
reporter on SRF. 
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Figure 3.3. Effect of SRF mutant clones on SRE-mCherry expression in the 
wing imaginal disc.  A) Wing disc from third instar larva harbouring positively-
marked (GFP-labelled) bs14 homozygous mutant clone (in green). SRF antibody 
staining (in blue) confirmed loss of the epitope recognised by the SRF antibody. 
mCherry reporter (in red) was below the level of detection. B) Wing disc from third 
instar larva harbouring negatively-marked bs14 homozygous mutant clone (+/+ cells 
are marked with two copies of GFP in green; +/ bs14 cells are marked with one copy 
of GFP; bs14/bs14 mutant cells lack GFP). The developmentally-controlled pattern of 
SRF expression (in blue) is clearly visible in intervein cells, except where staining is 
lost in SRF-mutant clones. SRE-mCherry expression, detected with an anti-RFP 
antibody, is also visible (in red). SRE-mCherry expression in SRF-mutant clones in 
the wing pouch is reduced somewhat but, notably, there is an elevated level in SRF-
mutant clones located outside of this region. 
 
 
Figure3.4. Genetic scheme used to create SRF mutant clone in wing discs. Virgin 
females of SRE- mCherry crossed to males of FRT42D, bs[14]/ CyO; 
A>CD2>GAL4, UAS-GFP/MKRS. Males from this cross have been crossed to virgin 
females of hsFLP122; FRT42, tub-GAL80/+ Crosses have been heat chocked at L2, 
and then GFP+ve wing discs were dissected from female third instar larvae and 
stained for anti-SRF and anti- RFP. 
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A) Positive selection of somatic clones 
 
B) Negative selection of somatic clones 
 
Figure 3.5. The use of FLP/FRT to produce homozygous mutants for mosaic 
analysis. Female larvae were heat shocked at 37 °C for an hour to induce 
homologous recombination between FRT sites using a heat shock inducible FLP 
recombinase during mitosis. (A) Approach to generate positively marked clones. In 
heterozygous or homozygous wildtype cells, GAL80 is expressed under the control 
of a ubiquitous tubulin promoter (tub-GAL80), which suppresses the expression of 
tub-GAL4 UAS-GFP. Of the two daughter cells produced following mitotic 
recombination, one is a homozygous mutant, in which tub-GAL80 is lost. This leads 
to derepression of GAL4 in these cells, triggering expression of UAS-GFP. (B) 
Approach to generate negatively marked clones. Mitotic recombination is induced as 
in A, except the non-mutant chromosome is marked with Ubi-GFP, which encodes 
GFP under the control of a ubiquitin promoter. Of the two daughter cells produced 
by recombination, one is homozygous mutant that is marked by the absence of this 
element, and does not express GFP, Image adapted from (Xu and Rubin, 1993) 
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mCherry expression could not be readily detected in these experiments either by 
staining with anti–RFP antibody or visualising mCherry directly (Figure 3.3.A)., 
most likely because there was only one copy of the transgene in these female flies. 
Previous experiments had utilised males carrying an X-chromosome insertion, which 
would have been hyperactivated due to dosage compensation. Consequently, it was 
hard to confirm whether SRF mutant clones lose the ability to induce the SRF 
reporter. Interestingly however, in mutant clones around outside of the wing pouch, 
elevated RFP expression was detected, suggesting that SRF may be a transcriptional 
repressor in this region of the wing disc (Figure 3.3.B). 
 
In mammalian cells, a small number of target genes of SRF and MRTF were shown 
to be downregulated in response to SRF induction (Esnault et al., 2014). Taking this 
work forward, it may be interesting to determine whether these are evolutionary 
conserved and respond similarly in the wing disc where patterns of repression could 
also be detected. 
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4 Cooperation of Pico and RasV12 during invasive cell migration 
4.1  Introduction 
Cell migration is essential for many biological processes such as wound healing, 
gastrulation during embryo development as well as for the generation of an effective 
immune response (Trepat et al., 2012). However, if migration occurs in cells that are 
considered as non-motile or at inappropriate times there can be severe consequences. 
Indeed, the active migration of tumour cells typically results in the invasion of 
neighboring tissues and the subsequent formation of secondary tumours, metastases, 
at ectopic sites, which are recognized as the leading cause of cancer-related fatalities. 
Unfortunately, the genetic and biochemical changes that are required in non-invasive 
tumour cells to facilitate the acquisition of motile cell behaviours are not fully 
understood due to the complex nature of the transformation process. In addition, 
interactions between the tumour cells and surrounding wild type cells have also been 
shown to play an important role in tumour cell progression (Sahai, 2005). 
 
It is difficult to artificially create such a complex genetic environment in a 
mammalian model system. In contrast, Drosophila has provided a sophisticated and 
genetically tractable model (Brumby and Richardson, 2003, Pagliarini and Xu, 
2003).  
 
The generation of genetically-defined tumour cells in Drosophila typically employs 
the MARCM (Mosaic analysis with a repressible cell marker) technique, which 
utilizes the GAL4-UAS expression system (Brand and Perrimon, 1993, Duffy, 2002), 
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the FLP/FRT site-specific recombination system (Golic, 1991), as well as a 
repressible cell marker. Non-invasive tumour cells result from the overexpression of 
a constitutively active form of the oncogene Ras (Rasv12) and they are genetically 
tagged with green fluorescent protein (GFP). Overexpression of Rasv12 in clones that 
are homozygous mutant for metastasis-suppressor gene or by co-overexpressing 
Rasv12 with a metastasis-promoting gene under UAS control can lead to cell invasion, 
which can be identified by the spread of GFP-labelled cells to more distant sites 
(Miles et al., 2011). Importantly, the ability to generate multiple genetic mutations in 
a small subset of cells in an otherwise wild type tissue, make it possible to model the 
events that take place during tumour development in humans. 
 
Previous studies using this model have shown that loss-of-function mutations in the 
cell polarity gene scribble (scrib) could cooperate with Rasv12 to drive metastasis 
(Brumby and Richardson, 2003, Pagliarini and Xu, 2003). Clones were generated in 
the eye-antennal imaginal disc/optic lobe region using the eyeless promoter to 
express the FLP recombinase (eyFLP).  Clonal cells, homozygous mutant for scrib 
and overexpressing with Rasv12, were GFP-labelled (Figure 4.1.).  When third instar 
ey> Rasv12, scrib-/- larvae were examined, it was found that the GFP-labelled tumour 
cells were no longer limited to the eye-antennal imaginal disc region, with secondary 
tumours observed in the hemolymph. By dissecting these larvae, it was found that 
tumour cells were capable of spreading from the primary tumours into neighboring 
tissues. Importantly, neither loss of scrib function nor Rasv12 overexpression could 
induce metastasis individually. 
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Figure 4.1. Drosophila cell invasion model. Shown are 
schematic drawings of larvae expressing GFP (in green) 
and other genes in the eye imaginal tissues. Expression of 
oncogenic RasV12 in 1st instar larvae results in the 
production of benign tumours by the 3rd instar stage 
(top). When additional genetic changes (X) are present 
(bottom), GFP-labelled tumours can disseminate to 
neighbouring or distant tissues (Bennett et al., 2015).  	  	  	  
 
 
This study revealed that the cell polarity genes scrib, lgl and dlg have a critical role 
in inhibiting tumour progression and metastasis (Pagliarini and Xu, 2003, Brumby 
and Richardson, 2003). Furthermore, it has been found that activation of JNK, 
interclonal cooperation, extracellular matrix remodeling and the immune system also 
have a role in invasion and metastasis in  
this model (Miles et al., 2011). Insights such as these into epithelial cancer biology 
have helped guide studies of cancer in more advanced model organisms (Vieira et 
al., 2008).  
 
Previous studies investigating the function of the MRL family members have 
implicated these proteins in the regulation of cell migration. It has been shown that 
overexpressing the two-mammalian MRL proteins; Lpd or RIAM in fibroblast cells 
can induce lamellipodia formation. In contrast, knocking-down the expression of 
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Lpd in mouse melanoma cells led to impaired lamellipodia formation and a reduction 
in F-actin levels (Krause et al., 2004, Lafuente et al., 2004). In addition, studies in C. 
elegans indicated that the successful long-range migration of embryonic neurons 
requires Mig-10, the worm MRL homologue (Chang et al., 2006, Manser et al., 
1997, Manser and Wood, 1990).  Since all MRL family proteins members share a 
highly conserved domain structure and regulate cell migration, it is likely that Pico 
shares this functional property. Indeed, initial studies in the context of border cell 
migration in Drosophila suggest this is the case (Law et al., 2013). 
 
Migration of the Drosophila border cell clusters occurs in two phases through the fly 
egg chamber. The fly PDGF receptor (PVR) predominantly regulates the front 
extension that characterise the early phase. Behaviour of the dynamic collective 
“tumbling” characterise the late phase (Bianco et al., 2007, Poukkula et al., 2011). 
Previous studies have found that overexpression of dominant-negative PVR (PVR-
DN) results in the appearance of a higher proportion of rear facing extensions 
(Prasad and Montell, 2007), causing premature tumbling of the border cell cluster. 
Overexpression or knockdown of pico abrogated migration with pico phenocopying 
the effect of PVR-DN by eliciting a premature tumbling phenotype (Law et al., 
2013). This observation suggests that tight control of pico function is critical for 
directed migration  through its effects on actin-based protrusions (Law et al., 2013).  
4.1.1 Aims 
In addition to its role in developmentally-controlled cell migration (Law et al., 
2013), overexpressed pico was previously shown to be capable of promoting the 
dissemination of RasV12-induced tumours by others in the Bennett laboratory 
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(Lyulcheva, 2006, Taylor, 2010). In these studies (Lyulcheva, 2006, Taylor, 2010), 
pico and RasV12 were expressed in all cells in which the eyeless-driven FLP 
recombinase (eyFLP) was expressed, ‘flipping out’ a cassette separating the Actin5C 
promoter from the GAL4 ORF, creating a functional driver that could express UAS-
transgenes in an eyeless-specific pattern. 
  
Utilising this system, co-expression of RasV12 and pico produced a noticeable 
increase in the size of the eye-antennal disc region and in some larvae led to the 
presence of the GFP-labelled cells at secondary locations. These phenotypes were 
not observed when either gene was overexpressed alone. The matrix 
metalloprotease, MMP1, was shown to be overexpressed in some but not all 
RasV12/pico cells (Lyulcheva, 2006, Taylor, 2010). Subsequent studies indicated that 
this was not due to stochastic effects of the immune response, a phenomenon that 
had been reported during studies of RasV12, scrib tumours (Vidal, 2010). This raised 
the possibility that cell types arising from eyFLP progenitors may behave differently 
to RasV12/pico overexpression. The purpose of work presented in this chapter was to 
explore this possibility, leading to the observation that pico cooperates with 
oncogenic Ras in glia to drive distinct oncogenic outcomes. SRF signalling had been 
implicated in the effects of pico/RasV12 cooverexpression; mal and various actin-
binding proteins had also been shown to cooperate with RasV12 (Lyulcheva, 2006, 
Taylor, 2010). Using the SRE-mCherry reporter reported in Chapter 3, the ability of 
these actin regulators to activate SRF was also determined. 
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4.2 Results. 
4.2.1 Paper summary 
 Taylor. E., Alqadri. N., Dodgson. L., Mason. D., Lyulcheva. E., Messina. G., 
Bennett. D. (2016). MRL proteins cooperate with activated Ras in glia to drive 
distinct oncogenic outcomes. 
Contributions of Authors: 
Taylor. E. Performed experiments to quantify effects of overexpressed pico and 
hLpd on oncogenic Ras-induced tumours (Fig. 1D-E). Performed experiments to 
demonstrate the effect of RasV12 /pico on extracellular matrix breakdown (Fig. 2, 3 
A, C, D, F). Performed experiments to quantify the effect of co-overexpressing mal, 
chic, ena with RasV12 ± pico on invasion (Fig. 7C-E). Analysed the data. Contributed 
to writing and editing the paper. 
 Alqadri. N. Performed experiments to demonstrate pico cooperates with oncogenic 
Ras in glia to drive distinct oncogenic outcomes (Fig. 5). Performed experiments to 
quantify the effect of co-expressing Repo-GAL80 on RasV12 /pico invasion (Fig. 6). 
Performed experiments to analyse the distribution of SRF in optic lobes (Fig. 7A-B). 
Analysed the data. Contributed to writing and editing the paper. 
 Dodgson. L. Performed experiments to test the role of egr mutations on 
RasV12/pico-mediated invasion (Fig. 4). Analysed the data. Contributed to writing 
and editing the paper. 
Lyulcheva. E. Performed initial experiments showing that overexpression of pico 
promotes invasion of RasV12-induced tumours (Fig.1A-B). Contributed to writing 
and editing the paper. 
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Bennett. D. Conceived and designed the experiments; secured funding for the work; 
analysed the data; contributed to writing and editing the paper. 
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Abstract  
The Mig10/RIAM/Lpd (MRL) adapter protein Lpd regulates actin dynamics 
through interactions with Scar/WAVE and Ena/VASP proteins to promote the 
formation of cellular protrusions and to stimulate invasive migration. 
However, the ability of MRL proteins to interact with multiple actin regulators 
and to promote SRF signalling has raised the question of whether MRL 
proteins employ alternative downstream mechanisms to drive oncogenic 
processes in a context-dependent manner. Here, using a Drosophila model, 
we show that overexpression of either human Lpd or its Drosophila 
orthologue Pico can promote growth and invasion of RasV12-induced cell 
tumours in the brain. Notably, effects were restricted to two populations of 
Repo-positive glial cells: an invasive population, characterised by JNK-
dependent elevation of Mmp1 expression, and a hyperproliferative 
population lacking elevated JNK signalling. JNK activation was not triggered 
by reactive immune cell signalling, implicating the involvement of an intrinsic 
stress response. The ability to promote dissemination of RasV12-induced 
tumours was shared by a subset of actin regulators, including, most 
prominently, Chicadee/Profilin, which directly interacts with Pico, and, Mal, a 
cofactor for SRF that responds to changes in G:F actin dynamics. 
Suppression of Mal activity partially abrogated the ability of pico to promote 
invasion of RasV12 tumours. Furthermore, we found that larval glia are 
enriched for SRF expression, explaining the apparent sensitivity of glial cells 
to Pico/RasV12 overexpression. Taken together, our findings indicate that 
MRL proteins cooperate with oncogenic Ras to promote formation of glial 
tumours, and that, in this context, Mal/SRF activation is rate-limiting for 
tumour dissemination. 
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Introduction 
 
Regulation of actin-based structures is critical for normal cell adhesion, 
morphology and motility. Correspondingly, aberrant cytoskeletal dynamics 
are implicated in the motility and dissemination of cancer cells. In addition to 
the direct effects of actin reorganisation, for example on lamellipodia-like 
structures at the leading edge of invasive cells, regulators of cytoplasmic 
actin also control the localisation and activity of myocardin-related 
transcription factors (MRTF/Mal), which are transcriptional coactivators of 
SRF, by regulating the availability of monomeric (G-)actin. Depletion of 
nuclear and cytoplasmic G-actin in response to increased actin 
polymerization increases the rate of MRTF/Mal translocation to the nucleus, 
reduces the rate of nuclear export of MRTF/Mal and derepresses the 
expression of genes that require MRTF/Mal for transcription, leading to SRF-
dependent transcription(Grosse et al., 2003, Sotiropoulos et al., 1999, 
Vartiainen et al., 2007).  
 
The Mig-10/RIAM/Lamellipodin (MRL) family of adapter proteins transduce 
signals derived from growth factor receptors, via interactions with Ras-like 
GTPases and/or phospholipids, to changes in the actin cytoskeleton, 
increased lamellipodia protrusion, cell motility and altered cell 
adhesion(Krause et al., 2004, Lafuente et al., 2004). Effects on the actin 
cytoskeleton are mediated by direct interactions with various actin regulatory 
proteins, including Ena/VASP, Scar/WAVE and Profilin(Krause et al., 2004, 
Lafuente et al., 2004, Law et al., 2013). MRL proteins are also capable of 
activating SRF signalling by altering the ratio of G:F actin(Lyulcheva et al., 
2008). MRL proteins are therefore good candidates for genes that drive 
tumour cell invasion and metastasis. Indeed, in breast cancer, Lpd is 
upregulated in tumours with lymph node metastases compared to lymph 
node-negative tumours(Ginestier et al., 2006) and also in highly invasive 
MDA-MB231 breast cancer cells compared to non-invasive MCF7 breast 
cancer cells or normal breast tissue(Ross et al., 2000). Furthermore, 
increased expression and membrane localization correlate with reduced 
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metastasis-free survival and poor prognosis in breast cancer 
patients(Carmona et al., 2016). Mechanistically, MRL proteins promote 
invasive 3D breast cancer cell migration via interactions with the actin 
regulators Scar/Wave and Ena/VASP(Carmona et al., 2016). Lpd is also part 
of the “Ras cancer signature” as it is upregulated in human breast epithelial 
cells transformed with oncogenic Ras(Bild et al., 2006). The “Ras signature” 
reflects the activation status of the Ras pathway and has been successfully 
used to identify patterns of pathway deregulation in human tumours and to 
identify clinically relevant associations with disease outcomes(Bild et al., 
2006). An understanding of the functional consequences of MRL-Ras 
interactions in cancer development is however currently lacking.  
 
Drosophila encodes only one MRL protein, called Pico, enabling the 
dissection of conserved cancer promoting effects of the MRL gene family in 
an animal model, with the potential to help guide studies in mammalian 
systems(Bennett et al., 2015). Many biological processes related to 
tumourigenesis and metastasis are well conserved in flies and nearly all of 
the genes linked to cancer progression in humans are present in the 
Drosophila genome (Brumby and Richardson, 2005, Bennett et al., 2015). 
Here we have tested the prediction that MRL proteins might cooperate with 
oncogenic Ras by promoting invasiveness of RasV12-induced tumours in the 
larval eye disc and brain. Notably, we observed tumour overgrowth and 
invasion, but these cooperative effects were restricted to cells expressing the 
pan-glial marker Repo; loss of overexpression in glia, and not in other cell 
types, completely suppressed oncogenic cooperation. Notably, SRF is 
strongly enriched in glia providing an explanation for why glia were 
specifically affected. Moreover, overexpression of mal, a cofactor for SRF, or 
chickadee, Drosophila profilin, also cooperated strongly with oncogenic Ras 
to drive glial invasion. Taken together, our findings provide experimental 
evidence for the role of MRL proteins in the hyperproliferation and 
transformation of glial tumours in vivo. Furthermore, Profilin and downstream 
SRF signalling predominantly drive this process rather than other MRL-
interactors, Ena/VASP and Scar/WAVE, as is the case in other contexts. 
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Results 
Pico co-operates with oncogenic Ras to promote tumour dissemination 
Oncogenic mutations in Ras are frequent events early stages of cancer 
development, driving proliferative overgrowth and contributing to tumour 
formation. The Ras pathway also modulates cytoskeleton organisation, cell 
motility and expression of metastasis signature genes (Choi and Helfman, 
2014), but cooperation between oncogenic Ras and its downstream targets 
are poorly understood. To test the interaction between Pico and Ras, we 
used a cancer model in Drosophila in which genetically-defined tumours can 
be induced in the developing eye disc and brain(Brumby and Richardson, 
2003, Pagliarini and Xu, 2003). First we examined the effect of 
overexpressing pico or RasV12 alone or together in GFP-labelled cells in the 
eye imaginal discs and optic lobes of wandering third instar larvae. Notably, 
coexpression of pico and RasV12 led to an accumulation of GFP-labelled cells 
and redistribution to more distant sites. This effect was not observed whether 
either gene was overexpressed in isolation (Fig.1A). To quantify the effects 
on tissue overgrowth we captured images of optical sections through brains 
dissected from the different genotypes and measured the volume occupied 
by GFP-labelled cells. There was no significant difference in volume of GFP-
labelled cells expressing pico or RasV12 alone compared to controls (Fig.1B, 
C). In contrast, pico and RasV12 co-overexpression resulted in a 1.9 fold 
increase in volume of GFP-labelled cells in the optic lobes compared to GFP 
alone controls, P<0.001 (Fig.1C).  
 
Inspection of the distribution of GFP-labelled cells in the brain revealed that 
GFP-labelled pico/RasV12 tumour cells had invaded into the ventral nerve 
cord (VNC) in the majority (82/100) of cases (Fig.1B), whereas cells 
expressing pico or RasV12 alone never extended beyond the optic lobe. To 
quantitate the tumour cell invasion phenotypes produced for each of the 
genotypes, brains were assigned to one of four categories based on the 
degree of VNC invasion observed:  Type 0, no invasion of the VNC; Type I, 
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tumour cell invasion occurring down one side of the VNC only; Type II, 
tumour cells invading both sides of the VNC; Type III, significant tumour cell 
invasion of the VNC combined with fusion of the optic lobes (Fig.1D). 
Cephalic complexes dissected from animals expressing pico and RasV12 
were entirely composed of Type 0 brains, whereas only 18% of RasV12/pico 
brains were found to exhibit no VNC invasion. 53% of RasV12/pico brains 
were found to have mild Type I invasion, and 21% and 8% of brains were 
assigned to Type II and Type III categories, respectively (Fig.1E). To test 
functional conservation, we examined the effect of ectopic overexpression of 
human Lpd (hLpd) in this system. Brains expressing hLpd showed no 
evidence of invasion, but, like pico, hLpd was able to drive invasion of 
RasV12-induced tumours, which occurred in 64/100 of cases (Fig.1E).  
 
We previously showed that pico promotes coordinated growth and 
proliferation in the wing imaginal discs prompting us to wonder whether the 
presence of GFP-positive tumour cells in the VNC could be simply explained 
by expansion of the population of tumour cells rather than by cell invasion. 
To address this, we tested the effects of co-overexpressing Drosophila 
cyclin-D (cycD) and cyclin-dependent kinase-4 (cdk4) in our assay. Cells 
overexpressing RasV12, cycD and cdk4, showed extensive levels of 
proliferation but were never located outside of the eye-antennal discs/optic 
lobe region. This is in agreement with previous reports that excessive 
proliferation does not account for presence of tumour cells in the VNC 
(Pagliarini and Xu, 2003). Together these data suggest that ectopic pico, can 
drive the dissemination of otherwise benign RasV12 tumour cells into 
neighbouring tissues.  
 
Invasive Pico/RasV12 tumours are characterised by elevation of MMP1 
and extracellular matrix remodelling 
Degradation of the extracellular matrix by matrix metalloproteases (MMPs) is 
required during tissue remodelling and during the progression of many types 
of cancer (Coussens and Werb, 2002, Srivastava et al., 2007). To investigate 
integrity of the extracellular matrix, we examined the distribution of Laminin, 
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which is a major component both of the basement membrane underpinning 
the basal side of epithelial cells and of the gliovascular basal lamina of the 
blood brain barrier. In brains ectopically expressing either pico or RasV12, 
Laminin staining of the optic lobes was found to be smooth and 
uninterrupted. In contrast, discontinuous Laminin staining was observed 
around the optic lobes of RasV12/pico brains, consistent with degradation of 
the extracellular matrix (Fig.2A). When we examined MMP expression we 
found that Mmp1 was found to be largely absent in brains overexpressing 
either pico or RasV12. In contrast, a marked increase in Mmp1 levels was 
observed in cephalic complexes expressing both pico and RasV12 (Fig.2B). 
Interestingly, Mmp1 expression was not detected in all RasV12, pico cells; 
Mmp1 staining was mainly observed in the marginal regions of the optic 
lobes and in the tumour cells that had invaded the VNC (Fig.2B).  
 
JNK activation is required for Pico/RasV12-mediated MMP expression 
and tumour cell spreading 
Studies of RasV12 tumours with impaired cell polarity (e.g. due to mutations in 
the tumour suppressor gene scrib) have revealed that JNK activation is 
critical for Mmp1 upregulation and tumour cell invasion of the VNC(Uhlirova and 
Bohmann, 2006). To assess the state of JNK signalling in RasV12/pico brains, we 
monitored the levels of puckered, a downstream target of JNK (Martin-
Blanco et al., 1998) using a lacZ enhancer trap (puc-lacZ). We observed 
limited puc-lacZ staining in brains expressing RasV12 or pico alone, but in 
RasV12/pico brains we observed a significant increase in the number of puc-
lacZ-positive nuclei (P<0.01) indicative of elevated JNK activation in these 
cells (Fig.3A,B). Not every cell showed puc-lacZ-positive nuclei indicating 
that JNK activation was not a necessary outcome of RasV12/pico 
overexpression (Fig.3A).  
 
To determine the requirement for JNK signalling in RasV12/pico-mediated 
metastasis we tested the effect of coexpressing a dominant-negative form of 
the Drosophila JNK, encoded by basket (bskDN). Ectopic overexpression of 
bskDN strongly suppressed JNK activation as monitored with puc-lacZ 
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(Fig.3B,C). Strikingly, overexpression of bskDN also reduced Mmp1 levels 
4.1 fold (P<0.01) in GFP-labelled tumour cells (Fig.3D,E) and also almost 
completely blocked RasV12/pico-mediated tumour cell invasion of the VNC 
(Fig.3F). In the absence of bskDN, evidence of spreading was observed in 
80/100 cases of RasV12/pico tumours, whereas in siblings co-expressing 
bskDN, invasion was only evident in 6/100 cases (Fisher’s exact test, 
P<0.0001). Using our scale of the extent of invasion (Fig.1D) the average 
stage score of invasion (ASI) in RasV12/pico larvae was 1.16 ±0.08 (mean 
±SEM), but this was significantly reduced by coexpression of bskDN to 0.06 
±0.02, (student’s t-test, P<0.001). Taken together, these data indicate that 
pico cooperates with oncogenic Ras to promote JNK activation, and that JNK 
activation is essential for invasion of RasV12/pico tumours. 
 
Haemocyte-mediated immune responses are not required for pico-
mediated invasion 
Accumulating evidence suggests that diversion of host immunity can 
contribute to the acquisition of invasive behaviour. In Drosophila, 
inflammatory responses, mediated by Eiger/TNF-producing haemocytes, 
trigger JNK activation leading to invasive behaviour of RasV12-induced 
tumours (Cordero et al., 2010) (Fig.4A). The mechanism of haemocyte 
recruitment to tumours is not well understood. To test the involvement of the 
immune response in RasV12/pico brains, we examined whether there was 
accumulation of haemocytes at sites of tumour invasion. Although we 
observed haemocyte recruitment to a proportion of RasV12/pico brains, 
haemocyte number was not correlated with presence or severity of cellular 
invasion; some invasive tumours lacked associated haemocytes (Fig.4B). To 
test whether pico-mediated metastasis is driven by diversion of the host 
immune response mediated byTNF/eiger, we tested the effect of RasV12 pico 
overexpression in an eiger null genetic background. Loss of eiger modestly 
suppressed invasion in RasV12/pico brains (Fig.4C); whereas 80/100 
RasV12/pico animals showed GFP-labelled cells in the VNC, invasion was 
observed in 67/100 RasV12/pico animals lacking eiger (eiger3/eiger3), which 
was at the borderline of significance (Fisher’s exact test, P=0.054). However, 
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there was little effect on the average stage of invasion, which reduced from 
1.16 ±0.08 to 1.14 ±0.10 (student’s t-test, P=0.88) when eiger was absent. 
Taken together this indicates that pico does not primarily promote invasive 
behaviour through diversion of a TNF-mediated immune response. 
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Pico cooperates with activated Ras to drive distinct oncogenic 
outcomes in glia  
When we looked at distribution of JNK activation more closely in RasV12 pico 
brains it was apparent that many puc-lacZ positive cells decorated the 
surface of the optic lobes. This non-random distribution made us wonder 
whether JNK activation was restricted to specific cell types. Indeed, we found 
the combination of eyFLP with AyGAL4 was capable of driving expression in 
a range of cells in the larval optic lobes (Fig.5A), consistent with previous 
reports showing expression in neuroblasts, lamina and medulla neurons, 
neurophils and medulla cortex glia (Chotard et al., 2005). When we looked at 
the distribution of neuronal and glial markers in GFP-labelled RasV12 pico 
tumours we found that almost all cells that were positive for puc-lacZ also 
stained for the pan-glial marker Repo. GFP-labelled cells invading into the 
VNC were of this type (Fig.5B, arrow); puc-lacZ staining in these cells is 
consistent with our genetic data indicating a requirement for JNK to mediate 
Mmp1 expression and extracellular matrix breakdown (see Fig.3). Although 
rare, we did observe a few Repo-negative GFP-labelled cells with puc-lacZ 
staining, although interestingly these were typically juxtaposed directly next 
to Repo-positive glial cells (Fig.5B, white arrowhead and inset, see 
Discussion). We also observed a distinct Repo-positive population consisting 
of many small cells that were puc-lacZ negative, located in a region of the 
optic lobe that had appeared to have overproliferated (Fig.5B, yellow 
arrowhead; Fig.5C). When we counted the number of Repo-positive cells in 
GFP-labelled tumours within the optic lobes (Fig.5C,D), we found that RasV12 
overexpression led to a 1.6 fold increase in glial number in GFP-labelled 
regions compared to GFP only controls (P<0.01). The increase in glial 
number was not matched by a significant increase in GFP-labelled tumour 
volume (Fig.1), most likely because many RasV12-overexpressing cells were 
small (Read et al., 2009). Co-overexpression of pico significantly enhanced 
the effect of RasV12 (Fig.5D), leading to a 2.3 fold increase in glial number 
compared to GFP alone controls (P<0.05). Taken together, the data above 
indicate that ectopic RasV12 and pico cooperate to promote overproliferation 
of one glial cell population in the developing optic lobe without the activation 
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of JNK, whilst promoting JNK activation and cell invasion in another glial 
population. 
 
Overexpression of RasV12 Pico in glia is necessary for an increase in 
tumour volume and cell invasion 
To test if the tumour overgrowth and invasion phenotypes we had observed 
in the optic lobe were due to ectopic expression of RasV12 and pico in eyFLP-
expressing Repo+ glia, we repeated our experiments in a repo-GAL80 
background to block GAL4-mediated expression specifically in repo-positive 
glia but not in other cell types (Fig.6A). When we measured the volume of 
GFP-labelled tumours in RasV12/pico optic lobes from animals with (n=8) or 
without repo-GAL80 (n=16), we found that repo-GAL80 reduced the mean 
tumour volume 2.9 fold (P<0.001) (Fig.6C). The mean intensity of Mmp1 
staining in GFP-labelled tumours was also reduced 5.1 fold (P<0.001) 
(Fig.6D). Correspondingly, there was a significant reduction in the instances 
of invasion into the VNC to 5/100 of cases (Fisher’s exact test, P<0.0001) 
and a corresponding reduction in the ASI to 0.05 ±0.02 (P<0.0001) (Fig.6E). 
As an additional test, we further validated these findings by using a more 
restricted eyeless-driven FLPase, ey(3.5)FLP, which does not drive 
expression in the optic lobes of the brain (Bazigou et al., 2007). 
Overexpression of RasV12 pico with ey(3.5)FLP did not replicate the growth 
and invasion phenotypes observed with eyFLP, consistent with our 
observations that overexpression in glia was required. Expression of RasV12 
specifically in GFP-labelled glia with repo-GAL4 was pupal lethal but led to 
overgrowth and extension of the larval VNC (mean VNC length 130% of 
control, Student’s t-test P<0.05, n=10). Co-expression of RasV12 with pico, 
led to lethality at the wandering larval stage and extension of the VNC was 
significantly enhanced (to 187% of control, P<0.01, n=9), again consistent 
with a co-operative interaction in glia.  
  
SRF is enriched in larval glia in the CNS 
Why should glia be particularly sensitive to coexpression of ectopic pico and 
RasV12? We recently demonstrated that overexpression of pico reduces the 
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ratio of G:F-actin and is capable of inducing activation of SRF signalling in 
vitro (Lyulcheva et al., 2008). This prompted us to question whether the 
cooperation between pico and RasV12 was mediated by SRF signalling. 
Although SRF is expressed throughout the adult brain (Donlea et al., 2009), 
where it plays roles in sleep and visual memory (Donlea et al., 2009, Thran et 
al., 2013), we wondered whether SRF expression is spatially regulated in the 
CNS earlier in development, as it is in other tissues such as the wing 
imaginal disc (data not shown). Notably, we detected strong anti-SRF 
antibody staining in glia from third instar optic lobes (Fig.7A-B). SRF staining 
was evident both in Repo positive surface glia (Fig.7A) and in other glial 
types (Fig.7B). 
 
The ability of Pico to promote tumour invasion is shared by selected 
actin regulatory genes 
To further examine the contribution of actin dynamics and SRF to the 
development of invasive cell behaviours, we tested the effect of co-
overexpressing oncogenic RasV12 together with Profilin/chic, which has 
multiple roles in the augmentation of F-actin dynamics, or with regulatory 
proteins that bind Pico and are known to control actin polymerisation by 
affecting the number of free barbed ends: Enabled/ena (anti-capping factor) 
and SCAR (actin nucleation) (Shekhar et al., 2016). We also tested the effect 
of ectopic mal, which encodes a cofactor for SRF and responds to changes in 
actin dynamics to induce SRF-dependent gene expression. Overexpression 
of any of the above factors alone in the absence of RasV12 did not induce 
invasive behaviour as determined by the lack of GFP-positive cells in the 
VNC. However, overexpression of mal, chic, ena or scar was sufficient to 
promote the acquisition of invasive behaviour in otherwise benign RasV12-
expressing tumours (Fig.7C). Based on the percentage number of larvae 
showing GFP-labelled cells in the VNC, these proteins can be ranked 
according to their invasive potential in this system, as follows:  mal (88%)> 
pico (79%)> chic (77%)> ena (35%)> scar (25%), where percentage of larvae 
with invasion into the VNC are shown in parenthesis (n=100 in each case). 
This is also in agreement with the average stage of invasion for RasV12-
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induced tumours co-expressing these regulators: mal (1.38 ±0.09)> pico 
(1.16 ±0.09)> chic (0.92 ±0.06)> ena (0.35 ±0.05)> scar (0.25 ±0.04). When 
we tested the effect of co-expressing RasV12 and pico together with either 
mal, chic or ena we found the degree of invasion observed was not 
significantly increased compared to the effect of pairwise combinations of 
these inducers or pico alone with RasV12 (Fig.7C-D). The lack of an additive 
effect suggests that these proteins may act in the same pathway to induce 
invasion, albeit to different extents.  
 
MRL proteins interact directly with Profilin, Ena/VASP and the Scar/Wave 
complex via a number of proline-rich regions present in their C-terminal 
regions (Hansen and Mullins, 2015, Krause et al., 2004, Lafuente et al., 
2004, Law et al., 2013, Lyulcheva et al., 2008). To test whether these regions 
of Pico might be necessary for promoting invasion of RasV12 tumours, we 
expressed a truncated version of pico encoding only its central RA-PH 
domain (picoRA-PH). picoRA-PH failed to promote cell invasion into the VNC 
alone or together with coexpression of RasV12 (0/100 cases of invasion in 
each case), suggesting that physical interaction between Pico and its 
downstream effectors are important for cooperation with oncogenic Ras. 
Profilin, Ena/VASP and the Scar/Wave complex affect the actin cytoskeleton 
directly but are also capable of promoting Mal-SRF activity via altered actin 
dynamics. To assess the likely contribution of direct verses indirect effects on 
the actin cytoskeleton, we tested the effect of a dominant-negative version of 
Mal (malDN), which lacks its C-terminal transcription activation domain (Han et 
al., 2004). Compared to RasV12/pico control animals, there was a significant 
reduction in the number of cases of tumour invasion in siblings coexpressing 
malDN (82/100 to 52/100 cases, respectively; Fisher’s exact test, P<0.0001). 
There was also a significant reduction in the average stage of invasion, from 
1.19 ±0.08 to 0.64 ±0.07 (student’s t-test, P<0.0001) when malDN was 
present (Fig.7E). Taken together this indicates that indirect effects via 
Mal/SRF signalling is rate-limiting for invasion of RasV12/pico tumours.  
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Discussion 
Here, we find that pico overexpression is capable of promoting distinct 
oncogenic behaviours in RasV12-induced tumour cells. In particular, we 
observed an invasive cell population showing elevation of JNK signalling, 
and a hyperproliferative population lacking JNK activation. These effects 
were restricted to glia since the affected cell populations labelled positively 
with the pan-glial marker, Repo, and cooperation between RasV12/pico was 
lost upon transcriptional repression in glia with repo-GAL80. In glia, JNK is 
likely to act as a proapoptotic signal as it does in epithelia – indeed, 
subperineurial glial cells possess a cryptic JNK-dependent apoptotic 
programme (Ohayon et al., 2009). However, any such programme must be 
suppressed by survival signals from oncogenic Ras as it is in other contexts 
(Wu et al., 2009). We found that Mmp1 expression was JNK-dependent, 
supporting the idea that JNK activation is subverted by tumour cells to 
promote invasion. Invasion of RasV12/pico tumours was not dependent on 
presence of haemocytes, nor was invasion significantly affected by complete 
loss of eiger/TNF function. One possibility is that transformed glial cells may 
be resistant to haemocyte attachment and/or signalling. Examination of the 
cell type specific expression pattern of TNF signalling components, such as 
the recently identified TNF/Eiger receptor Grindelwald (Andersen et al., 
2015) may provide a mechanistic explanation for why glia respond differently 
from epithelial tumour cells to circulating immune cells. Alternatively, 
transformed glia may express inhibitory cell surface or secreted molecules 
making them refractory to the innate immune system, as is the case for 
human glioma cells (Friese et al., 2004).  
 
Interestingly, a small number of Repo negative cells overexpressing 
RasV12/pico, adjacent to Repo positive RasV12/pico tumour cells, also 
displayed elevated JNK activity. In addition to roles in CNS development and 
function, glia are considered to be primary immune cells of the CNS that 
survey the CNS for neuronal damage, modulating inflammatory responses 
and engulfing debris or foreign material (Logan and Freeman, 2007). The 
JNK pathway mediates glial engulfment activity in Drosophila (Shklover et 
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al., 2015, Macdonald et al., 2013), raising the intriguing possibility that 
RasV12/pico stimulates glial phagocytosis of tissue damage caused by 
premalignant tumour cells. Diversion of the glial damage response program 
by carcinoma cells has previously been reported in murine organotypic brain 
slice co-cultures (Chuang et al., 2013), stimulating local invasion in tumours 
resistant to glial-induced apoptosis. It will therefore be interesting to examine 
whether this phenomenon is JNK-dependent. 
 
Recent work has shown the actin cytoskeleton acts both upstream and 
downstream of JNK (Rudrapatna et al., 2014, Kulshammer and Uhlirova, 
2013, Fernandez et al., 2014) and, conceptually, changes in cell tension 
resulting from altered actin cytoskeleton may trigger JNK as part of a stress 
response. We were interested to explore whether actin regulators that 
associate with Pico could similarly cooperate with RasV12. In breast cancer 
cells, the ability of Lpd to promote 3D invasion relies on its interactions with 
both Ena/VASP and Scar/WAVE (Carmona et al., 2016). Although both ena 
and scar were capable of cooperating with RasV12 in our model, their effect 
was modest compared to the effect of chic (Drosophila Profilin). This might 
be because Ena and Scar are not limiting, or it might reflect a specific 
requirement for Chic. Interestingly, in this regard, Profilin assists in 
coordination of actin turnover (Balcer et al., 2003, Didry et al., 1998), which is 
the driving force for membrane protrusion and spreading of some types of 
glia in the CNS (Nawaz et al., 2015). Recent work has also demonstrated 
that changes in actin dynamics driven by MRL proteins and their binding 
partners can activate SRF signalling (Lyulcheva et al., 2008, Pinheiro et al., 
2011). This raised the issue of whether effects we observed were due to 
direct or indirect effects on the actin cytoskeleton. Several lines of evidence 
suggest that Mal/SRF signalling is important for pico/RasV12 cooperation: 
firstly, SRF expression is enriched in glia; secondly, the effects of 
overexpression of mal were at least as potent as those of pico; thirdly, malDN 
suppressed the pico-mediated invasion of RasV12-induced tumours. In 
mammalian cells the majority of SRF target genes encode cytoskeletal 
components (Esnault et al., 2014) and recent work in Drosophila suggest 
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that actin itself is a key homeostatic target (Salvany et al., 2014). Control of 
Mal/SRF activity therefore may provide a mechanism by which cytoskeletal 
gene expression is coordinated with cytoskeletal regulation. Our data 
showing that mal can similarly cooperate with oncogenic Ras suggests that 
actin-dynamics via Mal/SRF signalling has a rate-limiting role, and could 
function to facilitate the direct effects on cytoskeletal remodelling.  
 
In summary, our data indicate that overexpression of MRL proteins is 
capable of driving invasion and overproliferation of RasV12-induced glial cell 
tumours in an in vivo experimental model. Notably, our findings, in glia, 
implicate Drosophila Profilin and SRF signalling in MRL-mediated tumour 
dissemination, whereas interactions between Lpd and Ena/VASP and 
Scar/WAVE have been reported to be critical in the invasion of breast cancer 
cells. This points to important differences in the mechanism of action of MRL 
proteins depending on the cellular context. Given that SRF is capable of 
promoting human glioma cell migration (Ziv-Av et al., 2011) and Lpd 
overexpression has been detected in glioma samples from patients 
(Petryszak et al., 2016), investigation into whether Lpd or SRF levels are 
associated with disease progression and patient outcome is warranted. 
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Material and Methods 
Fly husbandry and genetics 
Flies were reared at 25°C under standard conditions. All initial Drosophila strains 
have been previously described. 3rd instar larvae were examined 6 days after egg 
laying. Genotypes are provided in a supplementary file. 
 
Immunohistochemistry  
Tissues were dissected from 3rd instar larvae were fixed and stained as 
(Ciurciu et al., 2013) with minor modifications. After fixation for 20 min in 4% 
(w/v) paraformaldehyde in PBS, dissected brains from third instar larvae 
were washed in PBS with 0.1% Triton-X (PBST), then blocked for 2 h in 
PBST with 5% FCS (blocking solution). Primary antibody staining was done 
overnight at 4ºC in blocking solution, washed three times with PBST and 
incubated with secondary antibody in blocking solution for 2 h at room 
temperature. After three washes in PBST, brains were mounted in 
Vectasheild mounting media (Vectorlabs). Primary antibodies were as 
follows: mouse anti-phospho-Histone H3 (Abcam, 1:500); rabbit anti-Laminin 
(1:1000); guinea-pig anti-Repo (1:1000); rabbit anti-Repo (1:25,000); mouse 
anti-NimC1 P1 (Kurucz et al., 2007)(1:30), mouse anti-MMP1 (1:1:1 mix of 
3A6B4, 3B8D12, 5H7B11 from DSHB diluted 1:10); mouse anti-β−gal 
(Promega, 1:100); mouse anti-SRF (Active Motif, 1:100). Secondary 
antibodies were conjugated to Alexa-Fluor 555 or 633 (Invitrogen, 1:500). 
TO-PRO-3 Iodide (Invitrogen, 1:1000) or DAPI was used to visualise DNA.  
 
Image acquisition and analysis 
Dissected tissues were imaged on Zeiss LSM710, 780 or 880 microscopes 
equipped with 405nm, 488nm, 568nm and 633nm lasers using either Fluor 
20x or Plan Apochromat 40x/1.3NA oil immersion objective. Images were 
imported into OMERO (Allan et al., 2012) and adjusted for brightness and 
contrast uniformly across entire fields where appropriate. Figures were 
constructed in Adobe Photoshop. Quantitative analysis of raw confocal data 
was conducted using Bitplane Imaris version 8.2.0 (Oxford Instruments). The 
GFP channel was segmented into 3D volumes (5µm surface grain size) by 
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absolute intensity using an automatically selected intensity threshold. To 
remove small unattached objects, only the two largest volumes were kept per 
experiment (corresponding in all cases to the optic lobes), and their volume 
measured. To count the number of Repo or puc-lacZ positive cells, the 
above volumes were used to mask the relevant intensity channel, which was 
then subject to spot segmentation using an estimated spot diameter of 5µm 
and background subtraction. Spots were subjected to an automatically-
thresholded intensity filter. All automatic thresholding was visually inspected 
and adjusted if necessary. For quantitation of Mmp1 staining, stacks were 
projected in 'z' and then background subtracted in the Mmp1 channel. The 
GFP channel was used to segment, then the selection was measured in the 
Mmp1 channel. Whole animal micrographs were captured with a ZF10 
stereomicroscope (Leica) using LAS software (Leica).  
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Figure 1. Pico promotes spreading of RasV12-induced tumours. A, 
Images of whole larvae showing distribution of GFP expression induced in 
the eye- discs and optic lobes of larva of different genotypes, as indicated. 
Expression of GFP alone or together with the transgenes indicated, was 
driven by flipping-out an FRT-flanked linker from an Act>GAL4 element using 
eyFLP (eyFLP, Act>GAL4). Overexpression of RasV12 with pico resulted in a 
dramatic increase in GFP-marked tissue sometimes leading to the formation 
of GFP foci at more distant sites (arrow). B, Distribution of GFP expression in 
dissected brains showing overgrowth of the optic lobe and invasion of GFP-
labelled cells into the ventral nerve cord in RasV12, pico brains (VNC, 
arrows). Scale bar 100µM. C, Quantification of the volume of GFP-labelled 
cells in the optic lobes of the indicated genotypes, based on optical sections 
taken throughout the entire brain. D-E, Quantification of the invasion 
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phenotype. D, Individual cephalic complexes were assigned to one of four 
categories, depicted, based on the degree of VNC invasion observed: Type 
0, no invasion of the VNC, Type I, tumour cell invasion occurring down one 
side of the VNC, Type II, tumour cells invading both sides of the VNC; and, 
Type III, significant tumour cell invasion of the VNC combined with 
overgrowth/fusion of the optic lobes. E, Stacked bar chart showing the 
percentage of brains expressing either RasV12, pico, hLpd, pico/RasV12 or 
hLpd/RasV12, classified into each of the four categories (n=100 
brains/genotype).  
 
 
 
 
Figure 2. Brains co-expressing RasV12 and pico display extracellular 
matrix degradation and ectopic expression of Mmp1. A, Optic lobes from 
larvae overexpressing pico, RasV12 or RasV12, pico under the control of 
eyFLP, Act>GAL4, stained with anti-Laminin antibody, which labels the 
surface of the optic lobes. Laminin staining was found to be severely 
interrupted in brains co-expressing RasV12 and pico but not from brains 
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expressing pico or RasV12 alone. B, Distribution of the metalloproteinase 
Mmp1. Little or no Mmp1 staining was observed in animals expressing 
RasV12 or pico alone. In contrast, animals co-overexpressing RasV12 and pico 
had elevated MMP1 around the edges of the optic lobes and at sites of 
invasion into the VNC (arrow).  
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Figure 3. Mmp1 accumulation and invasion into VNC is dependent on 
JNK activation. A, Co-overexpression of RasV12 and pico in GFP-labelled 
tumours (green) leads to JNK activation in some tumour cells, based on β-
galactosidase staining to detect puc-lacZ (red). Top panels show low 
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magnification images of brains, lower panels show magnified images of 
tumours invading into VNC, which are enriched in puc-lacZ staining. Scale 
bars, 100 µm.  
B, Quantitation of number of puc-lacZ positive foci in GFP-labelled areas of 
the optic lobes from the indicated genotypes. B,C Blockade of JNK activation 
with dominant-negative Bsk/JNK (BskDN) suppresses activation of the JNK 
pathway. C, Representative images showing puc-lacZ induction in RasV12 
pico tumours and suppression of this effect by BskDN: the top row of images 
were taken from representative RasV12 pico larval brains; the bottom row 
were taken from siblings coexpressing BskDN. D,E Blockade of JNK 
activation with dominant-negative Bsk/JNK (BskDN) suppresses the induction 
of Mmp1. D, Representative images of RasV12 pico tumours with or without 
BskDN. E, Quantitation of mean intensity of Mmp1 within GFP-labelled RasV12 
pico tumours in the presence or absence of BskDN. F, BskDN suppresses 
RasV12/pico-mediated invasion into the VNC. Graph summarising extent of 
invasion in the different genotypes (n=100 brains of each type) according to 
the scale introduced in Figure 1, with 3 being the most severe and 0 
corresponding to no invasion.  
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Figure 4. Invasion is not driven by haemocyte recruitment and 
TNF/Eiger-dependent signalling. A, Possible model of extrinsic signalling 
from haemocytes to JNK activation in tumours. In the absence of RasV12, 
activated JNK leads to cell death, whereas in its presence, JNK promotes 
Mmp1 expression and cellular invasion. B, Images of dissected brains 
showing distribution of haemocytes, as detected with an anti-NimC1 P1 
antibody. Haemocytes were not detected in brains expressing pico or RasV12 
alone. In pico or RasV12 brains, haemocytes were sometimes observed at 
sites of invasion, but this was not a necessary outcome. C, Graph 
summarising extent of invasion in the different genotypes (n=100 brains of 
each type).  
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Figure 5. Distinct oncogenic effects in glial populations. A, Schematic 
outlining heritable overexpression in glial lineages following expression of 
eyFLP in glial progenitors and removal of an FRT-flanked linker from 
Act>GAL4 reconstituting the Act-GAL4 driver. This then constitutively drives 
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expression of UAS-GFP and other UAS constructs in daughter cells. B, (Top 
panels) Optic lobe from third instar larvae, with start of the VNC to the right of 
the image, showing the effect of co-expressing RasV12 and pico with this 
system. In particular, two distinct effects are observable in glia (Repo +ve, in 
blue): activation of JNK, marked with puc-lacZ (red) and accumulation of glial 
cells in a region proximal to the ventral nerve cord (yellow arrowhead). Inset 
is a magnified image of a Repo -ve cell staining positive for puc-lacZ (white 
arrowhead). Magnified images (bottom) show the GFP and puc-lacZ labelled 
population that has invaded into the VNC (arrow). Scale bars, 50 µm. C, 
Anti-Repo staining showing the effect of RasV12 and pico co-overexpression 
on glial distribution and number in optic lobes. Repo-stained images are 2D 
projections of confocal z-stacks from the bottom and top of the same optic 
lobe. Bottom sections reveal stereotypical arrangement of glia (arrows) in 
control optic lobes and those overexpressing pico, which is lost upon 
expression of RasV12. Scale bar, 100 µm. D, Graph showing quantification of 
number of Repo-positive glia in GFP-labelled areas of the optic lobes from 
the indicated genotypes. 
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Figure 6. Transcriptional blockade in glia blocks cooperation between 
RasV12 and pico. A, Schematic showing suppression of GAL4-mediated 
overexpression in glia using repo-GAL80. B, Brains (outlined with dashed 
line in first set of panels) overexpressing RasV12, pico with or without repo-
GAL80, showing distribution of GFP-labelled cells (green) and Mmp1 (red). 
Animals co-overexpressing RasV12, pico displayed invasion of Mmp1-
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expressing cells into the VNC (arrow). Mmp1 staining and invasion were 
suppressed in siblings containing repo-GAL80; optic lobes of these animals 
were also reduced in size. Scale bars, 100 µm. C, Measurements of the 
volume of GFP-labelled RasV12, pico optic lobe tumours with or without repo-
GAL80. D, measurements of mean intensity of Mmp1 staining in RasV12, pico 
tumours with or without repo-GAL80. E, Stacked bar chart summarising 
extent of invasion in the different genotypes (n=100 brains of each type). 
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Figure 7. Mal is rate limiting for tumour dissemination. A-B, Distribution 
of SRF in the third instar larval optic lobes. SRF antibody staining (red) 
overlaps that of Repo (blue) both at the surface (A) of the optic lobes and in 
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cross-section (B). In cross-section, staining in epithelial (eg), marginal (mg) 
and medulla neurophil (mng) glia is evident. C, Cooperation between RasV12 
and cytoskeletal regulators resulting in cancer cell invasion into the VNC. 
Graph summarising extent of invasion in the different genotypes (n=100 
brains of each type) according to the scale introduced in Figure 1, with 3 
being the most severe and 0 corresponding to no invasion. D, Summary of 
statistical tests for results of (C), showing pairwise combinations in each 
experiment; frequency, number of brains showing invasion/total number; 
FET, fisher’s exact test; ASI, average stage score of invasion; STT, 
Student’s t-test. E, malDN partially suppresses the effect of RasV12, pico 
cooverexpression. Graph summarises extent of invasion in the different 
genotypes (n=100 brains of each type). 
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4.2.3 Actin regulators modulate the SRE-mCherry expression	  
In the paper presented above, we propose that pico promotes cellular invasion, at 
least in part, through the activation of SRF signalling. SRF signalling is induced by 
changes in actin dynamics (Miralles et al., 2003), specifically by a change in the 
ratio of G:F actin sensed by the SRF cofactor Mal. It is thought that Pico regulates 
actin dynamics through its interaction with actin regulators, such as Chic, Ena, 
Scar/Wave, leading to an increase in filamentous actin (F) levels (Small et al., 2002) 
and reduction of monomeric actin (G) (Taylor, 2010). Reduction in the inhibitory 
binding of G-actin to the SRF cofactor MAL, enables translocation of MAL to the 
nucleus where it complexes with SRF to facilitate in the transcription of SRE-
containing genes. In Chapter 3, we made use of an SRE-mCherry reporter to monitor 
SRF activation in the wing disc; both pico and mal induced SRE-mCherry 
expression. However, the effects of chic, ena and scar had not been determined. 
With respect to the paper described above, it would be useful to fill this knowledge 
gap because it is possible that chic, ena and scar do not have an equal ability to 
promote SRF activation, which might be correlated with their ability to promote 
cellular invasion.  
 
To test this, chic, ena and scar were overexpressed in the posterior compartment of 
the wing imaginal disc using hh-GAL4  in the presence of the SRE-mCherry reporter 
(Crossing scheme in figure 4.3.).  
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Figure 4.2. Dissected wing discs from wandering males third instar larvae, 
showing the level of SRE-mCherry reporter expression (in red, detected with anti-
RFP antibody staining) in response to overexpression of different actin cytoskeleton 
regulators (mal, chickadee, ena and scar,) under the control of hh-GAL4 in the 
posterior half of the disc, which is marked with GFP (in green). Genotypes are 
ordered according to the qualitative strength of response from top (highest induction 
of mCherry) to bottom (lowest induction). Discs overexpressing mal and chic are at 
a slightly earlier stage when basal expression (apparent in the anterior half of the 
disc) is below the level of detection. Discs with ena and scar, which are visibly 
larger, are at a later stage and basal reporter gene activation can be observed in the 
anterior half, albeit at a lower level or in fewer cells than the posterior half. 15 wing 
discs were dissected and stained, the reporter has been observed in 12 discs out of 
15. 
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Figure 4.3. Genetic scheme used examine the effect of overexpressing different 
actin regulators under the control of hh>GAL4. Virgin females expressing 
hh>GAL4 crossed to males expressing actin regulators (mal, ena, chickadee and 
scar). Then GFP+ve wing discs were dissected from third instar larvae and stained 
for anti- RFP. 
 
Wing discs were dissected and stained with anti-RFP antibody prior to being imaged 
by confocal microscopy. A clear increase in the expression level of mCherry was 
detected in response to mal or chic overexpression. A lower level of reporter gene 
induction was detected in response to ena or scar overexpression.  
4.3 Discussion 
As outlined in the draft manuscript above, several lines of evidence suggest that 
Mal-SRF signaling is limiting for the effects of RasV12/pico on tumour invasion. 
Additional analysis of SRF activity, using the SRE-mCherry reporter, in wing 
imaginal discs supports the notion that extent of invasion may be correlated to 
degree of SRF induction; mal and chic had more pronounced effects than ena and 
scar on RasV12-induced tumours and also induced SRF most strongly. Attempts (not 
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shown) were made to examine SRE-mCherry expression in the brain, but 
measurements were unsatisfactory because of a high signal to noise ratio.  
 
A key piece of evidence showing the requirement for Mal/SRF signaling in cellular 
invasion has come from testing the effect of a dominant negative version of Mal 
(DN-Mal) on the ability of RasV12/pico tumours to become disseminated (Taylor, 
2010). Partial suppression of the invasion phenotype was observed, but the efficacy 
of DN-Mal has been hard to determine and so the full extent of Mal/SRF 
involvement still remains somewhat open to question. Attempts were made to assess 
the effect of DN-Mal on SRE-mCherry expressionin the wing imaginal disc, but this 
could not be readily determined because of low and somewhat variable basal levels 
of SRE-mCherry expression.  
 
An alternative approach to testing the role of Mal/SRF might be to examine 
proliferation and invasion in null mal or bs/SRF mutant clones expressing 
RasV12/pico. For practical reasons, this will be hard to do for mal mutants, which 
reside on the same chromosome as UAS-RasV12 and UAS-pico, but could be achieved 
more easily for bs/SRF mutants. However, clone production will be hard for glial 
lineages with low proliferation rates; for astrocyte-like glia or subperineurial glia, 
mutant clones will have to be induced in the embryo when these glia are still 
mitotically active.  
 
It would be interesting to explore which glia subtypes hyperproliferate in response to 
pico/RasV12 and which subtypes undergo invasion. Based on their location and 
morphology, Drosophila glia have been classified into different subtypes (Figure 
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4.4): perineurial glia (II) and subperineurial glia of the surface glia (I), the cortex glia 
(III), ensheathing glia (V) and astrocyte-like glia of the neuropile subtype (VI) 
(Freeman and Doherty, 2006, Edwards and Meinertzhagen, 2010, Awasaki et al., 
2008). In adult flies, Perineural glia have been shown to function in the formation 
of Blood Brain Barrier (BBB). While this subtype does not express repo, the pan-
glial cell marker, during early larval development (Nassif et al., 1998), repo does 
become evident during early pupal stages (Awasaki et al., 2008, Stork et al., 2008). 
Subperineurial glia help in septate junctions formation, as are considered a major 
component of BBB in larvae. Cortex glia enwrap neuronal cell bodies, forming a 
mesh in the bran cortex region (Freeman and Doherty, 2006, Awasaki et al., 2008). 
Finally, it is  thought that neuronal survival is promoted by Neuropile glia through 
providing trophic support based on the morphology of the Neuropile glia (Awasaki 
et al., 2006).  Neuropile glia can be categorised as ensheathing or astrocyte-like.  
 
Figure 4.4. Main morphological subclasses of glial cells in Drosophila. (A) 
Schematic overview of the central neuronal system (CNS) of the Drosophila third-
instar larvae. Optic lobes and ventral nerve cord shown in grey. (A’) dark grey 
represent the cortex, the region of cell bodies and the synaptic neuropil shown in 
light grey. I- VI represent the different subtypes of glial cells. B-G are the confocal 
images of glial subtypes morphology. Figure reproduced from(Stork et al., 2012).   
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The shortage of tools makes testing the glial subtypes quite difficult. There are not 
that many antibodies to stain different glia subtypes in larval brain. The only glial 
subtype that can be distinguished by antibody staining is the subperineurial glia, 
using anti-Moody antibodies (Stork et al., 2012). However, an alternative approach 
would be to express pico with glial-specific GAL4 drivers that are expressed in 
different subtypes, e.g.: spg-GAL4 for subperineurial glia, alrm-GAL4 for Astrocyte-
like glia and nrv2-GAL4 for Cortex glia (Stork et al., 2012). Dissected brains could 
then be examined for effects on proliferation or cellular invasion as described above. 
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5 Physical and functional interactions between MAPK and Pico 
5.1 Introduction 
Pico is capable of interacting with multiple proteins (Lofthouse, 2013), many of 
which are implicated in its role in hyperplastic growth and invasion, either through 
direct effects on the actin cytoskeleton or indirectly via downstream SRF activation, 
as discussed in the previous chapters. Multiple lines of evidence suggest that MRL 
proteins also associate with kinases and phosphatases, which are enzymes that 
regulate the phosphorylation state of proteins (Lofthouse, 2013). Reversible protein 
phosphorylation is an important mechanism of post-translational regulation, since 
the addition or removal of phosphatase groups can affect the ability of proteins to 
interact with one another, or affect their sub-cellular localisation and activity. MRL-
associated kinases and phosphatases are therefore well placed to regulate dynamics 
of MRL function and render them sensitive to upstream signals acting on the 
associated kinase and phosphatases. For instance, Lpd associates with and is 
phosphorylated by Abl  and this interaction positively regulates binding of Lpd to 
Ena/VASP proteins (Michael et al., 2010). Since Ena/VASP-binding sites in Lpd are 
not directly phosphorylated by Abl kinases, it is possible that Lpd’s tertiary structure 
is altered by the phosphorylation of Lpd, thus unmasking the Ena/VASP-binding 
sites (Michael et al., 2010). An intriguing possibility is that differential formation of 
trimolecular complexes between Lpd, c-Abl, and individual Ena/VASP proteins 
might allow for fine-tuning of signalling responses.  
Drosophila pico was originally identified in a yeast two-hybrid screen for 
serine/threonine protein phosphatase 1 (PP1) binding proteins (Bennett et al., 2006). 
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Binding of PP1 to Pico was found to be mediated by a canonical PP1-binding motif 
in Pico (Bennett et al., 2006); mutation of the critical Phe residue in this motif 
(F816A) is sufficient to abolish binding (Lyulcheva, 2006). More recently, 
bioinformatics analysis also revealed a highly conserved MAPK-binding motif 
adjacent to the N-terminus of the RA domain, which mediates an interaction with 
MAPK in S2 cell extracts (Lofthouse, 2013). Mutation of either the PP1-binding or 
MAPK-binding motifs enhances pico-mediated overgrowth of the wing, suggesting 
that MAPK and PP1 normally limit the effects of overexpressed pico (Lofthouse, 
2013, Lyulcheva, 2006). The substrates of Pico-bound PP1 and MAPK are not 
known, but Pico itself is known to be a phosphoprotein, having been shown to be 
phosphorylated at Ser819 in a large proteomics study of embryo extracts 
(Bodenmiller et al., 2007). A “phospho-mimetic” mutation of this site (S819D) 
abolished the effect of overexpressed pico on wing overgrowth, whereas a non-
phosphorylatable mutation (S819A) recapitulated the effect of disrupting MAPK 
binding. Additionally, PicoS819D, but not Pico∆MAPK or PicoS819A, was able to bind 
PP1 in cell extracts, suggesting the existence of a potential phosphorylation cascade 
(MAPK binding à pico phosphorylation at S819 à PP1 binding) involving MAPK 
and PP1 which deactivates the Pico complex. 
The functional effects of the various site-directed mutants and their ability to bind 
PP1 and MAPK are summarised in Figure 5.1. 
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Figure 5.1. Functional effects of the site-directed mutants in Pico and the ability 
of wild type and Pico variants to bind PP1 and MAPK. The domain structure of 
the Pico protein is shown together with that of the Pico variants listed on the left of 
the figure. RA = Ras-association domain, PH = Pleckstrin homology domain, P = 
Proline rich regions. The ability of the proteins to bind MAPK and PP1 is illustrated. 
X indicates the position of the site-directed mutant in the respective constructs. To 
the right of the figure is a summary of the effects of overexpression (OE) in the 
developing wing. 
	  	   161	  
5.2 Aims 
The main aim of the work presented in this chapter was to test a model put forward 
by Lofthouse (Lofthouse, 2013), based on the analysis of site-directed mutations 
described above, which proposed that MAPK binding leads to phosphorylation of 
Pico and the recruitment of PP1, resulting in the suppression of Pico activity in 
hyperplastic tissue overgrowth (see Chapter 4). This was assessed by determining 
the possible epistatic relationships between PP1-binding, MAPK-binding and Pico 
phosphorylation using double mutant pico constructs engineered to possess F816A 
or ∆MAPK (K221A; K224A; L229A) mutations in the presence of a second-site 
S819D mutation.  
 
The second aim of this chapter was to determine the importance of this putative 
regulatory mechanism in contexts other than wing overgrowth. To address this, the 
ability of pico∆MAPK to cooperate with oncogenic Ras was compared to that of picowt 
in the cell invasion model described in Chapter 4. 
 
5.3 Confirmation of loss of MAPK-binding to Pico 
Previous work performed in the Bennett lab had indicated that mutation of three 
conserved residues in a putative MAPK-binding motif in Pico (K221A; K224A; 
L229A) abolished the ability of Pico to interact with MAPK (Lofthouse 2013). To 
confirm this interaction, S2 cell extracts expressing Venus-tagged Pico
WT
,
 
Pico
ΔMAPK
, Pico
ΔPP1
, Pico
S819A 
and Pico
S819D 
variants were subjected to GFP-Trap 
pull-down and precipitates were examined for the presence of endogenous MAPK. 
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Unlike the other Pico variants, Pico
ΔMAPK
 was unable to bind MAPK, confirming the 
importance of K221, K224 and L229 for MAPK-binding.  
 
Figure 5.2. Blots showing presence of MAPK in precipitates from S2 cells 
expressing Pico wild type and variants. Pull-downs were carried out on S2 cells 
expressing Venus-tagged Pico
WT
,
 
Pico
ΔMAPK
, Pico
ΔPP1
, Pico
S819A 
and Pico
S819D 
constructs using GFP-Trap. Non-transfected S2 cell extracts were employed as a 
negative control. The samples were examined by western blot for the presence of 
MAPK. The result indicates that the Pico
ΔMAPK 
was unable to bind MAPK. This blot 
is representative of 3 experimental repeats. 
 
 
5.4 Rationale for making double mutations in pico 
Based on preliminary binding data from fly extracts (Lofthouse, 2013), loss of 
MAPK binding to Pico, or mutation of Ser 819 to Ala, blocked binding of Pico to 
PP1 (Figure 5.1). This suggests there may be a cascade whereby MAPK 
phosphorylation of S819 promotes the recruitment of PP1, which in turn acts to limit 
Pico function. To test this idea further, the following double mutants of Pico were 
generated; 1) S819D and MAPK-binding mutant; 2) S819D and PP1-binding 
mutant. (Figure 5.3). The rationale for making these constructs was as follows. If 
PP1-binding, and suppression of pico function, depends on the phosphorylation of 
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S819 by MAPK then the S819D mutation should compensate for the loss of MAPK 
binding in Pico
ΔMAPK
, bind to PP1 and limit tissue overgrowth. Conversely, because 
S819 phosphorylation is upstream of PP1-binding, the S819D and PP1-binding 
double mutant should still fail to bind PP1 and promote enhanced tissue overgrowth.  
	  
Figure 5.3. Expected capabilities of double mutants of pico; S819D (SD) and 
MAPK-binding mutant, and the S819D and PP1-binding mutant. SD and 
MAPK double mutant should suppress the effect of MAPK mutant; bind to PP1 and 
suppress overgrowth. SD and PP1 double mutant should not bind to PP1, and should 
therefore promote overgrowth. 
 
5.4.1 Generation of pico double mutant constructs 
First, generating PicoSD-MAPK double mutant. Pico
S819D 
construct and Pico
ΔMAPK
 
had previously been cloned into a Gateway pDONR221 entry vector to enable 
simple shuttling of the gene into appropriate destination vectors via LR 
recombination. Since the MAPK-binding site resides in a unique restriction fragment 
(SacI/SalI) in this vector, the MAPK-binding mutation could be combined with the 
S819D mutation by subcloning. For this, both pDONR221 Pico
ΔMAPK  
and 
pDONR221 Pico
S819D 
were digested with SacI and SalI (Figure 5.4). Products were 
run on a low melting agarose gel to separate the products. The resultant ≈ 500bp and 
	  	   164	  
≈ 5000bp bands were cut from the pDONR221 Pico
ΔMAPK  
and pDONR221 Pico
S819D 
lanes, respectively, before being purified with a gel extraction kit. Following gel 
purification of the DNA fragments, ligation was performed to insert the short 
fragment of pDONR221 Pico
ΔMAPK  
≈ 500bp into the vector pDONR221 Pico
S819D 
using T4 DNA ligase and the products transformed into competent cells. These cells 
were subsequently plated onto selective media and single colonies picked. 
Sequencing was then employed to validate the newly formed constructs (data not 
shown). 	  
 
 
Figure 5.4. SacI-SalI restriction sites. Schematic diagram showing SacI-SalI 
restriction sites within the Pico
ΔMAPK
mutant and pDONR221 Pico
S819D 
vectors.  	  
Second, generating PicoSD-F816A double mutant. PCR-based site-directed 
mutagenesis was used to create the Pico SD- F816A 
 
double mutant constructs. Briefly, 
overlapping primers complementary to the proposed mutational sites, but possessing 
specific changes required for each construct, were synthesised. A high-fidelity DNA 
polymerase was used to amplify the complete pDONR221 Pico
S819D
vector via PCR, 
before the resultant products were exposed to the endonuclease DpnI. DpnI 
Pico
ΔMAPK
 Pico
S81
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specifically cleaves methylated DNA created by DNA methyltransferases (DNMTs) 
present within the host cell of the parental Pico
S819D 
strand, but not the PCR reaction 
mix. Consequently, only the DNA of  pDONR221 Pico
S819D 
vector  was digested, 
where as the new mutants was not digested to be able to be transformed into 
chemically competent cells and end joining by the host cells. These cells were 
subsequently plated onto selective media and single colonies picked. To ensure that 
the cloning worked, three colonies were picked and digested with SacI-SalI to 
confirm that there is a 500bp insert and with StuI to check whether the wild type 
fragment has been replaced with the mutant because StuI able to cut the wild type 
but not the mutant (Figure 5.5). Sequencing was then employed to validate the newly 
formed constructs.  
 
Figure 5.5. Agarose gel electrophoresis to validate the cloning.  Three colonies 
were picked from the plates then SacI-SalI and StuI restriction digests were 
performed. The resulting products were run on an agarose gel, which confirmed the 
correct orientation of the inserted constructs. 
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5.4.2 Insertion of constructs into flies 
Following generation of pico double mutation constructs within the pDONR221 
entry vector, an appropriate destination vector needed to be selected to enable their 
expression within flies using the Drosophila GAL4-UAS system.  The pTVW vector 
(#1091) was selected from the Drosophila Genomics Resource Centre (DGRC). 
pTVW possesses a UASt promoter to enable somatic expression under the direction 
of GAL4, and an N-terminal Venus tag. Venus is an enhanced Yellow Fluorescent 
Protein (YFP) fluorophore derived from Green Fluorescent Protein (GFP) following 
the addition of several mutations (Rekas et al., 2002). 
  
Shuttling the constructs from the pDONR entry clones into pTVW destination 
vectors was performed using the LR recombination. The resultant products were 
transformed into competent cells that were selected on the presence of amp
r 
and the 
absence of the toxic ccdB gene, which is present in unrecombined destination 
vectors. The accuracy of the insertion and the orientation of the pico double mutants 
constructs within the pTVW vectors were verifying using Xhol and SacII restriction 
digestion enzymes. The results confirming correct incorporation by gel 
electrophoresis of the restriction products is shown in (Figure 5.6). 
 
 
	  	   167	  
 
Figure 5.6. Agarose gel electrophoresis to validate pTVW Pico vectors following 
LR recombination. Xhol-SacII restriction digests were performed on pTVW Pico 
vectors following LR recombination. The resulting products were run on an agarose 
gel and confirmed correct orientation of the inserted constructs.  
 
Following validation of the destination vectors, P-element mediated germline 
transformation was used to generate transgenic flies possessing copies of the UAS- 
controlled Venus tagged Pico constructs by Genetic Services, Inc (USA). Briefly, the 
pico double mutant constructs, positioned between P-element ends and alongside a 
white+ minigene marker within the pTVW vectors, were injected into w
1118 
embryos 
along with the helper vector pUChsDelta2-3 to provide a source of P-element 
transposase. Afterward, the P-element with UASt-Venus Pico as its cargo was 
randomly transposed to an indiscriminate chromosomal site (Spradling and Rubin, 
1982). The resulting flies were then returned for further analysis. 
5.4.3 Determination of Venus-Pico expression levels in fly extracts 
Constructs could be located in regions of generally high (euchromatin) or low 
(heterochromatin) gene expression because of the random nature of P-element 
insertion, dictating in turn the expression levels of the construct itself. As such, the 
relative Venus-Pico expression level was assessed for each line. Male flies 
expressing the pico double mutant constructs were crossed to virgin females 
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containing da-GAL4 driver, then progeny were collected. Visualisation of 
fluorescent Venus in flies carrying the da-Gal4 driver and one copy of the transgene 
of interest was first carried out for verification and analysis of ectopic protein 
expression. Following attempts to confirm expression levels through Western blot 
analysis using anti-GFP (Life technologies) proved successful to enable appropriate 
lines for each construct to be selected for future use (Figure 5.7, 5.8 and Table 5.1). 
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Figure 5.7. Examination of the pico double mutant expression level under the 
control of da-GAL4. Western blots were carried out to assess the relative expression 
levels of Pico double mutants using anti-GFP antibody. Further control blots were 
carried out using anti-Actin antibody to control for total protein in the samples. 
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Figure 5.8. Average expression level of Pico double mutations. Expression level 
of Venus-Pico in different transgenic Drosophila lines normalized to the level of β- 
Actin. Results are expressed as mean ± SE for the different genotypes (n=3). 
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Table 5.1. Quantification of Westerns blot of different Drosophila lines. 10 adult 
flies were collected from different Drosophila lines presented in (A) and (B). The 
resultant gels were blotted with anti-GFP antibody and anti-β-actin as a loading 
control. The blots were separately scanned by densitometry and the area under the 
peak corresponding to each protein was first normalised to that of actin. 
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Once characterisation was completed, appropriate lines were selected from each 
construct for use in future experiments. Choices of transgenic lines were made based 
on their relative expression levels, characterised as either high (e.g. PicoSD-FA21), 
moderate (e.g PicoSD-FA7.2), or low (e.g. PicoSD-FA5).  
 
5.5 Quantification of the effect of single site-directed mutations in pico on wing 
overgrowth 
To assess the effect of the double mutants on pico function, their ability to promote 
tissue overgrowth when overexpressed under the control of MS1096-GAL4 was 
determined. For comparison, a panel of UAS-Venus-tagged pico transgenic flies 
carrying single site-directed mutations were first analysed: Pico
WT
,
 
Pico
ΔMAPK3
, 
Pico
ΔPP1
, Pico
S819A 
and Pico
S819D
. It had previously been demonstrated that the 
presence of an N-terminal Venus-tag did not affect pico's ability to promote wing 
overgrowth (Jonchere and Bennett, 2013). Wings from 30 male adult flies were 
examined from each genotype and compared to sibling MS1096-GAL4 control flies 
grown in the same vials to ensure identical genetic and environmental backgrounds. 
 
5.5.1 The ability of Pico to induce growth and proliferation 
To determine the effect of pico transgenes on tissue growth, adult wings were 
dissected from flies expressing the Venus-tagged pico variants and the surface area 
was measured using ImageJ. Wings from Venus-Pico
WT2 
 were 6% bigger than the 
MS1096-GAL4 control (Figure 5.10A). Ectopic expression of the Pico
MAPK3 
and 
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Pico
F816A
 mutants resulted in significantly enhanced wing overgrowth compared to 
their controls (p<0.001), with increases in wing size of 15% and 19% observed, 
respectively (Figure 5.10B, C). This effect was considerably higher than that 
observed in flies expressing Venus-Pico
WT
. These data indicate that disruption of the 
PP1 and MAPK binding motifs potentiates the effect of ectopic Pico.  
 
Flies expressing the non-phosphorylatable Pico
S819A 
and phosphomimetic Pico
S819D 
constructs using the MS1096-GAL4 driver were assessed to determine the role of 
phosphorylation in regulating the function of Pico. Ectopic Pico
S819A 
caused 20% 
increase in wing size. Contrastingly, overexpression of Pico
S819D 
led to a minor 2% 
increase in wing size, suggesting that phosphorylation at serine 819 may disrupt the 
ability of Pico to induce tissue overgrowth.  
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Figure 5.10. Ectopic expression of pico
ΔMAPK3 , pico
F816A  and pico
S819A mutants 
display significant overgrowth compared to Venus-pico
WT2 
. A-E, Representative 
adult wings from male MS1096-GAL4 flies with and without UAS-Venus-pico 
variants. (A) Wings from flies containing the MS1096-GAL4 driver only were used 
as a comparative control in each cross. A representative example is shown here. (B) 
Flies expressing Venus-Pico
ΔMAPK3
under the control of the MS1096-GAL4 driver 
yielded a 15% increase in wing size while ectopic (C) flies expressing Venus-
pico
F816A 
and (D) flies expressing non-phosphorylatable Venus-pico
S819A
 caused 
significant overgrowth, with increases in wing size of 19% and 20%, respectively. 
(E) Overexpression of phosphomimetic Venus-pico
S819D 
 showed only a slight 
increase compared to the control. Wing area is expressed as a percentage of control 
(mean ±SD, n=40). 
 
	  	   175	  
5.5.2 Ability of pico double mutants to induce growth and proliferation 
Having established the effect of single mutants in pico, the double mutants generated 
in this chapter were then analysed. As shown in Figure 5.11. below, ectopic Pico
SD-
ΔMAPK4 
caused a very slight increase in wing size 3%. This is significantly reduced 
compared to the effect of Pico
ΔMAPK3
 alone (p<0.001), suggesting that the S819D 
mutation is capable of compensating for the loss of MAPK binding, consistent with 
the model of Lofthouse (Lofthouse, 2013)., Also in keeping with our expectations, 
Pico
SD-FA(16)  
 and Pico
SD-FA(10) 
led to a considerable increase in wing size of 15% and 
8%, respectively, comparable to the effect of Pico
F816A
  alone. This would be 
expected if loss of PP1 binding was epistatic to S819 phophorylation, which is 
mimicked in these experiments by the S819D mutation. 
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Figure 5.11. Substitution of Serine 819 modulates the effect of other site-
directed mutations on pico-mediated overgrowth. (A) Flies containing only the 
MS1096-GAL4 driver were utilised as a comparative control and exhibited wing 
sizes comparable to w
1118
. (B) Flies expressing pico
SD-ΔMAPK4 
 only caused a 
negligible 3% wing overgrowth, whereas (C) overexpression of pico
SD-FA16 
and (D) 
pico
SD-FA10
 were found to possess wings displaying a considerable 15% and 8% 
increase in wing size. Wing area is expressed as a percentage of control (mean ±SD, 
n=40).  
 
5.5.3 Western blot using anti-GFP 
An important caveat to the interpretation of the experiments performed above is that 
the expression level of Venus-Pico constructs might not be equivalent to one 
another. Consequently, the phenotypic effect of overexpression might not be a 
function of the site-directed mutations harboured by each pico variant. 
 
To examine this, 20 wing discs were dissected from flies expressing Venus-pico
WT 
and mutants 
and extracts were examined by immunoblotting with an anti-GFP 
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antibody. Blotting with anti-Actin antibody was used to control for total protein. 
Notably, the levels of PicoΔMAPK3, PicoF816A, and PicoS819A, which promote 
exaggerated overgrowth were expressed at higher levels than Pico
WT2
, whereas 
Pico
S189D
 and Pico
SD-ΔMAPK4 
, which display reduced overgrowth compared to  
Pico
WT2
 were expressed at lower levels. One must therefore caution the 
interpretation of the growth studies reported above and in Lofthouse (Lofthouse, 
2013) since the differing effects of site-directed mutants might reflect their level of 
expression rather than effects on pico function. 
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Figure 5.12. pico level of production in different Drosophila lines. Total extracts 
from w
1118
, MS1096-GAL4 UAS-pico
WT2
, MS1096-GAL4 UAS- picoΔMAPK3
  
, 
MS1096-GAL4 UAS-pico
F816A
 , MS1096-GAL4 UAS-pico
S819A   
, MS1096-GAL4 
UAS-pico
S189D
 , MS1096-GAL4 UAS- pico
SD-ΔMAPK4
 , MS1096-GAL4 UAS-pico
SD-
FA16
 and MS1096-GAL4 UAS- pico
SD-FA10
wing discs were analysed by Western 
blotting to ascertain the levels of Venus-Pico using anti-GFP antibody and anti-Actin 
as a control. The results showed that the MS1096-GAL4 Pico
S189D
 and MS1096-
GAL4 Pico
SD-ΔMAPK4
 displayed very little apparent of Pico compared to the other. 
Figure 5.13. Expression level of Venus-tagged Pico in fly extracts as determined 
by anti-GFP Western blotting. The graph shows the expression level of Pico in 
different Drosophila lines. Flies expressing PicoS819A have the highest level of 
protein. While flies expressing PicoSD-ΔMAPK4 have the lowest level of the protein. 
Results are expressed as mean ± SE for the different genotypes (n=3). 
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Table 5.2. Quantification of Venus-Pico protein levels in Drosophila extracts. 20 
wing discs were collected from different Drosophila lines then 4 win discs were 
loaded per lane. The resultant gels were blotted with anti-GFP antibody and anti-β- 
actin as a loading control. The blots were separately scanned by densitometry and 
the area under the peak corresponding to each protein was first normalised to that of 
actin and then ratioed to the level of that protein 
found in w1118 flies. The mean relative abundance mean ± SE form three separate 
experiments is shown. 
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5.6 Characterisation of wild type and mutant pico transgenes 
A second aim of this chapter was to test the ability of pico∆MAPK3 to cooperate with 
oncogenic Ras compared to that of picoWT in the cell invasion model described in 
Chapter 4.  Given the findings reported above, we reanalysed expression levels of 
the available pico∆MAPK3 and picoWT transgenic lines to ensure we could make robust 
inferences about the functional effects of the site-directed mutations. This was done 
using an alternative approach to Western blotting; in brief, the Venus-tagged 
proteins were expressed in a segmented fashion using engrailed-GAL4, which is 
expressed in a few cells along segment boundaries, and intensity of Venus 
fluorescence measured by densitometry. Images were captured with equivalent 
settings in order to compare relative expression levels. picoWT line 2 and pico∆MAPK 
line 3 had the highest expression level, with pico∆MAPK3 being approximately twice 
the level of picoWT2, consistent with the measurement of protein levels by Western 
Blotting (Figure 5.13). picoWT lines 4 and 6, and pico∆MAPK lines 8 had lower levels 
of expression. (Figure 5.14. and 5.15).  
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Figure 5.14. Representative images of larvae expressing different transgenic 
lines of Venus-pico wild type, and MAPK mutant under the control of an 
engrailed-Gal4 driver. Images (1,2 and 3) represent Venus-pico wild type line 2, 4 
and 6. Images (4,5 and 6) represent Venus-pico MAPK mutant line (3,5 and 8). 
These show fluorescence of the Venus-tagged protein in the different lines, which 
can be used to measure of the relative abundance of the ectopic protein. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15. Expression level of Venus-tagged Pico in larvae as determined 
fluorescence level. The graph shows the expression level in different lines of Venus-
picoWT o r ΔMAPK. Expressing level of Venus-picoΔMAPK3 is almost twice the level of 
Venus-picoWT2.  
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5.7 Disruption of MAPK-binding to Pico promotes metastasis of RasV12 -induced 
tumours 
Previous work, described in Chapter 4, showed that overexpression of pico, under 
the control of eyFLP is capable of promoting the invasion of RasV12-induced tumours 
in the larval CNS. The eyeless promoter that was utilised drives expression 
throughout the eye-antennal imaginal discs as well as in a number of defined regions 
of the optic lobes, but not in the VNC. Therefore it is possible to determine if tumour 
cells have migrated from their original location by examining the localisation of 
GFP-labelled cells in the cephalic complex, which consists of -antennal discs (ED), 
optic lobes (OL), and ventral nerve cord (VNC).  
 
To compare the effect of picoWT2 or4 and picoΔMAPK3 on RasV12-induced tumours, 
larvae of the following four genotypes were generated (crossing scheme presented in 
Figure 5.16.) 
1- eyFLP/Y; !"#!!"#$%&! ; !!!"!!!"#!,!"#!!"#!  
2- eyFLP/Y; !"#!!"#$%&! ; !!!"!!!"#!,!"#!!"#!"#!!"#$%!!"#$  !"#  
3- eyFLP/Y; !"#!!"#$%&!"#!!"#$%!!"#$  !"#; !!!"!!!"#!,!"#!!"#!  
4- eyFLP/Y; !"#!!"#$%&!   ; !!!"!!!"#!,!"#!!"#!"#!!"#$%!!"#$  !!"#$% 	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Figure 5.16. Crossing scheme used to generate ey> RasV12, ey>picoWT2 and 4, 
ey>picoΔMAPK3 larvae to examine the effect of pico MAPK binding mutation. The 
first scheme was to generate a virginiser tester strain and the second scheme was to 
generate the larvae harbouring RasV12 induced tumours with or without pico. 
 
50 brains were dissected from third instar larvae overexpressing RasV12 alone, RasV12 
and picoWT2 or RasV12 and picoWT4. 20 brains were dissected from larvae 
coexpressing  RasV12 and picoΔMAPK3. Fewer brains were dissected of this genotype 
because the cephalic complex from its attachments without damaging the underlying 
structures. The brains were examined using a fluorescence stereomicroscope. RasV12 
overexpression resulted in an increase in the eye-antennal discs size and exhibited a 
loss of morphology, however, no cell migration was observed (Figure 5.17). 
Overexpression of RasV12/ picoWT resulted in significant overproliferation of the eye-
antennal imaginal discs and an accompanying loss of morphology. Furthermore, 
GFP-tagged tumour cells were no longer exclusively found in the eye discs and optic 
lobes, with invasion of the VNC clearly visible (Figure 5.17). Two independent 
insertions of the wild type pico transgene showed similar effects with RasV12 despite 
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being expressed at different levels (Figure 5.17). However, overexpression of a 
version of pico lacking its MAPK binding site (picoΔMAPK3) showed an enhanced 
effect with RasV12 relative to wild type pico; larvae exhibited massive growth in the 
eye disc and loss of morphology in the optic lobes (Figure 5.17).  
 
  
Figure 5.17. Overexpression of pico in conjunction with oncogenic RasV12 
promotes tumour cell migration. The figure shows representative cephalic 
complexes. Image (A, B and C) illustrates the effect of RasV12 alone; (D, E, F, G, H 
and I) show the effect of RasV12 and Wild type Pico;(J, K and L) show the effect of 
RasV12 and mutant Pico in MAPK binding site. 50 brains were dissected from third 
instar larvae. 
RasV12 
RasV12 
+PicoWT2 
RasV12 
+PicoWT4 
RasV12 
+PicoΔMAPK3 50 µm
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The tumour cell invasions produced from each of the phenotypes (picoWT line 2 &4) 
were quantified (Figure 5.18). The degree of invasion was assigned one of four 
categories based on the degree of the invasion into the ventral nerve cord. Type 0 
corresponded to no invasion to the VNC; type I corresponded to tumour cell invasion 
occurring down one side of the VNC; type II corresponded to tumour cell invasion 
from both side of the VNC; type III corresponded to significant tumour cell invasion 
to the VNC as well as overgrowth of the optic lobes. The two WT overexpression 
lines (line 2 and 4) caused a similar degree of overgrowth in the eye disc and 
invasion of the tumour cells to the ventral nerve cord when expressed with RasV12 
(0.98± 0.12) and (0.98± 0.11) respectively. 28% of the RasV12and picoWT (line 2) and 
26% of the RasV12and picoWT (line 4) brains were found to exhibit no VNC invasion 
(Figure 5.18). 54% of the brains of the RasV12and pico WT (line 2) and 56% brains 
of the RasV12 and picoWT (line 4) were found to have type I invasion (Figure 5.18). 
10% and 12% of brains of the RasV12and picoWT (line 2&4) were assigned to type II 
invasion respectively, and 8% and 6% of brains of the RasV12and picoWT (line 2&4) 
were assigned to type III categories respectively (Figure 5.18). Brains dissected from 
larvae expressing RasV12alone were entirely composed of type 0 (Figure 5.18).  
 
The tumour cell invasions produced from RasV12 picoΔMAPK3 could not be quantified 
as a result of the enormous growth of the eye disc, which made it impossible to 
discriminate between the optic lobes and ventral nerve cord. Larvae of RasV12 
picoΔMAPK5and 8 also have abnormal brains, similar to RasV12 picoΔMAPK3 brains, which 
make it difficult to dissect without damaging the underlying structures. 
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Figure 5.18. Quantification of the severity of metastasis observed in 
ey>RasV12and ey>RasV12, picoWT2 and 4 brains. A) Type 0 corresponded to no 
invasion to the VNC; type 1 corresponded to tumour cell invasion occurring down 
one side of the VNC; type 2 corresponded to tumour cell invasion from both side of 
the VNC; type 3 corresponded to significant tumour cell invasion to the VNC as well 
as overgrowth of the optic lobes. 50 brains were dissected for each genotype. 
 
5.8 Discussion 
Previous work presented in the literature had identified the Ser 819 as a site of 
phosphorylation within Pico (Bodenmiller et al., 2007). Studies utilising PicoΔMAPK, 
which disrupts binding to MAPK, implicated MAPK in the phosphorylation of 
Serine 819 (Lofthouse, 2013), a residue situated next to the PP1-binding motif.  
 
The investigations also indicated that Pico mediates growth. Previous work within 
the Bennett laboratory has developed a series of site-directed mutants of pico such as 
Protein Phosphatase 1 binding site mutation (PicoF816A), non-phosphorylatable 
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(PicoS819A) and phosphomimetic  mutations of S819 (PicoS819D) and mutation in the 
MAPK binding site  (Pico∆MAPK3), which affect on Pico functions (Loufthouse, 
2013). These mutations have been examined for their effect on pico-mediated growth 
by measuring effects on adult wing size. Wings expressing picoF816A and pico∆MAPK3 
mutants showed significant overgrowth compared to wild type pico indicating that 
disruption of the PP1- and MAPK-binding motifs potentiates the effect of ectopic 
pico. This finding identifies potential roles for PP1 and MAPK as negative regulators 
of pico function. In addition, the importance of the phosphorylation in regulating 
pico's activity was examined by using flies expressing the non-phosphorylatable 
picoS819A and phosphomimetic picoS819D constructs, although it should be noted that 
substitution of Ser819 for an Asp residue may not fully replicate the effects of 
covalent addition of a phosphate group to Ser. Wing measurements showed that 
there was a significant increase in wing size in flies expressing picoS819A, that was 
comparable to expression of picoWT2. Contrastingly, overexpression of picoS819D 
caused a slight increase in wing size, suggesting that phosphorylation at serine 819 
may disrupt the ability of pico to induce tissue overgrowth. These findings were 
examined further by generating double mutant constructs: PicoSD-ΔMAPK and PicoSD-
FA. Flies expressing picoSD-ΔMAPK showed a reduction in wing size compared the wing 
produced from flies expressing the pico∆MAPK mutant, confirming that the ability of 
pico to promote tissue overgrowth can be disturbed by the phosphorylation at Ser 
819, whilst picoSD-FA retained the ability of picoF816A to produce exaggerated 
overgrowth.  
 
An important caveat to the findings above however is that the expression level of the 
Venus-pico transgenic lines used in these experiments was not equivalent. This 
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problem is most likely caused by different position effects associated with each of 
the transgenes, which were inserted randomly into the Drosophila genome using P-
element transposition (Spradling and Rubin, 1982). A highly efficient site-specific 
transposition system has been reported that makes use of the Streptomyces φC31 
integrase (Groth et al., 2004). Studies have been shown that φ C31 used for either 
simple insertion plasmids or for larger constructs (Venken et al., 2010), via a single 
attP site (integrated) and attB sites (vector) recombination (Cherbas et al., 2015). 
Two new sequences, attL and attR, are produced from this recombination, that 
occurs at a core TTG common to both site (Kuhstoss and Rao, 1991, Rausch and 
Lehmann, 1991)(Figure 5.20).  Now that well-characterised Drosophila strains 
containing attP landing sites are widely available, it would be desirable in the future 
to use this system to compare the effects of UAS-pico variants and will help to 
confirm their functional effects.  
 
Figure 5.19. φC31-mediated integration of DNA into the Drosophila genome. An 
attP in the Drosophila genome acts as the recipient site. A pUAST plasmid 
containing attB is coinjected with φC31integrase mRNA into attP-containing 
recipient embryos, leading to insertion of the transgene into attP site. Two new 
sequences attL and attR are formed resulting in preventing further integrase-
catalysed movement of the integrated transgene. Figure adapted from (Fish et al., 
2007).  
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In the last part of this chapter, disruption of the MAPK binding site was examined 
for its ability to promote cellular invasion compared to a wild type pico transgene. 
Data showed that co-overexpression of RasV12 and pico had a greater effect on 
tumour growth than overexpression of RasV12 on its own, in keeping with the 
findings reported in Chapter 4. It is useful to note that the presence of an N-terminal 
Venus tag did not obviously interfere with pico’s ability to promote invasion in this 
context. Disruption of the MAPK binding site in pico caused significant overgrowth 
in the eye disc compared to wild type pico. This suggests that MAPK binding may 
negatively regulate pico’s activity in the eye disc as it does in the wing. However, 
the effects of pico∆MAPK3 on the invasion of RasV12-induced tumours was hard to 
assess because brains coexpressing these proteins were morphologically abnormal.  
One way to address this issue might be to make clones of cells co-expressing 
pico∆MAPK3 and RasV12, to limit the amount of tissue affected. Alternatively, it would 
be interesting to test the effect of overexpression with glial-specific drivers, which 
also may limit the morphological defects but reveal effects on e.g. proliferation and 
invasion of the different glial subtypes. 
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6 General discussion 
6.1 A novel tool for monitoring SRF activity 
This thesis has employed the model organism, Drosophila melanogaster to examine 
the role of the MRL protein in promoting tissue growth and cell migration. It has 
been proposed that members of this family facilitate the transduction of signals 
derived from membrane receptors to changes in the actin cytoskeleton allowing 
regulation of actin dynamics, cell adhesion, migration and growth (Krause et al., 
2004, Lafuente et al., 2004, Lyulcheva et al., 2008, Colo et al., 2012b). In addition, 
MRL proteins have been reported to have the ability to activate serum response 
factor (SRF) in vitro (Pinheiro et al., 2011), but in vivo evidence for MRL-induced 
SRF signalling had been lacking. To address this we generated an SRF responsive 
reporter gene that faithfully replicates the endogenous pattern of SRF expression and 
reveals developmental-dependent changes in the level of expression (Chapter 3.2.2). 
In Chapter 3 we demonstrate that pico is capable of inducing the expression of this 
reporter in developing wing imaginal discs. The reporter is also responsive to 
overexpression of the SRF cofactor Mal and other actin regulators, including Ena, 
Chic, Scar that can alter actin dynamics (Chapter 4.3). These findings are consistent 
with a model, proposed by Lyulcheva that Pico induces SRF activation via its 
association with actin regulators (Lyulcheva, 2006, Lyulcheva et al., 2008). It would 
be interesting to test this explicitly using site-directed mutagenesis of the Ena and 
Scar binding sites in Pico.  
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Although several lines of evidence suggest that the SRF reporter described in 
Chapter 3 is induced in response to changes in actin dynamics and developmental 
cues, it has not yet been demonstrated that expression is diminished in cells lacking 
SRF. However, the difficulty of detecting basal mCherry expression made it hard to 
confirm whether bs/SRF mutant clones lose the ability to induce the SRF reporter 
(Chapter 3.2.3). Analysis of the effect of clones in the pupal wing, where expression 
is strongest, might help to address this issue. Of note, however, was the observation 
that mutant clones in the periphery of the wing disc showed elevated reporter 
activity, indicating that bs/SRF negatively regulates the reporter in a spatially-
dependent manner.  
 
A prerequisite to understanding mechanisms of transcriptional activation and 
inhibition mediated by SRF in the wing disc is the identification of SRF-target 
genes, which are not yet fully determined. In the ovary, actin itself has been 
proposed to be a key SRF target (Muehlich et al., 2016).  Another potential target, 
uncovered by transcriptomics analysis performed by Vincent Jonchere (see Chapter 
3) is deterin, which encodes Drosophila Survivin. To test the importance of deterin, 
we examined the effect of overexpressing pico in wing imaginal discs with or 
without deterin RNAi knockdown (deterinIR), using activated Caspase 3 antibody to 
identify cells undergoing apoptosis. A dramatic increase in the number of cells 
undergoing cell death were observed when coexpressing pico, particularly in the 
wing pouch where SRF and SRF-dependent gene expressed (Chapter 3.2.2). These 
data suggest that pico-induced deterin expression is necessary to suppress 
proliferation induced apoptosis.   
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6.2 The role of MRL proteins in hyperplastic growth and cell invasion 
Previous studies in the Bennett laboratory demonstrated that Pico, in addition to its 
role as a growth regulator, possesses the capacity to regulate cell spreading in model 
of cancer metastasis (Taylor, 2010). Using the Drosophila RasV12 model of 
metastasis it was found that co- expression of RasV12 and pico promoted the 
breakdown of extracellular matrix and tumour dissemination (Chapter 4.2.2).  In 
Chapter 4, we report the results of genetic experiments revealing that the effects of 
coexpressing RasV12 and pico are restricted to glial cells in the CNS, which are 
enriched in SRF. SRF signalling is therefore also implicated in the cooperative 
phenotypes in the larval brain that we have described. These studies could 
potentially be extended by looking at the levels of the SRE-mCherry reporter in 
metastatic brains. Preliminary experiments were performed along these lines (not 
shown) but the level of mCherry fluorescence was very weak, though detectible in 
glia, but the signal to noise ratio was low making quantitation impossible. One way 
to address this in the future might be to make use of multiple transgenic insertions of 
the SRE-mCherry construct.  
 
It would be also interesting to use the reporter in studying cell invasion in other 
contexts. pico and mal have independently been reported to play a role in invasive 
border cell migration in the Drosophila ovary (Law et al., 2013, Somogyi and Rørth, 
2004). Ectopic overexpression of pico was found to promote migration of the border 
cell cluster towards the oocyte, while depletion of pico by RNAi resulted in retarded 
migration of the cluster relative to wild type (Law et al., 2013). Scar may be an 
important mediator of pico’s affects on the actin cytoskeleton in border cells, but 
whether indirect effects via Mal-SRF are involved is not clear (Law et al., 2013).  
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Analysis of the SRE-mCherry reporter in this context might help to clarify this 
matter. 
 
6.3 Regulation of MRL protein function by reversible phosphorylation 
Reversible phosphorylation is a key mechanism that provides temporal and spatial 
control to cellular processes and the organisation of cellular structures, including the 
actin cytoskeleton, which is dynamically regulated. It is perhaps not surprising 
therefore to find MRL proteins associated with kinases and phosphatases. The Ser 
819 has been identified as a site of phosphorylation within Pico (Bodenmiller et al., 
2007).  
 
Previous studies indicated that phosphorylation of Serine 819 modulates binding of 
PP1 to Pico at residues 813-816 and that phosphorylation and PP1-binding was 
dependent on binding of MAPK to Pico at a more N-terminal site (Lofthouse, 2013). 
Here we found that Pico
∆MAPK
, Pico
F816A 
and Pico
S819A
, which all prevent binding to 
PP1, enhanced proliferative effects compared to Pico
WT
 suggesting that PP1-binding 
negatively regulates pico function (Chapter 5.4.1). These findings were examined 
further by generating double mutant constructs: PicoSD-ΔMAPK and PicoSD-FA. 
Reduction in wing size was observed in flies expressing PicoSD-ΔMAPK, which would 
be predicted to allow binding to PP1, compared to wings produced from flies 
expressing the Pico∆MAPK , inhibits PP1-binding (Chapter 5.4.2). These data indicate 
that the ability of pico to promote tissue overgrowth can be disturbed by the 
phosphorylation at Ser 819 and are consistent with a functional interaction between 
Pico-associated MAPK and PP1. In contrast, picoSD-FA showed a similar ability to 
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promote wing overgrowth to picoF816A, which would be expected if this double 
mutant prevents binding to PP1 (Chapter 5.4.2). In addition, data in this report 
suggests that Pico’s activity is negatively regulated by MAPK binding in the eye disc 
as it does in the wing, as disruption of the MAPK binding site in pico caused 
significant overgrowth in the eye disc compared to wild type pico (Chapter 5.6). 
Clearly, it will be necessary to confirm the predictions of this model biochemically, 
e.g. to show that the double mutants display the expected PP1-binding 
characteristics. It would also be useful to test genetic interactions between pico, 
MAPK and PP1 mutants to provide further evidence of the functional interactions. 
An outstanding question is what are the targets of Pico-associated PP1? If MAPK 
phosphorylates Pico to regulate PP1 binding, then what does PP1 dephosphorylate? 
One possibility is that PP1 dephosphorylates a Pico-associated protein, such as Ena 
or Chic/Profilin, or another actin-associated protein to fine tune the effects on the 
actin cytoskeleton. 
 
Finally, it should be said that the work in this thesis focusses on the analysis of pico 
gain-of-function. This is particularly relevant to understanding the roles of pico in 
aberrant situations, such as cancer, where MRL proteins are overexpressed. 
However, future work should also assess the effect of disrupting physical 
interactions between endogenous Pico and its binding partners, which will provide 
insights into the importance of regulatory mechanisms during normal development. 
This could be achieved by expressing the pico transgenes reported in this thesis in a 
mutant background or by using gene-editing approaches to engineer the site-directed 
mutations into the native locus. Given the homology between Pico and its human 
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orthologues, it will also be interesting to test whether regulation of MRL function by 
serine/threonine phosphorylation is conserved in human cells.  
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